A Flow Cytometric Study of the Cellular Changes During Rat Hepatocarcinogenesis. by Walker, Karen A.
A flow cytometric study of the cellular changes 
during rat hepatocarcinogenesis
Karen A, Walker
A thesis submitted for the degree of Doctor of 
Philosophy in the University of Surrey
MRC Toxicology Unit 
Woodmansterne Road 
Carshalton
Surrey September 1985
ProQuest Number: 10804107
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10804107
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
Abstract
In this study, a range of phenotypic markers were examined 
including membrane, cytoplasmic, and nuclear features which 
undergo alteration following transformation. To enable the flow 
cytometric analysis of these markers, a number of methods of 
fluorescently tagging the cells having a particular feature were 
examined. These included fluorescent dyes, fluorogenic substrates 
for enzyme markers, and fluorochromes conjugated to antibodies.
Aflatoxin is known to have a considerable effect on the 
normal rat liver cell ploidy pattern. Flow cytometric analysis of 
cells and nuclei stained with a dye which intercalates into DNA, 
showed that the carcinogen induces division of the tetraploid 
population and those cells having two diploid nuclei.
Three enzymes, previously reported to be associated with 
transformation, y-glutamyl transpeptidase, alkaline phosphatase, 
and guanidinobenzoatase, were studied with respect to rat 
hepatocarcinogenesis using fluorogenic substrates for the 
enzymes. On reaction with enzyme positive cells, the fluorescent 
products of soluble substrates appeared to become associated with 
the enzyme-negative cells preventing distinction of the two 
populations. Non-soluble fluorogenic substrates, however, allowed 
analysis and quantitation of those cells having the enzyme.
The effect of aflatoxin on the development of cellular 
resistance to a number of xenobiotics was monitored, flow 
cytometrically, by the cells' sensitivity to adriamycin and by 
the relative cellular concentration of glutathione and 
glutathione-S-transferase. It appeared that the carcinogen has an
effect on the degree of resistance to xenobiotics of all the 
cells in the liver, although a proportion of the cells showed a 
greater resistance than the main cellular population.
The use of antibodies to fluorescently tag certain 
populations of cells was also studied. This proved to be a 
technically simple method of staining the cells, however the 
importance of having an antibody which will successfully mark all 
the cells having the antigen of interest was demonstrated.
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Chapter 1 General introduction
/
1.1 General introduction to liver carcinogenesis
(a) Carcinogenicity of aflatoxin B1
A large number of chemical carcinogens including 
nitrosamines (Magee and Barnes, 1967), 2-acetylaminofluorene 
(Farber, 1956), and aflatoxins (Butler and Barnes, 1963) were 
shown by early workers to exert their effect on the liver. 
Aflatoxins are the secondary metabolites produced by the mould 
Aspergillus flavus which grows on peanuts. It was the toxin which 
caused the outbreak of turkey *Xr disease in 1960. The disease 
has also been reported in other animals including pigs and cattle 
and in each case there was pathological evidence of acute liver 
necrosis (Newberne and Butler 1969). Clifford and Rees in 1967 
investigated the mechanism of action of aflatoxin B1 and 
concluded that the toxin inhibits the production of nuclear RNA, 
probably by preventing the transcription of DNA by RNA 
polymerase. These authors also suggested that aflatoxin B1 might 
have some effect on the cell membrane since they found leakage of 
hepatic enzymes into the serum.
Neal and Butler (1978) demonstrated that feeding of Fischer 
344 rats with 4ppm aflatoxin Bj contaminated diet for more than 3 
weeks induced neoplasia in the liver. An histological examination 
of the rat livers, during a 6-week period of feeding with the 
carcinogen, showed proliferation of oval cells and bile ducts
after 3 weeks, followed by parenchymal cell necrosis, and then 
extensive parenchymal cell proliferation. In parallel with the 
histological study, zonal centrifugation of isolated hepatocyte 
nuclei showed alterations to the normal ploidy patterns as 
described by Johnson et al.. (1968). A decrease in the numbers of 
tetraploid nuclei, and a corresponding increase in the diploid 
population, as compared to age matched controls, was observed. 
Another interesting feature of aflatoxin Bj feeding is the 
generation of a population of hepatocytes resistant to the toxin 
(Judah et al.. 1977). Other carcinogens have been reported to 
similarly induce a resistant hepatocyte population (Solt et al.. 
1980). This resistance may be a consequence of the increased 
levels of glutathione observed during carcinogen feeding (Judah 
et al.. 1977, Fiala et al.. 1976).
(b) Phenotypic changes during carcinogenesis
Chemically induced rat hepatocarcinogenesis has been used in 
many studies designed to examine the origin and development of 
neoplasia. The process resulting in hepatocellular carcinoma 
seems to be a series of stages each of which has been extensively 
reported.
After short-term administration of a carcinogen, nodules of 
changed cells can be observed in sections of the liver. 
Conventional histological staining with haematoxylin and eosin 
will reveal what are termed 'hyperplastic nodules', that is areas 
of cell proliferation easily distinguished from the normal 
quiescent liver cells. If histochemical staining techniques are
employed, 'enzyme-altered foci' will be visible. Many 
hyperplastic areas when histochemically stained do show 
alterations from the normal enzymic phenotype so the terms are 
not exclusive and areas of liver showing either or both of these 
phenomena will be refered to as preneoplastic. Cells which 
compose these areas seem to have the potential to become 
hepatocellular carcinomas, but will not necessarily do so.
Much of the work involving the use of hepatocarcinogens has 
been conducted to examine the concepts of initiation and 
promotion. Farber (1984) considers the hyperplastic nodules, or 
enzyme-altered foci induced by short-term carcinogenic 
administration to be 'initiated cells'. If carcinogen 
administration is continued, or if another cell proliferative 
regime is used e.g. phenobarbitone or partial hepatectomy, then 
promotion is considered to take place, and neoplasia will result. 
A complete carcinogen is defined as a substance able to induce 
both initiation and promotion.
After initiation very many preneoplastic foci can be 
observed in sections of liver, however only a very few of these 
foci persist during promotion to become hepatocellular 
carcinomas. Tatematsu et al.. (1983) have shown for one
carcinogenic model that the regression of foci Is a result of 
redifferentiation of the changed cells to phenotypically normal 
appearing liver. Farber (1980) has suggested that promotion is 
the result of the initiated cells having acquired resistance to 
the cytotoxic effects of the carcinogen. While proliferation of 
the normal hepatocytes is inhibited, the resistant initiated 
cells can respond to cell proliferative stimuli. Thus the
initiated cells during promotion undergo clonal expansion. 
Alternatively it has been suggested that another type of 
alteration is required for promotion (Williams, 1980, Emmelot and 
Scherer, 1980). Emmelot and Scherer suggested that resistance to 
cytotoxity of the carcinogen induced in normal hepatocytes could 
give rise to foci of enzyme-altered cells which are not 
preneoplastic and are reversible in phenotype. These authors 
hypothesise that it requires two carcinogenic 'hits' i.e. genetic 
alterations, to induce the true precancerous state. However, as 
yet, it is unclear what determines a focus of initiated cells to 
regress or to continue to proliferate and eventually become liver 
cancer. Hepatocellular carcinoma is considered to have been 
established when the neoplastic cells can be seen to invade into 
the surrounding tissue, and when metastases are present, usually 
in the lungs. The altered focus does seem to be the earliest 
detectable stage in the carcinogenic process, and the emphasis of 
this study will be on some of the phenotypic changes observed at 
this time. A number of properties of cells thought to be in this 
premalignant state are listed in Table 1.
Table 1.1
Some of the cellular changes observed in hyperplastic nodules of 
rat liver induced by chemical carcinogens.
Phentotypic change Reference
Increased gamma glutamyl transpeptidase Kalengayi et al., 1975
Increased alpha-fetoprotein Sell, 1978
Reduced glucose-6-phosphatase Goldfarb,1973
Reduced adenosine triphospatase Scherer et al.. 1972
Increased glutathione content Demi and Oesterle 1980
Resistance to iron accumulation Yamamoto et al.. 1971
Altered metabolism of glycogen Bannasch, 1976
Resistance to cytotoxicity Solt dt al., 1980
Changes in nuclear ploidy Schwarze et al.. 1984
Increased alkaline phosphatase Karasaki, 1975
(c) Oncogenes and carcinogenesis
It is now well established that carcinogenesis is a 
multistage process consisting of a number of 'rare events' which 
can be separated by prolonged time intervals (Farber and Cameron, 
1980). Some of the features of initiation and promotion by 
chemical carcinogens have been discussed above. Recently there 
has been considerable interest in transforming genes and the part 
which they may play in the process of carcinogenesis. Evidence 
has been obtained that a single point mutation in the nucleic 
acid sequence of a human normal cellular oncogene c-Ha-ras. 
leading to an amino acid substitution in the gene translation 
product, is solely responsible for its transforming potential 
(Reddy et al.. 1982). NIH 3T3 cells, a mouse fibroblastic cell 
line, can be induced to undergo transformation following 
transfection with activated ras oncogene. However it has been 
suggested that these cells are already preneoplastic (Cooper and 
Lane, 1984). Further, studies of the transforming activity of 
activated Ha-ras when transfected into primary cultures of 
hamster (Newbold and Overall, 1983) and rat embryo (Land et al..
1983) fibroblasts have resulted in no transformed colonies of 
cells, as assayed by focus formation. Despite this, both groups 
observed that the activated ras oncogene did confer anchorage 
independence upon the hamster and rat embryo fibroblast cells.
Land et al. (1983) then transfected rat embryo fibroblasts 
with another oncogene, activated mvc. This had no apparent effect 
on the cellular phenotype. However if Ha-ras and mvc were applied 
together to the cells, many foci of transformed cells resulted.
It has been suggested, therefore, that some of the 67 identified 
oncogenes may be involved in the early stages of carcinogenesis,
and others in the later stages of the disease (Cooper and Lane,
/
1984).
Normal cellular oncogenes have been described as 
'proto-oncogenes', and these also have the potential to be 
oncogenic if improperly expressed (Shih and Weeks, 1984). 
Recently, c-Ha-ras oncogene was found by Northern blot analysis 
of total RNA to be elevated in tumour derived from the liver of 
rats treated with 3'-methyl-4-dimethylaminoazobenzene. 
Non-tumourous areas from the same livers and hepatoma derived 
cell lines also expressed elevated cellular ras. The cellular mvc 
gene was found to be elevated only in the tumour cells and the
hepatoma cell lines (Makino et al.. 1984). The authors have
suggested that elevation of cellular ras may be related to
hepatocyte proliferation and increased levels of c-mvc with 
hepatocarcinogenesis.
It is therefore possible that phenotypic changes observed 
during the process of carcinogenesis are related to the presence 
of an activated oncogene or oncogenes and/or elevated cellular 
oncogenes. In both cases the normal mechanisms for cellular
growth control appear to be involved (Bishop, 1982). If this is 
correct, the phenotypic changes which occur during neoplasia may 
become particularly important when methods of therapy are 
considered, since attempts to alter cancer cell growth may affect 
the normal cell population also. In this study, phenotypic 
changes in hepatocytes have been monitored during treatment of 
rats with the hepatotoxin and carcinogen aflatoxin B^. In
addition, some preliminary studies have been made of changes in 
the phenotype of epithelial cells into which has been introduced 
the activated oncogene ras.
1.2 General introduction to flow cytometry
(a) Mode of operation
The advent of flow cytometry has allowed the characteristics 
of individual cells, in large numbers, to be analysed and 
subpopulations to be recognised. This differs from conventional 
biochemical analysis where subpopulations of cells may be 
undetected when results are averaged for each cell. In addition, 
cell subgroups revealed during flow cytometric analysis can then 
be sorted from the rest of the cell population.
The flow cytometers in use today evolved from the Coulter 
counter which measures the volume of cells made to flow in single 
file, and was the first automated blood counter. The three most 
widely used machines now are the Cytofluorograf instruments made 
by Ortho Diagnostics Inc., Westwood, M.A., the Fluorescence 
Activated Cell Sorter (FACS) made by Becton-Dickinson, FACS 
Systems, Sunnyvale, C.A., and the Coulter EPICS series of cell 
sorters. Coulter Electronics Inc., Hialeah, F.L. In this study, 
an Ortho Cytofluorograf System 50-H was used.
Flow cytometers require the sample for analysis to be in the 
form of a single cell supension. The sample is introduced into a 
flow chamber where it is surrounded by a sheath fluid. 
Differences in pressure of the sample stream and the sheath fluid 
result in the cells in the sample being drawn into single file. 
The cells then pass through the beam of a light source - usually 
a laser tuned to a specific wavelength. When a cell passes into 
the laser beam, light will be scattered, and if the cell is
stained with a fluorochrome, light of a different wavelength will 
be emitted. Scattered light and fluorescence emission is then 
passed through a series of optical filters and mirrors which 
allows light of different wavelengths to be collected by 
appropriately positioned optical fibres and conducted to separate 
photomultiplier tubes (Fig 1.1). The data signals are then passed 
from the photomultiplier to a computer system where the data can 
be stored and analysed.
The amount of light scattered when a particle passes through 
the light beam may be proportional to the size of the particle, 
however other factors can influence light scatter. The shape, 
refractive index and granularity of the particle also affect the 
forward angle scatter, and therefore this parameter cannot be 
directly related to cell size.
90° light scatter appears to be mostly due to light 
reflected from the cells' internal structure and therefore is 
used as an index of granularity of the cell. Analysis of forward 
angle scatter and 90° scatter of the incident light beam allows 
the subgroups within the general leucocyte population to be 
ditsinguished and the relative proportions evaluated without the 
need for fluorescent markers.
The emitted fluorescence from a cell stained with a 
fluorochrome or fluorogenic substrate is however the most 
commonly used parameter.
To quantitate the number of cells in a specific subgroup of 
a large population, the required cells are 'gated', that is the 
upper and lower limits of the parameters being measured are 
defined by means of the computer. Gating of a certain group of
Fig 1.1 Diagram of the light collection system of the Ortho 
Cytofluorograf.
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cells is also used when subpopulations are to be sorted from the 
general populations. Saline sheath fluid is used when cells are 
to be sorted allowing the entire sample stream to be momentarily 
charged when the. appropriate signal is detected. As the stream 
exits from the flow chamber, vibration due to a transducer fitted 
to the bottom of the flow cell causes the stream to break into 
many thousands of droplets per second. A droplet containing a 
required cell will be charged and deflected into a collection 
vessel when it passes between two electrostatically charged 
plates. It is possible to sterilise the equipment in order to 
culture viable cells which have been sorted.
(b) Applications
The range of applications of flow cytometry is very large, 
and increases as new fluorochromes and fluorogenic substrates are 
developed. Multiparameter analysis has been made possible by 
combinations of fluorochromes and dual-wavelength excitation.
(i) DNA analysis
Analysis of cellular DNA content by flow cytometry is now a 
relatively simple procedure and is being increasingly employed as 
a method of determining effects on specific cell populations e.g. 
the effect of toxic substances at different stages of the cell 
cycle (Skilleter et al.. 1983), and also for the detection of 
malignant cells which tend to have an aneuploid amount of DNA 
(Braylan et al.. 1984). A number of fluorescent stains which
stoichiometrically bind to DNA are used, Propidium iodide 
(Krishan, 1975) and ethidium bromide (Nicolini et al.. 1977)
which intercalate into double stranded nucleic acids are 
frequently chosen because of their ease of use. As these dyes 
will stain ENA also, cells must be treated with RNase for DNA 
analysis.
Another group of DNA fluorochromes are those which bind 
noncovalently to specific base pairs, for example mithramycin 
(Crissman and Tobey, 1974) which binds preferentially to the 
guanine-cytosine rich regions of DNA and the bis-benzimidazole 
dyes Hoechst 33258 and 33342 (Arndt-Jovin and Jovin, 1977), which 
bind to adenine-thymine rich regions. The latter dyes are 
reportedly vital stains and have been used to sort viable cells 
of specific DNA content (Lydon et al.. 1980) A third of these 
base pair binding dyes, 4'-6-diamidino-2-phenylindole (DAPI) has 
been used to stain for the DNA content of paraffin-embedded human 
tumours allowing flow cytometric analysis of archival material 
(Hedley et al.. 1983).
(ii) Surface properties
Another major application of flow cytometry is the detection 
of cell surface antigens. An early example was the sorting of T 
and B lymphocytes on the basis of membrane-bound immunoglobulin 
by Kreth and Herzenberg (1974). Lovett et al. (1984) have 
extensively reviewed the use of monoclonal antibodies and flow 
cytometry in the fields of haemopathology and immunopathology. 
Other examples are the use of monoclonal antibodies to screen a
number of cell lines for cellular oncogene product (Drebin 
et al.. 1984), and as an alternative method for cell-cycle 
analysis (Dean et al.. 1974)
Fluorescein isothiocyanate (FITC) is most frequently used as 
the fluorescent tag when antibodies are being employed for flow 
cytometric analysis of surface antigens. Two colour 
immunofluorescence can be achievied using FITC in combination 
with Texas Red (Titus et al,. 1982), which requires excitation at 
two wavelengths and hence two lasers, or phycoerythrin (Oi 
et al.. 1982) which requires exciting light at one wavelength
only and hence only one laser is required.
(iii) Other applications
Enzyme activity and kinetics have also been determined by 
flow cytometry. The sensitivity of fluorogenic substrates has led 
to their increasing use in conventional biochemical studies, and 
the substrates have been adapted for use with flow cytometers 
(Dolbeare and Smith, 1977, Durand and Olive, 1983).
Individual chromosomes in metaphase can be distinguished in 
the flow cytometer and karyotyping can be achieved giving far 
greater accuracy than visual analysis (Langlois et al., 1982).
Studies of differential uptake and retention of fluorescent 
anticancer drugs into normal and resistant cells have also been 
conducted using the flow cytometer as a tool (Krishan and 
Ganapathi, 1980, Austin et al,. 1984).
Pure populations of lung cells have been isolated by using 
the fluorescent probe phosphine-BR, a lipid-seeking molecule
which specifically stains the type II cells which have a high 
phospholipid content (Leary et al.. 1982),
Flow cytometers have also been used for the evaluation of 
antigenic distribution on bacterial spores and vegetative cells 
(Phillips and Martin, 1983), This may be important as a method 
for the detection of viral antigens expressed in a host cell.
Some of these applications will be discussed in greater 
detail in the chapters which follow.
(c) Separation of neoplastic cells from normal liver cells
No reports appear in the literature to date attempting to 
separate transformed liver cells from normal liver cells using 
the flow cytometer. However, attempts have been made to isolate 
pre-neoplastic cells from rat liver after feeding of the animal with 
a carcinogen using other techniques. Mori et al. (1982) loaded 
rats with iron after feeding 2-acetylaminofluorene and then 
isolated the hepatocytes by collagenase perfusion. The cells were 
then fractionated on Ficoll gradients, and the percentage of 
cells excluding iron and positive for GGT (i.e. the altered 
cells) was determined for each fraction. This method gave 
enrichment of cells from altered foci, but complete purification 
was not achieved. Hanigan and Pitot in 1982, attempted to isolate 
gamma-glutamyl transpeptidase positive cells by incubating 
hepatocytes from rats also fed 2-AAF on Petri dishes coated with 
an antibody to GGT. However this resulted in isolation of only 
15% of the GGT positive cells in the total population of 
hepatocytes.
The separation of preneoplastic, neoplastic and normal cells 
from the livers of animals fed a carcinogenic regime would appear 
to be an area in which the flow cytometer could make a
t
contribution. In the study reported here, some of the changes 
which occur in rat hepatocytes during aflatoxin induced 
carcinogenesis, are examined for their suitability for use in the 
flow cytometer and are assessed for their possible value in 
sorting early changed cells from the general population.
Chapter 2 Materials and Methods
2,1 Materials
Agfa-Gevaert Osray M3 Photographic film, Dunstable, Bedfordshire 
Apathy's mounting medium, Raymond Lamb, London,
Argyle medicut cannula, Arterial Medical Services, London. 
Bio-Rad silver staining kit, Bio-Rad Laboratories Ltd, Watford. 
Collagenase, Boehringer-Mannheim, Lewes, Sussex.
Foetal calf serum. Imperial Laboratories Ltd, Salisbury. 
Gentamycin 10 mg/ml, Gibco Europe, Paisley, Scotland.
Goat anti mouse IgG, Miles Laboratories Ltd, Stoke Pages, Slough 
Bucks.
Goat anti rabbit IgG, Miles Laboratories Ltd.
Hanks balanced salt solution, Gibco Europe.
Heparin 1000 units/ml, Vestric Ltd, Croydon, Surrey.
L-glutamine 200 mM solution,Imperial Laboratories. 
L-y-glutamyl-7-amino-4-methyl coumarin. Universal Biological 
Ltd., London.
[*5S]methionine, (specific activity, 14.44 mCi/ml), The 
Radiochemical Centre, Amersham, Bucks.
Monobromobimane, Calbiochem-Behring c/o Cambridge BioScience, 
Hardwick, Cambridge.
Millipore filter (0.2 p), Sera-Lab, Crawley Down, West Sussex. 
N«-benzoylarginine-7-amino-4-methyl coumarin hydrochloride. 
Universal Biologicals.
N^-dansyl-homoarginine, Gift from Dr F.S,Steven, University of 
Manchester.
xy
N-(L“y-glutamyl)-4-methoxy 2-napthylamide, Universal Biological 
Ltd.
5-nitrosalicylaldehyde, Eastman Organic Chemicals, Kodak Ltd, 
Kirkley, Liverpool.
Normal mouse serum, Serotec, Bicester, Oxon.
Nybolt nylon bolting cloth, John Staniar and Co Ltd, Manchester. 
Petri dishes Lux, Flow Laboratories, Irvine, Scotland.
Sagatal, May and Baker, Dagenham, Essex.
Sodium bicarbonate 7.5%, Flow Laboratories.
iVc-W.
[*H]thymidine, (specific activity, 1 mCi/m/), The Radiochemical 
Centre.
Trypsin, Imperial Laboratories Ltd.
Whatman filter paper, Whatman Labsales Ltd, Maidstone, Kent. 
Williams'E Medium, Flow Laboratories.
All other chemicals used were obtained from Sigma Chemical Co., or 
BDH Chemicals Ltd., both of Poole, Dorset.
2.2 Animals
In the AFBj^  feeding experiments described, male rats of the 
inbred Fischer strain 344 were used. The male of this strain is 
particularly sensitive to the effects of AFB^ and thereby 
provides a good model for hepatocarcinogenesis.
The rats were housed in plastic and wire cages containing no 
more than 6 rats per cage, in an environmentally controlled room 
at 19 C + 2 C with a humidity of 50% + 10%, and a lighting cycle
of 12 hours. Animals were allowed feed (MRC 4IB pellets) and
water ad libitum.
Balb/c mice were used for the raising of antibodies. The 
mice were treated similarly to rats in the same environmental 
conditions and were fed expanded MRC 41B pellet and allowed water 
ad libitum.
New Zealand White rabbits were also used for antibody
production. The rabbits were housed in wire cages with natural 
lighting and temperature conditions, and were allowed rabbit
pellets and water ad libitum.
2.3 Cell culture techniques
(a) Subculturing of cell lines
Cells were grown on plastic petri dishes in Williams* E 
Medium (WEM), containing 2 mM glutamine, 0.05 mg/ml gentamycin 
and 5% foetal calf serum (FCS) (refered to as complete WEM). On 
attaining confluency, the cells were subcultured as follows: The 
medium was aspirated and replaced with an equal volume of 0.25% 
trypsin in phosphate buffered saline (PBS) for 2 min at room 
temperature. The trypsin solution was then removed and the cells 
were incubated at 37°C for approximately 8 min or until the cells 
began to detach from the petri dish. The cells were washed from 
the dish with fresh complete WEM and diluted appropriately, 
usually 1:3 or 1:4 before reseeding onto petri dishes.
(b) Harvesting cells for subsequent staining
Cultured cells were harvested for subsequent staining by 
detaching from petri dishes using trypsin as described above and 
washing from the dish with PBS or Hank's balanced salt solution 
(HBSS) buffered to pH 7.0 by the addition of sodium bicarbonate 
and containing 5% foetal calf serum. Generally the cells were 
pelleted by low speed centrifugation (50 x g) and washed by 
resuspension in PBS or HBSS.
(c) Isolation of hepatocytes
Hepatocytes were isolated from rats by collagenase perfusion 
by a modification of the technique of Berry and Friend (1969), 
and of Seglen (1972), as described by Paine and Legg (1978).
The animal was anaesthetised by intraperitoneal injection of 
Sagatal (0.2 ml per lOOg body weight). The abdomen was opened and 
the hepatic portal vein exposed. Two lengths of cotton thread 
were placed around the hepatic portal vein and the bile duct, and 
the hepatic portal vein was cannulated using an Argyle Medicut 
intravenous cannula (16 or 18 gauge by 45 mm) containing heparin 
(1000 units/ml). The cannula was ligated securely using the 
cotton threads and the descending vena cava was then cut. The 
liver was perfused at a rate of 50 ml/min with HBSS without 
calcium or magnesium, buffered with sodium bicarbonate and 
oxygenated with 95% 02 :5% CO^ (v/v), to maintain the acidiity at 
pH 7.4. While the liver was perfusing with the perfusate running 
to waste the liver was excised and placed on a platform above a 
reservoir of HBSS, and the apparatus was switched to a closed 
circuit perfusion. The total volume of perfusate was 
approximately 100 ml to which was added a solution of collagenase 
of 20 mg in 10 ml HBSS prefiltered through a 0.2 micron Millipore 
filter. The perfusion was continued at 50 ml/min and 37°C for 
approximately 30 min until the liver showed signs of breaking up. 
The liver was then transferred to a glass measuring cylinder and 
gently agitated with a glass rod in a total volume of 50 ml of 
HBSS containing 2.5% FCS. The FCS was included to inhibit the 
collagenase from further digestion of the cell membranes. The
cell suspension was then transferred into a 250 ml round bottomed 
flask, and gently rolled for 3 min to further disperse the cells 
(Drochmans et al. 1975). The cell suspension was then filtered 
through nylon bolting cloth (125 micron pore size) to remove 
large clumps of cells and debris. The cells were then washed and 
centrifuged 3 times at 50 x g for 2-3 min in complete WEM.
This washing procedure results in purification of the 
hepatocytes with loss of the non-parenchymal cells (e.g. 
endothelial cells, fibroblast and Kupffer cells) as a result of 
their differing cell densities.
The cell viability was assessed by exclusion of 0.1% trypan
blue in PBS using a haemocytometer. Cell viabilities of between
75-90% were routinely obtained.
For studies of liver cell division by bromodeoxyuridine 
(BudR) incorporation, the cells were seeded at a density of 6 x 
10* cells on a 100 mm diameter petri dish in WEM. Additions were 
as described in Chapter 2.10 (b) and Chapter 5.
For staining of hepatocytes as described in Chapter 3, the 
cells were generally washed twice in PBS or HBSS containing 
calcium and magnesium pH 7.0 to remove phenol red which can
affect fluorescence emission.
In some studies of fluorescent staining, aliquots of
hepatocytes were incubated with 1.62 mg/ml CCl^ in HBSS for 15 
min to disrupt the plasma membrane. The effectiveness of this 
treatment was confirmed as the cells failed to exclude trypan 
blue.
2.4 Quantitative assays for possible marker compounds for 
neoplasia
(a) y-glutamyl-transpeptidase (GGT) quantitation
(i) Assay of GGT content of cell lines
GGT was assayed quantitatively by the method of Smith et al. 
(1979) as follows:
Reagents: 10 mM L-y-glutamyl-7-amino-4-methyl coumarin in
methoxyethanol
10 mM 7-amino-4-methyl coumarin (AMC) in 
methoxyethanol
0.1 M ammediol/HCl buffer pH 8.5 
50 mM glycine buffer pH 10.4
Substrate solution: 200 pM L-y-glutamyl-AMC in ammediol/HCl pH
8.5 containing 20 mM glycylglycine and 0.1% Triton-X-100
Method: Cells were removed from the plate with trypsin (Chapter
2.3 (a)) and after washing and resuspending in PBS were disrupted 
by being ultrasonicated using a Dawe Soniprobe (Dawe Instruments 
ltd., Western Avenue, London) at 2 amps for 10 s. Loss of 
cellular structure was confirmed by microscopic examination. The 
enzyme activity was then assayed by adding 100 pi of the 
disrupted cell suspension appropriately diluted to 250 pi of 
substrate and incubating at 37 C for 10 min. The reaction was
stopped by the addition of 2 ml of ice-cold glycine buffer. 
Non-specific activity was monitored by the addition of the 
inhibitors of GGT 5 mM serine and 10 mM sodium borate (Meister 
et al.. 1981) to the substrate solution. A standard curve was 
prepared by making duplicate 0.2-20 pM solutions of AMC in 
ammediol buffer. A standard curve was included each time GGT was 
measured. Fluorescence was measured in a Perkin-Elmer LS-5 
fluorimeter (Perkin-Elmer Ltd., Beaconsfield, Bucks.), excitation 
370 nm and peak emission 440 nm. Results were expressed as nmoles 
AMC produced/min/10* cells.
(ii) Assay of GGT content of liver samples
Samples of liver tissue from control and AFB fed rats were 
weighed and homogenised in 2 ml PBS using an IKA Ultraturrax 
(Janke and Kurikel Gmbh and Co., Staufen, W. Germany) (30 s). 
Appropriate dilutions of the homogenate were made in 0.1 M 
ammediol/HCl buffer pH 8,5, and 100 pi aliquots were assayed for 
GGT as described above.
(b) Alkaline phosphatase quantitation
The method for the quantitation of alkaline phosphatase was 
adapted from that of Torriani (I960). In this method, 
p-nitrophenol phosphate is the substrate and the p-nitrophenol 
released by enzymatic hydrolysis can be measured
spectrophotometrically. In alkaline solution, p-nitrophenol 
absorbs at 405 nm, whereas the substrate does not absorb at this 
wavelength.
Reagents: 0.1 M sodium carbonate-bicarbonate buffer pH 10.0 
5 mM p-nitrophenol phosphate substrate solution in 
alkaline buffer
0.05 mM p-nitrophenol standard in alkaline buffer
Method: 0.8 ml of carbonate-bicarbonate buffer was added to 2 ml 
of substrate solution and thoroughly mixed. At zero time, 0.2 ml 
of cell sonicate (as prepared in Chapter 2.4 (a) (i))
appropriately diluted in PBS was added and the change in 
extinction at 405 nm followed. To prepare the standard curve, a 
range of p-nitrophenol solutions was prepared from the standard 
solution and a graph of extinction against concentration was 
plotted. A standard curve was included each time alkaline 
phosphatase was measured. Results were expressed as nmoles of 
p-nitrophenol produced /min/10* cells.
(c) Quantitation of intracellular adriamycin content
Cells lines grown on 100 mm petri dishes were washed twice 
with HBSS pH 7.0 (to remove phenol red) and incubated with 
adriamycin made up to the required concentration in HBSS. Cells 
were then incubated with the drug for 3 hours at 37 C.
After incubation, the medium containing the drug was 
removed, and the cells detached from the plate with trypsin in
PBS as described in Chapter 2.3 (b). The cells were then washed 
in HBSS.
Adriamycin was extracted from the cells by resuspending the 
cells pooled from duplicate plates in 2 ml of 0.3 M HC1 in 50% 
ethanol and briefly ultrasonicating using a Dawe Soniprobe (2 
amps for 10 s). Microscopic examination confirmed that the cell 
structure was completely disrupted. The sonicates were then 
centrifuged at 50,000 g for 30 min to remove cellular debris 
prior to fluorimetry.
The amount of adriamycin present was determined by measuring 
the fluorescence peak of each sample on a Perkin-Elmer LS-5 
fluorimeter. Excitation wavelength was 420 nm and emission peak 
determined by scanning between 580 and 590 nm. Adriamycin was 
quantitated by reference to a standard curve of molarity of 
adriamycin plotted against fluorescence emission (Fig 2.1). A 
standard curve was prepared for each experiment by measuring the 
fluorescence of the adriamycin solutions which were used for the 
cell incubations. The number of cells per plate was determined by 
counting in a haemocytometer counting chamber and the results 
were expressed as pg of adriamycin per cell.
(d) Quantitation of glutathione (GSH) content of JB1 and BL9L 
cells
To quantitate the GSH content of JB1 and BL9L cells, the 
cells were harvested from petri dishes (Chapter 2.3 (b)), and 
resuspended in PBS to give approximately 10* cells/ml. 1 ml of 
cell suspension was then sonicated and incubated with 60 pi of
4# U
Fig 2.1 Standard curve of adriamycin concentration.
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1 mM monobromobimane (mBrB) (in acetonitrile) and 20 pi of 10,000 
g mouse supernatant containing glutathione S-transferases 
(GSH-transferases). 1 ml of 0.1 mM Tris MgCl^ buffer pH 7.7 was
added and the cell sonicate incubated for 15 min at room 
temperature. Cellular material was spun down by centrifugation 
for 30 min at 50,000 g. GSH standards of between 0 and 0.05 
pmoles were incubated with 20 pi of GSH-transferase preparation 
and 60 pi of 1 mM mBrB. Volumes were made up to 2.08 ml.
The fluorescence in samples and standards was measured on a 
Perkin-Elmer LS-5 fluorimeter, excitation wavelenght 400 nm and 
emission wavelength 475 nm. Results were expressed as pmoles 
GSH/10* cells.
2.5 Histochemical staining for marker compounds
(a) Histochemical stain for GGT
For the histochemical determination of GGT the method of 
Rutenberg et al (1969) was adapted as follows:
Reagents: N-(L-y-glutamyl)-4-methoxy 2-napthylamide (GMNA)
Fast blue B.B. 
glycylglycine
0.1 M phosphate buffer pH 6.7
Method: 2.5 mg GMNA was dissolved in 6 ml of 0.1 N NaOH 
containing 1.8% NaCl. When in solution 8 ml of phosphate buffer
was added, and then 6 ml of 0.1 N HC1. 10 mg fast blue and
58.8 mg glycylglycine were then dissolved in the substrate 
solution.
Sections prepared by fixation in cold (0 C - 4 C )  acetone 
and embedded in paraffin wax were dewaxed in xylene and 
rehydrated before rinsing in distilled water. Sections were 
liberally covered with the substrate solution, and colour was 
allowed to develop during 10-15 min incubation at 25 C. Following 
incubation, sections were rinsed in 0.9% normal saline and then 
covered with 0.1 M copper sulphate solution for 2 min, then 
rinsed again with saline. Sections were counterstained with 
haematoxylin for 2 min and rinsed in tap water and then distilled 
water before mounting in Apathy's aqueous mounting medium.
Cells on culture dishes were stained for GGT by first fixing 
the cells with 70% ethanol for 10 min and then staining as 
described for fixed sections above.
(b) Histochemical stain for alkaline phosphatase
Cells grown as monolayers on glass coverslips or on culture 
dishes were washed with PBS twice and fixed in cold acetone for 
at least 10 min and no more than 24 hours, or in 70% ethanol for 
5-10 min. The fixative was removed and the cells washed with PBS.
Paraffin embedded sections of acetone fixed liver were 
dewaxed in xylene and rehydrated through ethanol and finally 
rinsed in distilled water.
The cells or liver sections were then stained using an 
adaptation of the method of Burstone (1961).
Reagents: Fast red TR
Napthol AS-BI
0.05 M Veronal acetate buffer pH 9.2
t . ■
Method: 10 mg of fast red TR and 10 mg napthol AS-BI were 
dissolved in 20 ml of veronal acetate buffer. The cells or 
sections were liberally covered with substrate solution and the 
colour allowed to develop - about 20 min. The substrate was then 
washed off and in some cases, the cells or sections were 
counterstained with Gills No. 2 haematoxylin for 2 min.
(c) Histochemical stain for guanidinobenzoatase
Paraffin embedded sections of liver fixed in formalin were 
dewaxed in xylene and rehydrated through alcohol to distilled 
water. The sections were then washed in isotonic NaCl before 
incubation for 2 min with 1 mM 9-aminoacridine in water 
containing 0.01 mM N-tosyl-L-lysine chloromethylane. The sections 
were then washed for a total of 6 min in isotonic NaCl, changing 
the washing solution 3 times. Frozen sections were also stained 
by this method. The sections were water mounted and coverslips 
sealed. The sections were examined under a Leitz Ortholux 2 
fluorescent microscope (Ernst Leitz Wetzlar Gmbh, V. Germany) 
fitted with filter block A giving UV excitation and having a long 
pass 430 nm emission filter. Photographs were taken on ASA 400 
colour film.
2.6 Fluorescent staining of marker compounds for flow cytometry
(a) Staining for DNA
Nuclei isolated by centrifugation of liver homogenates in 
sucrose (Chapter 2.9 (c)) were stained for DNA by incubating in 
0.005% ethidium bromide in PBS containing 0.05% ribonuclease 
(RNase) for 5 min at a density of 0.5 x 10* nuclei/ml.
Nuclei from hepatocytes prepared by collagenase perfusion 
(Chapter 2.3 (c)) were isolated and stained for DNA by incubation 
in 0.005% ethidium bromide, 0.1% sodium citrate, 0.1% 
Triton-X-100 and 0.05% RNase. This medium disrupts the plasma 
membranes releasing the nuclei. However microscopic examination 
revealed that some cytoplasm remains around the nuclei. This 
resulted in poor fluorescent profiles in the flow cytometer, the 
fluorescence peaks being broad due to variation in the amount of 
cytoplasm attached to each cell contributing to the nuclear 
fluorescence. Therefore the cells in suspension were 
ultrasonicated with a Dawe soniprobe at 1 amp for 5 s to free the 
nuclei from the remaining cytoplasm. After sonication, nuclei 
stained orange and completely free of cytoplasmic contamination 
could be observed by fluorescence microscopy. (Fig 2.2 and 2.3).
Nuclear staining of intact cells was achieved by preincubating 
hepatocytes with 0.1% RNase and 0.02% Triton-X-100 for 30 min at 
37 C. This preincubation was required to prevent cytoplasmic RNA 
staining. The cells were then stained in 0.005% ethidium bromide 
in PBS containing 0.02% Triton-X-100. The addition of this 
concentration of Triton-X-100 allowed penetration of ethidium
Fig 2.2 Hepatocytes stained with ethidium bromide in sodium 
citrate solution containing Triton-X-100 and RNase.
Fig 2.3 Sample of nuclei shown in Fig 2.2 after 
ultrasonication.
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bromide into the cell, without severely disrupting the plasma 
membrane. Examination under the fluorescence microscope revealed 
whole cells with orange stained nuclei and no cytoplasmic 
staining.
Cells or nuclei stained for DNA with ethidium bromide were 
analysed by flow cytometry using 488nm excitation wavelength from 
the Argon laser and emission measured through a long pass filter, 
cut off 630 nm. Data was analysed on protocol DNADISC (Appendix 
1).
(b) Staining for GGT
(i) yGAMC as substrate
Cell line cells were harvested from petri dishes or primary 
hepatocytes isolated by collagenase perfusion were washed in PBS. 
yGAMC was made up to 200 pM in ammediol buffer with 20 mM 
glycylglycine as for the fluorimetric quantitation of GGT 
(Chapter 2.5 (a)). The cells were incubated in the substrate
solution for 5 min before analysis in the flow cytometer. 
Excitation wavelength used was 351-356 nm on the Krypton laser, 
and fluorescence emission was collected through a band pass 
filter with peak transmission of 470 nm.
(ii) yGMNA-NSA as substrate
Cells were stained for GGT activity by the method of 
Vanderlaan et al., (1979) and by this method as modified by
Haskill et al,. (1983).
Vanderlaan et al., (1979) employed the following procedure: 
5 mg of y-glutamyl-4-methoxy-2-naphthylamide (yGMNA) was 
dissolved in 100 pi of dimethylformamide (DMF) and 100 pi of IN 
HC1. 5 mg of 5-nitrosalicylaldehyde (NSA) was dissolved in 50 pi 
DMF. These two solutions were then made up together to 5 ml with 
0.1 M Tris pH 8.0 with 40 mM glycylglycine and 80 mM NaCl.
Haskill et al.. (1983) modified this method slightly as 
follows: 2 mg of yGMNA was dissolved in 100 pi of IN NaOH and 100 
pl DMF. This was added to 40 mM glycylglycine in 10 ml Tris 
buffer pH 7.8, and then to 2 mg NSA in 10 ml Tris buffer. This 
solution was filtered.
To inhibit GGT activity 5 mM serine and 10 mM sodium borate 
was included in solutions used to stain some of the samples.
(c) Staining for alkaline phosphatase
For fluorescence photomicrography, cell line cells growing
on petri dishes had medium removed and were washed twice with
PBS. The cells were them incubated with 200 pM 3-0-methyl 
fluorescein phosphate (MFP) in PBS for 2 min. The substrate 
solution was then removed, and the cells were observed 
immediately using a Leitz Ortholux 2 fluorescence microscope with 
filter block 12: emission long pass filter with cut off
wavelength of 515nm.
For flow cytometric* analysis of alkaline phosphatase 
activity, hepatocytes isolated by collagenase perfusion, or cells 
growing in monolayer culture, detached from petri dishes using
38
trypsin and washed in PBS, were incubated with 200 pM MFP at a 
density of 0,5 x 10« cells/ml for 3 min. The cells were then 
analysed immediately in the flow cytometer whilst still suspended 
in the substrate solution. Laser excitation wavelength was 488 nm 
on the Argon laser and a band pass filter with peak emission of 
530 nm was used.
The cells were analysed using protocols DNRSTUDY or
THREEPTDIF (Appendices 2 and 3).
(d) Staining for guanidinobenzoatase
Cell line cells harvested from petri dishes were washed in 
isotonic NaCl, The cells were then resuspended in 10 mM
N«-dansyl-homoarginine and incubated for 2 min in the solution. 
The cells were then pelleted from the staining solution, washed 
twice and resuspended in isotonic NaCl. Hepatocytes isolated by 
collagenase perfusion were stained by the same method immediately 
after preparation.
The cells were analysed in the flow cytometer using
excitation line 251-356 nm of the Krypton laser, and emitted
light was collected through a 465-475 nm band pass filter. This 
emission filter was not ideal as the emission maximum of 
positively stained cells is around 400 nm, however a filter which 
would block the emission fluorescence of free 
N«-dansyl-homoarginine (maximum 510 nm) was required. The cells 
were analysed using protocols DNRSTUDY or MARKERS (Appendices 2 
and 4)
(e) Staining for adriamycin content
Cells grown on petri dishes were incubated with adriamycin 
as described in Chapter 3.6. After the incubation period, the 
cells were harvested with trypsin and washed in ice-cold HBSS. 
Trypsinisation of monolayers of cultured cells following 
treatment with adriamycin has been previously reported not to 
result in artefacts causing alterations in the cellular content 
of the drug (Durand and Olive, 1981). This was confirmed in 
preliminary experiments in the present study when cells were 
either removed by trypsinisation and washed before incubating 
with the drug, or treated with the drug prior to trypsinisation. 
Similar differences between uptakes of adriamycin by JB1 and BL9L 
cells were seen as compared to those incubated while still 
attached to the petri dishes. The cells were kept on ice until 
analysed in the flow cytometer. Exciting laser wavelength was the 
488nm line of the Argon laser and emission filter a long pass 
filter cut off 500 nm. The analysis protocol used was DNRSTUDY 
(Appendix 2).
Hepatocytes isolated by collagenase perfusion were assayed 
in the flow cytometer for intracellular adriamycin content 
following the incubation of 10 x 10* cells in 10 ml HBSS 
containing the appropriate adriamycin content. The cells were 
incubated for 3 hours at 37 C with occasional agitation. The 
cells were then washed twice and resuspended in ice-cold HBSS and 
kept on ice before sampling in the flow cytometer. Analysis and 
data presentation was as described for cell lines above.
(f) Staining for cellular thiols
Cells line cells harvested from culture dishes or freshly 
isolated hepatocytes were incubated in suspension with the 
appropriate concentration of monobromobimane (mBrB), in PBS 
(stock mBrB was 1 mM in acetonitrile). Observation of the cells 
under the fluorescence microscope indicated that penetration of 
the compound into the cells was very rapid, as the cells showed 
fluorescence emission almost immediately.
The cells were analysed in the flow cytometer. The 406 nm 
laser line of the Krypton laser was used as the excitation 
wavelength, and fluorescence emission was collected through a 
long pass filter with 50% transmission at 425 nm.
(g) Staining for surface antigen with antibody
Hepatocytes isolated by collagenase perfusion or cell lines 
harvested from petri dishes were washed in PBS, and then 2-5 x 
10* cells were pelleted in 1 ml conical centifuge tubes. The 
cells were resuspended in 100 pi normal mouse serum and incubated 
at room temperature for 5-10 min. To the tubes was then added 300 
pi of the primary antibody and this was incubated with the cells 
for 20 min on ice, vortexing 2 or 3 times during the incubation 
period. The cells were then pelleted and washed twice with PBS 
containing 5% FCS. The cells were pelleted and resuspended in 500 
pi of a 1:1000 dilution of anti-mouse IgG conjugated to FITC, and 
incubated for 20 min on ice vortexing 2 or 3 times. The cells 
were again washed twice with PBS containing 5% FCS, and were
finally suspended in 1 ml PBS. The cells were analysed in the 
flow cytometer using the 488 nm excitation line and emission 
collected through a band pass filter with peak transmission of 
530 nm, and protocol DNRSTUDY (appendix 2).
(h) Staining for BudR incorporation
Cells fixed in 70% ethanol were washed in absolute alcohol 
and then defatted in chloroform:methanol, 2:1 for 4 min. The 
cells were then washed in absolute alcohol and rehydrated through 
70% ethanol to water. They were then treated for 1 hour at 37 C 
with 0.2% RNase, pelleted, and then for 30 min at 20 C with 0.2% 
Triton-X-100. Cells were pelleted again then incubated for 30 min 
at 37 C with 0.4% pepsin in IN HC1. This treatment results in the 
loss of a large amount of the cells' cytoplasm, although a small 
amount is retained around the cell nuclei and the nuclei from 
binucleated cells remain associated. The 'cells' were then washed 
twice in PBS and incubated for 15 min at 20 C in 0.5% Tween 20 
and 0.5% normal goat serum in PBS. The cells were pelleted and 
incubated for 1 hour at 20 C with PBS containing 0.5% Tween 20, 
0.5% normal goat serum and 5 pi anti-BudR antibody in tissue 
culture supernatant (raised in rat). The cells were again washed 
twice with PBS and incubated for 15 min at 20 C with PBS 
containing Tween 20 and normal goat serum. This was replaced with 
PBS containing Tween 20, normal goat serum and 10 pi goat 
anti-rat conjugated to FITC and incubated for 1 hour at 20 C. 
After incubation the cells were pelleted and washed twice in PBS 
before resuspending in 4 ml PBS containing 10 pg/ml propidium 
iodide (PI). They were left to stain overnight, and the following 
day were analysed flow cytometrically for green (FITC) and red 
(PI) fluorescence using excitation wavelength 488 nm. The data 
were analysed using the protocol ABDNA2 (appendix 5).
2.7 Immunological assays
(a) Immunoelectrophoresis
Michaelis-buffer (pH 8.2) was made by disolving 13.38 g 
sodium diethyl barbiturate and 8.83 g sodium acetate trihydrate 
in 500 ml water.
50 ml buffer and 50 ml water were combined in an Erlenmeyer 
flask to which was added 1 g agarose. The solution was heated and 
stirred until clear. The Camag immunoelectrophoresis kit (Camag, 
4132 Muttenz, Switzerland) was used. 6 microscope slides are 
placed in a frame which is fitted into a levelling table. 10 ml 
of the agarose solution was distributed over each row of three 
microscope slides and the gel was allowed to set for 15-20 min. 
The gel punch was used to cut a trough with one well on either 
side, in each agarose coated microscope slide. The gel was 
removed from the wells and the wells were then filled with 2.5 pi 
of the antigen to be electrophoresed. The frame was then placed 
in the electrophoresis chamber which contained Michaelis buffer. 
Cellulose acetate contact strips pre-soaked in buffer were placed 
so that one end lay over the ends of each row of the microscope 
slides and the other in the buffer. The power supply was 
connected and the samples electrophoresed, generally for 60 min 
at 250 volts. After this time the immunoframes were removed from 
the chamber and the strips of gel in the troughs removed. The 
trough was then filled with 100 pi antiserum, and the gels 
incubated in a humid chamber overnight at room temperature. The 
immunoglobulins present in the antiserum diffuse from the trough
and on reaction with the electrophoresed antigens, form lines of 
precipitation.
(b) Ouchterlony diffusion plates
1% agarose was made up in Michaelis buffer pH 8.2 as 
described for immunoelectrophoresis. (Chapter 2.7 (a)). 2 ml of 
agarose solution was added to a 35 mm petri dish and allowed to 
set.
Six wells surrounding one well were cut and up to 10 pi 
could be added to each well. The antigen was added to the central 
well and antiserum at appropriate dilutions added to the outer 
wells.
(c) Stain for agarose gel
Following Ouchterlony diffusion or immunoprecipitation, 
agarose gels were washed for at least 6 hours in normal saline 
solution to remove excess protein, and then stained as follows : 
Gels are first allowed to dry. A stock solution of 0.6% 
Coomassie Brilliant Blue (CBB) G250 was made in methanol.
The staining solution used was 9:2:9 of CBB:acetic acid:H^0. 
The dried gels were stained for 10 min and then destained in 
several changes of 50:50 methanol:4% acetic acid.
(d) Immunoprecipitation
Reagents:Borate buffer
10 mM sodium borate pH 7.5 
150 mM NaCl 
0.5% Triton-X-100 
0.5% Deoxycholate.
Immunoprecipitations were performed by a method modified 
from that of Cullen and Schwertz, (1976).
An appropriate dilution of enzyme made up to 0.5 ml in 
borate buffer was incubated with 50 pi of antibody diluted in 
PBS, for 1 hour at room temperature in Eppendorf centrifuge 
tubes. 25 pi of appropriate second antibody (depending on the 
nature of the primary antibody), goat anti rabbit or goat anti 
mouse IgG heavy and light chain was then added, and incubated 
overnight at 4°C.
The following day, the precipitate formed was spun out and 
the supernatant tested for enzyme activity and compared with a 
control where the first antibody had been replaced with 50 pi 
PBS.
(e) Immunohistochemical staining
(i) Staining for BudR incorporation
Cold acetone fixed sections of liver were stained for BudR 
incorporation by an adaptation of the method described in
Becton-Dickinson's Source Book Section 3.80.2
The paraffin wax sections were first dewaxed and rehydrated. 
Endogenous alkaline phosphatase was inactivated by incubating the 
sections for 15 min in 15% acetic acid. They were then rinsed in 
PBS containing 0.5% Tween 80. Slides were then immersed in 0.07 N 
NaOH for 2 min to dissociate double stranded DNA into single 
strands, facilitating coupling of the primary antibody with 
incorporated BudR. The slides were again rinsed in PBS-Tween 80 
and the excess buffer removed and the slice placed in a humid 
box. 100 pi of anti-BudR (Becton-Dickinson) diluted 1:10 in 
PBS-Tween was incubated with the section for 1 hour at room 
temperature. The slides were washed 3-4 times with PBS-Tween and 
excess buffer removed. 100 pi of goat anti-mouse IgG (whole 
molecule) conjugated to alkaline phosphatase diluted 1:50 in PBS 
containing 1% BSA was added to the sections and incubated for an 
hour at room temperature. The sections were washed 3-4 times with 
PBS-Tween 80 and then covered with the substrate solution, 
comprising 10 mg Fast Red TR, and 10 mg Napthol AS-BI in 20 ml 
0.05 M veronal acetate buffer pH 9.2.
The substrate solution was left .on the sections until red 
colour developed - approximately 20 min. The sections were washed 
with PBS followed by distilled water and then counterstained with 
Gill's No.2 haematoxylin. They were then mounted in Apathy's 
aqueous mounting medium.
(ii) Staining for surface antigens
Sections were treated in essentially the same way as for
staining for BudR incorporation. Before blocking endogenous 
alkaline phosphatase, non-specific binding of antibody had to be 
blocked with FCS (1:5 dilution) unless tissue culture supernatant 
was the source of the primary antibody. The incubation in 0.07 N 
NaOH refered to above was not required for staining for surface 
antigens and was omitted.
2.8 Assays of radioactive labelling
(a) Autoradiography
[*5S] methionine labelled proteins (Chapter 4.4) resolved by 
SDS-PAGE were stained with Page Blue 83 as described in Section
2.9 (f). The gel was then dried onto Whatman No. 3 filter paper. 
The dried gel was then placed in an autoradiograph cassette with 
photographic film : Agfa-Gevaert Osray M3. The gel was exposed 
for 3 weeks at -70pC before developing, as this was considered a 
suitable exposure time for number of counts applied (C. Power, 
personal communication)•
(b) Determination of [,5S] methionine incorporation into cell 
lines
Samples of proteins from cell lysis secreted into medium, or 
from papain digestion (Chapter 4.4), were diluted to give 
approximately equal protein concentrations. From these 200 pi 
aliquots were taken and to these were added 5 pi of 10% BSA and 
then 10% TCA. A precipitate was allowed to form by incubating on
ice for 10 min. The precipitates were then collected onto 
labelled Whatman glass fibre filters GF/C and were each washed 
with 5 ml of 5 % TCA containing unlabelled 0.1 M methionine, 3 
times, then with 5 ml distilled water and finally with 5 ml 
ethanol. The filters were then allowed to dry in air and were 
placed in minivials with 4.5 ml Beckman CP scintillant cocktail 
and counted for 10 min in a Packard Tri-Carb 460 scintillation 
counter (Packard Instruments Ltd., Caversham, Berks.), with 
automatic quench correction. Radioactivity is expressed as dpm 
(disintegrations per minute).
(c) Determination of (8H)thymidine incorporation into primary 
hepatocytes
After incubation with [*H] thymidine (Chapter 5.2 (b)), the 
medium was removed and the cells rinsed twice with PBS + 2mM 
unlabelled thymidine. The cells were scraped off the dishes into 
4 ml of ice-cold TCA. They were then centrifuged at 1000 rpm for 
2 min and washed twice with 4 ml of cold 5% TCA. The cells were 
solubilised by resuspending in 0.5 ml 1M NaOH and incubating at 
25°C overnight. DNA was precipitated from the alkaline cell 
digest by adding IN HC1 and incubating on ice for 30 min. The 
precipitate containing the DNA fraction was then pelleted and the 
supernatant discarded. The precipitate was resuspended in 1 m l tl00/o 
perchloric acid and the DNA hydrolysed by heating at 90°C for 15 
min. The precipitate which remained was pelleted leaving the 
hydrolysed DNA in solution. 100 pi aliquots of the supernatant 
were mixed well with 4 ml of CP scintillant and dpm were counted
in a Packard Scintillation Counter. The perchloric hydrolysate 
was also used for determination of DNA content (Chapter 2.9 (b)).
/
2.9 Other analytical techniques
(a) Protein estimation
Protein was estimated by the method of Lowry et al.. (1951)
(b) DNA estimation
DNA was estimated by the diphenylamine method of Burton 
(1956) as modified by Giles and Myers (1965) and Richards (1974).
(c) Isolation of hepatocyte nuclei
Nuclei were isolated by an adaptation of the method of 
Widnell and Tata, 1964.
32 g of liver were pooled from 4 rats and divided into 8 
portions of 4 g. These were homogenised in 10 ml of 0.21 M 
sucrose containing 1 mM MgCl^. The homogenate was filtered 
through 4 layers of gauze and washed through with a further 10 ml 
of the sucrose solution. The homogenate was underlayed with 7 ml 
of 0.34 M sucrose containing 3 mM MgCl^, and centrifuged for 10 
minutes at 1500 rpm. The supernatant was discarded, and the 
pellet resuspended in 20 ml of 2,4 M sucrose containing 1 mM 
MgCl^, and transferred to 50 ml high speed centrifuge tubes, and 
centrifuged for 60 min at 10,000 rpm. After centrifugation, the
pellicle was carefully freed and discarded with the supernatant. 
The nuclear pellet was then resuspended in 5 ml of 0.21 M sucrose 
containing 1 mM MgCl^. The nuclear preparations were examined 
microscopically before being fractionated by density gradient 
centrifugation.
(d) Density gradient centrifugation of hepatocyte nuclei
The nuclear fractions were prepared as described in Neal 
et al.. (1976). Nuclei were centrifuged through a gradient of 20% 
to 50% sucrose, formed in an M.S.E. type A-XII zonal rotor, at 
1000 rpm for 20 min. The separated nuclei were collected in 10 ml 
fractions. The nuclei were spun out of the sucrose solution (2000 
rpm for 10 min) and washed and resuspended in PBS for staining 
with ethidium bromide. Aliquots for DNA quantitation were washed 
twice in 10% trichloroacetic acid and resuspended in 10% 
perchloric acid. DNA in the sample was then hydrolysed and 
quantitated (Chapter 2.4 (b)).
(e) Papain quantitation
(i) Spectrophotometrie assay
Papain proteolytic activity was assayed spectrophotometrically by 
the method of Arnon (1970) as follows :
Substrate : 43.5 mg of benzoyl-DL-arginine-p-nitroanilide
hydrochloride (BAPA) dissolved in 1 ml of DMSO, and volume 
adjusted to 100 ml with 0.50 mM Tris buffer pH 7.5 containing 5 
mM cysteine and 2 mM EDTA. Papain solutions ranging between 0 and 
100 |ig papain in water had 5 ml of the substrate solution added
and were incubated at 25°C for 25 min. The reaction was stopped
by the addition of 1 ml of 30% acetic acid. P-nitroaniline
produced was measured spectrophotometrically at 410 m. Activity
was expressed as the amount of enzyme which will hydrolyse 1 
Mmole of substrate per min. A standard curve is shown in Fig 2.4.
(ii) Fluorimetric assay
The spectrophotometrie method for assaying papain 
concentration was suitable for samples containing greater than 
0.24 units of activity, where 1 unit will hydrolyse 1.0 pmoles of 
N«-benzyoyl-L-arginine ethylester per minute, but would not be
sensitive enough to assay smaller quantities of the enzyme.
Therefore the following fluorimetric method was developed from 
that of Kanaoka et al.. (1977).
Substrate N^-benzoylarginine^-amino^-methyl coumarin 
hydrochloride (Bz-Arg-7AMC.HC1) was dissolved in DMSO to give a 
stock solution. Substrate was then added to 50 mM Tris buffer pH
7.5 containing 5 mM cysteine and 2 mM EDTA to give a final
concentration of 0.05 mM.
As for the spectrophotometric assay, a range of 
concentrations of papain between 0 and 20 Mg/ml were incubated 
with 5 ml of the substrate solution for 25 min at 25°C. The
Fig 2.4 Standard curve of papain activity.
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Fig 2.5 Standard curve of papain activity - fluorimetric 
assay.
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reaction was again stopped by the addition of 30% acetic acid 
(Fig 2.5).
The quantity of 7AMC formed was measured fluorimetrically 
using a Perkin-Elmer LS-5 fluorimeter, excitation wavelength 380 
nm and emission 440 nm. Results were expressed as the amount of 
enzyme which will hydrolyse 1 nmole of substrate per min.
(f) SDS-polyacrylamide gel electrophoresis
Proteins derived from papain digestion of JB1 and BL9L cells 
were analysed by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE). Proteins were resolved on a 10% or 
12.5% polyacrylamide gel using the method of Laemmli, (1970). 
Reagents:
Resolving gel (final concentrations)
10% or 12.5% from stock of 30% acrylamide/0.8% N,N'~
methylene bisacrylamide
50% 0.75 M Tris/HCl buffer pH 8.8
0.12% N,N,N'-tetramethylethylene diamine (TEMED)
0.1% sodium dodecyl sulphate (SDS)
0.01% (NH.)nS„0o, ammonium persulphate 4 Z JL o
Stacking gel (final concentrations)
3% acrylamide from stock solution 
17% 0.75 M Tris/HCl buffer pH 6.5 
0.1% TEMED 
0.1% SDS
Electrode buffer 
0.3% Tris 
1.45% glycine 
0.1% SDS
Sample buffer (final concentrations)
0.2% 0.75 M Tris/HCl buffer pH 6.5 
50% w/v urea 
0.1% SDS
10% 2-mercaptoethanol
containing also 0.002% bromophenol blue
Stain
0.6% Page Blue 83 in methanol:20% acetic acid 1:1
Destain
10% methanol/7% acetic acid
A slab gel was made in a Raven vertical slab gel apparatus 
(Raven Scientific Ltd. Suffolk), To 10 |il of the sample contain^ 
75 to 100 pg of protein was added 20 pi sample buffer followed by 
incubation in a water bath at 100°C for 5 min. 15 pi of each 
sample was then loaded onto the gel. The current applied was 15 
mA while the sample moved through the stacking gel and was 
increased to 25 mA through the resolving gel. The progress of the 
electrophoresis could be followed by observing the movement of
the bromophenol blue. When the tracking dye was around 1 cm from 
the bottom of the gel, the current was switched off and the gel
removed and fixed in 25% TCA for 5 min, then washed with water
/
and then 10% acetic acid.
The gel was stained with Page Blue 83 overnight and then 
destained the following day until the background blue staining 
cleared. In some experiments in which silver staining was used, 
gels stained with Page Blue 83 were completely destained in 40% 
methanol/10% acetic acid before using the Bio-Rad Silver Staining 
Kit. In other cases, gels were fixed in 40% methanol/10% acetic 
acid overnight instead of fixation in TCA, and the following day 
were silver stained.
(g) Absorbance spectrum of monobromobimane
A preliminary experiment was necessary to determine if 
monobromobimane (mBrB),in order to react with cytosolic thiol 
compounds, had to exert a cytotoxic effect on the cell to cross 
the cell membrane. This was examined by assaying the leakage of 
lactate dehydrogenase (LDH) from the cells during incubation with 
mBrB. As LDH activity is normally assayed by measuring the 
formation of NAD from NADH by the decrease in absorbance at 
340 nm, it was necessary to ensure that the absorbance of mBrB 
would not interfere in this assay.
A solution of monobromobimane of 10 pg/ml was made up in 
HBSS, and the absorbance of the solution scanned between 500 nm 
and 200 nm (Fig 2.6). At 340 nm, the mBrB solution absorbs very 
little and therefore the assay of the leakage of LDH activity
Fig 2.6 Absorbance spectrum of monobromobimane.
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from cells could be used as an assay for cell death.
(h) Measurement of lactate dehydrogenase
LDH was measured essentially according to the method of 
Wroblewski and LaDue, (1955).
Reagents: 100 mM sodium phosphate buffer pH 7.4
reduced nicotinamide adenine dinucleotide (NADH)
2.5 mg/ml in buffer
sodium pyruvate 3 mg/ml in buffer
Method: Activity is measured in a total volume of 3 ml consisting 
of 2.5 ml phosphate buffer, 100 pi NADH solution and 300 pi of 
enzyme solution. The reaction is started by the addition of 100 
pi of sodium pyruvate solution, and the decrease in absorbance at 
340 nm is measured for 2-3 min.
2.10 Experimental protocols
(a) Treatment of cells with papain solution
Cells were grown on petri dishes until almost confluent. The 
medium was then removed from the dishes and the cells washed with 
PBS. Papain was made up to the appropriate concentration in PBS 
containing 2-mercaptoethanol. Just sufficient solution to cover 
the plate was used. The cells were then incubated with papain 
solution for periods up to 5 hours. During this period, JB1 cells 
tended to detach from the plate, and so after removing and
retaining the supernatant from the plates, the solution was 
centrifuged to remove any cellular material.
At the concentrations used in this study it was observed 
that papain tended to form a precipitate at low temperatures. 
Since papain-solubilised cellular proteins were to be analysed by 
SDS-PAGE and as little contaminating papain as possible was 
wanted, the temperature of the protein containg samples was 
reduced and the precipitated papain removed by centrifugation. 
Measurements of GGT activity before and after this centrifugation 
indicated that very little cellular protein was lost as a result 
of this procedure.
(b) Induction of hepatocyte DNA synthesis by EGF
Hepatocytes were isolated by collagenase perfusion and
plated out at a density of 6 x 10* cells in a 150 mm petri dish 
in WEM containing 5% FCS. The cells were allowed to attach to the 
dish during a three hour period, after which the medium was 
replaced and supplemented with epidermal growth factor (EGF) at 
the required concentrations.
After 27 hr 10 pM BudR was added, and at 42 hr after the 
initial plating, the cells were harvested using 0.05%
trypsin-0.02% EDTA solution. They were then washed once in 
complete medium and once in PBS. The cells from 1 x 150 mm petri 
dish were then resuspended in 0.5 ml PBS and 5 ml of absolute
alcohol was added with vigorous mixing. Generally the cells were
fixed overnight before staining.
Chapter 3 Fluorescent markers for transformed cells
3.1 Examination of fluorescent markers for transformed cells
/
In this chapter, 6 different changes which occur during 
aflatoxin (AFB^) induced carcinogenesis have been examined. 
Although the number of changes which occur is much greater than 
this, these 6 features have been chosen as they represent, at 
least in part, the diversity of biological parameters which are 
found to be altered in the early focal lesions i.e. enzymic and 
non-enzymic constituents of nucleus, cytosol and cell membrane. 
In addition, these features enable both qualitative and 
quantitative analysis of the early lesions by flow cytometry, and 
hopefully will have the potential to be used as a method of 
separation of the neoplastic from the normal cells.
For most of the markers a model system of two cell lines, 
one derived from an AFB^ induced hepatoma, JB1 (Manson et al.. 
1984-), and one derived from normal hepatocytes, BL9L, (Judah 
et al.. 1977) has been initially studied. The methods developed
for determining differences between the cell lines have then been 
applied to freshly isolated hepatocytes from normal and AFB^ fed 
animals.
3.2 Ploidy of liver cells
(a) Introduction
The normal changes in rat liver cell ploidy which occur 
during ageing of the animal have been recognised for some time 
(Carriere, 1969). The mechanism of polyploid cell formation is 
not yet understood, neither is its significance clear. Nadal and 
Zajdela (1966) showed, in rats, that the appearance of polyploid 
cells is directly related to the disappearance of binucleated
cells during ageing of the animal. At age 7 weeks they found 41% 
of cells were binucleate and this decreased to 30% at around 14 
weeks and to 25% at 9 months of age. Carriere (1969) explains the 
formation of polyploid cells as follows: First there is failure 
of the cytokinetic mechanism which results in the appearance of 
binucleated cells. When these binucleated cells subsequently 
undergo mitosis, both nuclei enter prophase together and share 
one spindle. If cytokinesis is successfully completed the result 
is two cells each having one tetraploid nucleus. If division does 
not take place then a cell with two tetraploid nuclei is formed. 
In addition, tetraploid nuclei formed as described above can then 
undergo mitosis to produce daughter tetraploid cells. The
function of liver cell polyploidy has been suggested by Brodsky
and Uryvaeva (1977) to be a mechanism allowing rapid growth of 
the liver to occur without affecting its functional capacity. 
That is, mature parenchymal cells retain the ability to
proliferate. Liver regeneration will take place in rats subjected 
to partial hepatectomy before there is a significant polyploid
cell population. In this case cells are mostly diploid. Partial 
hepatectomy of older animals, having a considerable proportion of 
polyploid and binucleated liver cells, leads to the formation of 
greater numbers of polyploid cells, although the binucleate 
population is dramatically reduced (Nadal and Zajdela, 1966). One 
of the changes which occurs in liver cells of rats fed aflatoxin 
Bj is the alteration of the normal pattern of ploidy (Neal 
et al.. 1976). After chronic feeding of animals with the toxin, 
the tetraploid population is greatly reduced, and there is a 
corresponding increase in the diploid population. A small 
increase in the proportion of octaploid and higher ploidy nuclei 
was also observed. These studies were conducted by separating 
isolated nuclei on the basis of size by density gradient 
centrifugation in a zonal rotor (Johnston, 1968).
From this study of Neal et al. (1976) and a subsequent study 
(Godoy et al., 1976), the authors suggested that differences in 
the ability to activate aflatoxin B1 between the tetraploid and 
diploid cells might account for the apparent sensitivity to the 
toxin of the tetraploid population.
Several other carcinogenic compounds have been reported to 
have the same effect including thioacetamide (Gonzalez-Mujica and 
Mathias, 1972), azo dyes (Neal and Butler, 1978, Styles et al..
1985), carbon tetrachloride (Steele et al.. 1981) and an
initiation/promotion regime of diethylnitrosamine plus partial
hepatectomy followed by 2-acetylaminofluorene (Schwarze et al.. 
1984). Steele et al.. (1981), Schwarze et al.. (1984) and Styles 
et al.. (1985) did not use density centrifugation, but instead 
stained the DNA of isolated nuclei or whole cells and established
the proportion of each ploidy group by flow cytometry. Steele 
et al. (1981) suggested that the disappearance of the tetraploid
cells is due to a greater sensitivity of the diploid population
/
to the carcinogen. The cells of the polyploid population, which 
are in a state of telophase arrest, rapidly divide to replace the 
necrotic cells. Styles et al.. (1985) suggest, additionally, that 
the loss of the tetraploid population, which is irreversible 
after cessation of the carcinogen feeding, is another 
manifestation of a return to the foetal state (Kalengayi et al.. 
1975).
Schwarze et al. (1984) support the theory that the 
tetraploid cells are resistant to the effects of hepatotoxic 
carcinogens, reasoning that the expression of genetic damage is 
less likely in a cell which has 3 copies of the normal gene as 
opposed to only one normal copy in the diploid cell. These 
authors propose that a change in the proportion of diploid cells 
may be the earliest marker for preneoplasia. However the 
disadvantage of using this as a marker for changed cells would be 
the considerable proportion of normal diploid cells that is 
always present in adult rats, and to an even greater degree in 
young animals.
Although the reasons for alterations to the normal liver 
cell ploidy following feeding of some carcinogens remains 
unclear, the change does seem to occur at an early stage during 
neoplasia. Flow cytometric studies of ploidy changes are 
relatively straightforward when the intercalating dyes ethidium 
bromide and propidium iodide are used to quantitate the amount of 
DNA in each nucleus. For these reasons, the changes in ploidy
during normal development and after feeding with aflatoxin 
were monitored by flow cytometric techniques. Although this was 
essentialy a repetition of the work of Neal et al. (1976), it was 
a simple system allowing familiarity with the complexities of 
flow cytometry to be gained, and is also potentially more 
informative than density gradient centrifugation studies.
(b) Results of flow cytometric studies of liver ploidy.
(i) Correlation of fluorescence intensity of nuclei with DNA
/
content.
To establish the DNA content of nuclei isolated from rat 
hepatocytes, nuclei were stained with ethidium bromide by the 
method described in Chapter 2.6(a). An example of the 
fluorescence pattern obtained is shown in Fig 3.1. This sample 
was obtained from a 200 g rat and has 47.1% diploid, 42.3% 
tetraploid and 0.8% octaploid nuclei. Observation of the stained 
nuclei under fluorescence microscopy reveals that the nuclei are 
completely isolated and nuclei from binucleate cells do not 
remain associated.
In order to determine if the fluorescence peaks observed 
following staining of nuclei with ethidium bromide do correspond 
to nuclei of different ploidy groups, rather than some artifact 
of staining, the following experiment was conducted:
Nuclei were prepared from 4 Fischer 344 male rats weighing 
190-200g. The nuclei were centrifuged through sucrose and 
subjected to density gradient centrifugation in a zonal rotor 
(Chapter2.9 (d)). A small sample of the original nuclear 
preparation was retained for DNA estimation. 10 fractions were 
collected and stained for DNA with ethidium bromide. These 
samples were analysed in the flow cytometer, and results obtained 
as in Fig 3.2. This was the best result of 3 such separations of 
nuclei giving 97% and 70% pure populations of diploid and 
tetraploid respectively.
Fig 3.1 The nuclear ploidy of a 200 g rat. Histogram Z1 shows 
diploids in region 1, tetraploids in region 2, and octaploids 
in region 3.
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Fig 3.2 Ploidy determination of fractions obtained by density 
gradient centrifugation of rat hepatocytes.
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Fractions 1 and 2 and fractions 8,9 and 10 were pooled. The 
cell concentrations in these pooled samples and the original 
nuclear preparation were determined by counting in the 
haemocytometer•
For estimation of DNA content, the nuclei were centrifuged 
and resuspended in 10% TCA and assayed as described in Chapter
2.9 (b).
The results of DNA estimations and flow cytometric analysis 
are given in Table 3.1.
From the value of DNA/nucleus for fractions 1 and 2 a 
diploid cell could be estimated to have 6.07 pg DNA and the 
average DNA per nucleus from pooled fractions 8,9 and 10 could be 
calculated to be 10.20 pg. From the actual value obtained it 
would therefore appear that the amount of fluorescence emitted by 
hepatocyte nuclei stained for DNA with ethidium bromide is 
directly related to the amount of DNA in the nucleus.
(ii) Binucleation of rat hepatocytes.
Isolation of nuclei by the method described above does not 
allow discrimination of those nuclei derived from single 
nucleated cells and those from binucleated cells. This is a 
disadvantage of the density gradient centrifugation method using 
isolated nuclei. However in the flow cytometer this feature could 
be examined if the whole cells were stained for DNA before 
analysis in the flow cytometer. Staining of cells with the vital 
stain Hoechst 33342 was not satisfactory as only poor resolution 
of ploidy peaks could be achieved. Alternatively whole cells were
Table 3.1 DNA estimations and flow cytometric analysis of 
gradient centrifugation fractions.
pg DMA/ %diploid mean Totetra- mean 
nucleus channel ploid channel
6.13 97 204 30 204
9.65 2 431 69 436
'Fractions' refers to those obtained by density gradient centrifug­
ation. 'Mean channel numbers' refers to the arbitrary units of 
fluorescence intensity in the flow cytometer.
Fractions
1 and 2
8,9 and 10
stained with ethidium bromide as described in Chapter 2.6 (a).
Differences were observed in the relative proportions of
'diploid', 'tetraploid' and 'octaploid' peaks. This can be
/
accounted for by the degree of binucleation observed in these 
animals. The results given in Table 3.2 are the means and 
standard errors of 4 rats weighing between 175-180g. If liver 
cells from a rat are stained with ethidium bromide and observed 
by fluorescence microscopy, large numbers of the cells are 
binucleated. Counting by means of a graticule revealed that 
around 40% of the hepatocytes of an animal of this age range are 
binucleated. From Table 3.2, it can be seen that around 46% of 
the cells are true tetraploids, and 74% of whole cells are 
tetraploid or binucleate diploids. Therefore an estimation of 40% 
binucleation correlates with these results, when it is taken into 
consideration that some binucleates will have two tetraploid 
nuclei.
(iii) Changes in rat hepatocyte DNA content with age and after 
feeding with AFB1
From 21 days old, Fischer 344 rats were fed AFI^ at 4ppm. 
Age matched controls were fed on non toxic ground nut meal. At 
intervals, 2 animals from each group were sacrificed for 
isolation of hepatocytes by collagenase perfusion (Chapter 2.3
(c)). The liver cells were then stained for DNA with ethidium 
bromide as described in Chapter 2.6 (a).
Fig 3.3 shows nuclei stained as above from a control animal 
aged 84 days. Fig 3.4 shows nuclei from an animal of the same age
Table 3.2 Relative proportions of ploidy groups from 175-180 g 
rats expressed as percentages.
isolated nuclei whole cells
Diploid 42.80 + 1.48 9.98 + 1.12
Tetraploid and 46.05+1.08 74.15+3.23
binucleate diploid
Octaploid and 1.00 + 0.04 8.45 + 0.40
binucleate tetraploid
Values given are the means and standard errors of ploidy determin­
ations of hepatocytes from 4 animals.
Fig 3.3 Ploidy of hepatocytes from a control animal aged 84 
days.
Fig 3.4 Ploidy of hepatocytes from an animal of the same age 
fed AFB^ at 4 ppm for 63 days.
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which has been fed AFB^ contaminated diet for 63 days. The 
relative proportions of diploid, tetraploid and octaploid nuclei 
were determined by means of the computer. The percentages of 
nuclei of each ploidy group are plotted in Fig 3.5 for control 
animals and Fig 3.6 for animals fed AFB^ at 4ppm for the number 
of days as shown.
(iv) Changes in adult rat hepatocyte DNA content during feeding 
with AFB1
Fischer 344 rats of 9-10 weeks of age were examined for 
changes in hepatocyte ploidy during feeding with 4ppm AFB^ in 
their diet.
Hepatocyte nuclei were isolated and stained as described for 
weanling animals.
At 9-10 weeks of age, approximately 50% of the rat liver 
cells are tetraploid. During feeding with the carcinogen, the 
proportion of tetraploid cells drops gradually, whereas the 
tetraploid population of control animals increases further. This 
is shown in Fig 3.7.
Fig 3.5 Change in rat hepatocyte ploidy with increasing age.
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Fig 3.6 Effect on hepatocyte ploidy of feeding AFI^ to rats 
from the age of 3 weeks.
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Fig 3.7 Effect on hepatocyte ploidy of feeding AFB^ to rats 
from the age of 9 - 10 weeks
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(c) Summary
In this section/ a simple method for determining the 
proportions of rat hepatocytes in each ploidy class wast .
described. The nuclei isolated from suspensions of liver cells 
were stained for DNA with the intercalating dye ethidium bromide. 
The fluorescence intensities of nuclei stained by this method 
were shown to be directly related to the amount of DNA in the 
nucleus.
The effect of the carcinogen AFI^ on the normal development 
of polyploid cells in the liver of young rats as they grow older 
was investigated. It was found that development of the tetraploid 
population was inhibited. As the nuclei of the hepatocytes are 
completely dissociated, it is not possible to determine if these 
nuclei are from 'true' diploid cells or from binucleated cells 
having two diploid nuclei.
DNA analysis of whole liver cells from animals weighing 
about 180g showed that around 40% of the cells are binucleate 
with most of these being binucleate diploids.
A further study would be required to determine if the change 
to a predominantly diploid population of isolated nuclei is due 
to an increase in binucleation rather than replacement of 
carcinogen-affected diploid cells with tetraploids which have 
gone into mitosis, or binucleate diploids which have achieved 
cytokinesis.
Some evidence is presented in Chapter 5 to suggest that the 
latter is more likely, although the origin of the resulting 
diploid cell population is still unclear.
3.3 Gamma-glutamyl transpeptidase and chemical carcinogenesis.
(a) Introduction
Gamma glutamyl transpeptidase (EC 2.3.2.2, GGT) is a 
membrane associated glycoprotein found in a number of normal and 
cancerous tissues. Enzyme activity is high in foetal rat liver 
but decreases soon after birth to low levels, however some 
activity remains in the bile duct cells. In the adult, activity 
in the kidneys is very high and is associated with the microvilli 
of the proximal tubule. In addition high levels of GGT activity 
are associated with the excretory follicle cells of the pancreas, 
and the villus cells of the jejunum.
The appearance of high levels of GGT in rat hepatomas was 
first reported by Fiala et al in 1972. In this case primary 
hepatomas were induced by 3 r-methyl-4-dimethylaminoazobenzene. 
Since then, increased levels of rat liver GGT have been reported
following treatment with a number of structurally unrelated
chemical carcinogens, including aflatoxin (Kalengayi et al.. 
1975), 2-acetylaminofluorene and diethylnitrosamine (Cameron 
et al., 1978). In addition the enzyme has been discussed widely 
as a possible marker for preneoplasia (Laishes et al, 1978, 
Vanderlaan and Phares, 1981, Hanigan and Pitot, 1982).
The enzyme has been shown by histochemical localisation 
(Marathe et al.. 1979), and subcellular fractionation studies
(Ding et al.. 1981), to be located on the plasma membrane with
the activity on the external surface of the cell membrane.
Purification of the enzyme can be achieved by protease digestion,
which cleaves the enzyme close to the cell membrane but retains 
enzyme activity, or by detergent solubilisation, which releases 
the whole molecule (Meister et al.. 1981). GGT purified from rat 
kidney consists of two subunits. Published molecular weights for 
the subunits vary, however after purification by papain digestion 
the heavy subunit is in the region of 46,000-49,500 kD and the 
light subunit 22,000-29,000 kD (Tate and Meister, 1981, Capraro 
and Hughey, 1983). The light subunit contains the gamma-glutamyl 
binding site, and is associated with the cell membrane by its 
interaction with the heavy subunit which spans the membrane (Tsao 
and Curthoys, 1982). Both subunits are required for enzyme 
activity (Gardell and Tate, 1981).
GGT catalyses the transfer of the gamma-glutamyl moiety from 
peptides, including glutathione, to a wide range of amino acid 
and peptide receptors. In 1973, Meister proposed the 
gamma-glutamyl cycle in which GGT is the key enzyme (Fig3.8). The 
hypothesis was that GGT acted as a carrier protein allowing 
transport of amino acids into the cell. Although there is no 
direct evidence that GGT acts as a transport protein, the finding 
that the enzyme does span the plasma membrane, has led some 
authors to consider the possibility (Tsao and Curthoys, 1982). 
More recently it has been suggested (Curthoys, 1983), that GGT in 
the kidney is unlikely to be involved with the transport of amino 
acids, but rather the enzyme cleaves the gamma-glutamyl group of 
glutathione, which cannot be taken up by the cell, allowing 
aminopeptidase to cleave cysteinylglycine to individual amino 
acids which can be taken up by the cell.
After carcinogenic feeding it has been found that GGT
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positive lesions in the liver are also rich in glutathione (Demi 
and Oesterle, 1980, Neal et al., 1981). Neal et al. in 1981, 
suggested that the enhanced glutathione levels found in 
preneoplastic lesions, could be the direct result of the
increased GGT activity. Therefore GGT positive cells which arise 
during chemical carcinogenesis would allow greater detoxification 
of the carcinogen resulting in these cells having greater 
resistance to the chemical than the surrounding normal tissue. 
Several groups have suggested that the appearance of increased 
levels of GGT in hepatocytes during carcinogenesis is due to the 
re-expression of foetal characteristics (Taniguchi et al.. 1974, 
Kalengayi et al.. 1975).
As GGT has been shown to be elevated early in aflatoxin 
induced carcinogenesis (Manson, 1983), this enzyme has been
examined as a possible marker for isolation of preneoplastic 
cells by flow cytometry. Attempts have been made to isolate GGT 
positive hepatocytes from the surrounding normal cells in the
liver by means of antibody coated petri dishes (Hanigan and 
Pitot, 1982). However this method allows recovery of only around 
15% of the GGT positive cells, and so may be selecting a specific 
subpopulation of the cells having the enzyme. Hanigan and Pitot 
have suggested that hepatocytes may be too large and too fragile 
to successfully sort using a flow cytometer, however there is no 
firm evidence to support this hypothesis. The possibility of 
using fluorescent substrates for GGT to distinguish and isolate 
preneoplastic cells has therefore been investigated•
The GGT activity to be found in liver sections and in the
two liver derived cell lines was established histochemically and
assayed quantitatively before staining with fluorescent 
substrates was attempted.
(b) Histochemical staining during AFB^ feeding
Fischer 344 rats were fed 4ppm aflatoxin B^  ^contaminated 
diet from age 3 weeks and were taken for liver sections at 
intervals up to 16 weeks. Portions of liver from these animals 
were fixed in buffered formalin and in cold acetone.
Sections of cold acetone fixed liver were stained for GGT as 
described in Chapter 2.5 (a).
The first effect observed after feeding weanling animals 
with AFBj is biliary hyperplasia. This is shown in Plate 3.1, 
where the animal was on AFB^ contaminated diet for 2 weeks. After 
3 weeks of feeding (Plate 3.2), some GGT activity, staining red, 
is present in the hepatocytes close to the portal areas. By 5 
weeks after the start of feeding, foci of GGT positive cells are 
visible (Plate 3.3). Liver sections after 10 weeks of AFB^ 
feeding show very many well developed GGT positive foci, whilst 
biliary hyperplasia has regressed (Plate 3.4). For comparison, a 
control animal liver section is shown in Plate 3.5. Higher power 
photographs of an early focus, Plate 3.6 and well developed 
focus, Plate 3.7, show that the GGT activity is localised in the 
cell membrane. A control section, at the same magnification, 
showing only the red staining of the GGT positive bile duct cells 
is shown in Plate 3.8.
No red staining was visible when GGT activity was inhibited 
by serine/borate.
These results confirm those reported by Manson in 1983.
PI at e 3.1
Liver section from a rat fed for 1 week, stained for GGT
activ ity  (x 56) .
Plate 3.2
Liver section from a rat fed AFB^  for 3 weeks, stained for GGT 
activ ity  (x 56)«
’ V
Plate 3*3
Liver section from a rat fed AFB^  for 5 weeks, 
activ ity  (x 56) .
Plate 3.4
Liver section from a rat fed AFB^  for 10 weeks, 
activ ity  (x 56) .
stained for GGT
. - «
stained for GGT
Plate 3*5
Liver section from a control animal aged 8 weeks, stained for 
GGT activ ity  (x 56) .
Plate 3.6
Liver section from a rat fed AFB^  for 3 weeks, stained for GGT 
activ ity  (x 224).
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Plate 3.7
Liver section from a rat fed for 10 weeks, stained for
GGT activ ity  (x 140).
Plate 3*8
Liver section from a control animal showing GGT activ ity  in  
the b ile  duct cells (x 140)*
(c) Histochemical staining of cell lines
Cells from the two established liver cell lines JB1 and BL9L 
were also stained histochemically for GGT activity as described 
in methods. JB1 cells stained for the enzyme are shown in Plate 
3.9. Almost all of the cells show some activity, although there 
is some variation in the amount of activity within this 
population. However the BL9L cell population shows no cells 
positive for the enzyme (Plate 3.10).
(d) Quantitation in cell lines
The amount of GGT in the two cell lines was quantitated by 
the procedure described in Chapter 2.4 (a) (i).
The range of GGT activities for the two cell lines found
was:
BL9L 0.006-0.050 nmoles AMC/min/106 cells
JB1 2.532-25.799 nmoles AMC/min/106 cells
When serine/borate was included in the incubating medium, no 
enzyme activity could be detected.
The variation encountered in the amount of activity appeared 
to be related to the passage number of the culture with the 
higher passage numbers showing lower activity than those lower 
passage numbers. However the degree of confluency did not appear 
to affect the enzyme activity.
yts
Plate 3.9
JB1 cells stained for GGT activ ity  (x 140).
Plate 3-10
BL9L cells stained for GGT activ ity  (x 140)
The amount of enzyme activity was also quantitated in 
sections of liver from control and AFI^ fed animals. Results are 
shown in table 3.3. Animals were fed a diet contaminated with 
l-2ppm AFB1* At this level of contamination the development of 
GGT positive foci is delayed 5-6 weeks as compared with those 
resulting from feeding with 4ppm AFB^ (M.M. Manson, personal 
communication). The values given are the means of duplicate 
samples, and the control value is the mean of the activity found 
in 3 animals.
(e) Staining cell lines and primary hepatocytes with yGAMC
As the substrate yGAMC for GGT has a fluorescent product, 
this was considered as a possible method for the distinction of 
GGT positive and negative cells in the flow cytometer.
BL9L and JB1 cells were stained for GGT using the yGAMC 
substrate as described in Chapter 2.6 (b) (i). The results are 
shown in cytograms and histograms Figs 3.9 and 3.10. BL9L cells 
show almost no fluorescence, whilst the JB1 cells show 
considerable fluorescence. However when a mixed population of JB1 
and BL9L cells is incubated with the substrate solution, two 
populations of differing fluorescent intensities cannot be 
distinguished, rather the cells seem to have fluorescence 
intensities of greater than BL9L cells alone and less than JB1 
cells alone (Fig 3.11). This suggests that GGT on the surface of 
JB1 cells is allowing the fluorescent product to be generated, 
but since the product is soluble, it is then becoming associated 
with the population as a whole.
Table 3.3 Quantitation of GGT in liver from rats fed AFB^
no. of weeks on 
AFB diet
0
9
11
13
nmoles AMC/min/g 
liver
82.94
315.10
549.32
1233.25
Values given are the means of duplicate samples, and the control 
value is the mean of the GGT activity found in 3 animals.
Fig 3.9 Flow cytometric analysis of BL9L cells stained for 
GGT activity with the fluorogenic substrate yGAMC.
/
Fig 3.10 Flow cytometric analysis of JB1 cells stained for 
GGT activity with yGAMC.
Fig 3.11 Flow cytometric analysis of a mixed population of 
JB1 and BL9L cells stained for GGT activity with yGAMC.
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A similar result is obtained when liver cells isolated from 
an AFBj fed animal are stained for GGT using yGAMC as a 
substrate. Fig 3.12 shows flow cytometric analysis of cells from 
an animal fed l-2ppm AFB^ for 9 weeks stained for GGT in this 
way. Analysis of cells from a control animal similarly stained is 
shown in Fig 3.13. The control animal cells show very little 
fluorescence contrasting with cells from the AFB^ fed animal 
which all have higher fluorescence intensity than the control rat 
cells. This cannot be the case, as histochemical staining of 
sections of the same liver clearly showed only a proportion of 
the cells to be positive for the enzyme.
(f) Staining cell lines and primary hepatocytes with yGMNA-NSA
JB1 and BL9L cells were stained for GGT using the substrate
gamma-glutamyl-4-methoxy-2-napthylamide (yGMNA) by the method of 
Vanderlaan et al.. and the modification of Haskill et al.. (1983) 
(Chapter 2.6 (b) (ii). JB1 cells stained green, and yellow
crystals could be observed (Plate 3.11). The inclusion of
serine/borate in the medium inhibited both the green fluorescence
and the crystal formation. BL9L cells showed no fluorescence. A 
mixed culture of JB1 and BL9L cells under bright field
illumination is shown in Plate 3.12. Under ultra-violet light,
the JB1 cells can be seen to fluoresce, however the BL9L cells 
emit no fluorescence (Plate 3.13). A scatter of yellow 
crystalline particles can be observed associated with both^ cell 
populations.
JB1 and BL9L cells were removed from petri dishes with
Fig 3.12 Flow cytometric analysis of hepatocytes from an 
animal fed AFB1 at 1 to 2 ppm for 9 weeks stained for GGT 
activity with yGMNA.
Fig 3.13 Flow cytometric analysis of hepatocytes from a 
control animal stained for GGT activity with yGMNA.
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Plate 3*11
JB1 cells stained for GGT activ ity  using the substrate tfG&NA 
(x 1370).
Plate 3.12
A mixed culture of JB1 and BL9L cells under bright f ie ld  
illumination (x 550j.
Plate 3.13
A mixed culture of JB1 and EL9L cells stained for GGT activ ity  
using the substrate JfGMNA (x 1370J,
trypsin, and washed in PBS containing 5% FCS. They were then 
incubated with the staining solution of Vanderlaan (Chapter 2.6
(b) (i)) for 15 mins at 37 C. JB1 and BL9L cells were stained
separately and as a mixed suspension of the two cell types. The 
cells were then analysed in the flow cytometer. The JB1 cells 
showed considerable fluorescence, and the BL9L cells showed no 
fluorescence (Figs 3.14 and 3.15) when they were stained 
separately. However as a mixed suspension, all the cells showed 
fluorescence to some degree although it was of lower intensity 
than the JB1 cells alone (Fig 3.16). Under the fluorescence 
microscope, all cells could be seen to have crystalline particles 
associated with the cell surface.
Hepatocytes derived from rats fed 4ppm AFB^ for between 5 
and 7 weeks were stained for GGT using this method, and compared 
with cells from control animals similarly stained. An incubation 
time of 60-90 min in the substrate solution caused cells from 
both control and fed animals to emit a dull green fluorescence. 
This could not be inhibited by the inclusion of serine/borate or 
1 mM AT125 (Allen et al.. 1980) to the buffer. Longer incubation 
with the substrate solution resulted in the formation of yellow 
crystals associated with the hepatocytes from the AFB^  ^ fed 
animal, but not with the control rats' cells. The formation of 
these crystals was inhibited by the presence of serine/borate, 
however all the cells derived from the AFB^ fed rats had 
associated yellow crystals. Hepatocytes stained for GGT by this 
method and counterstained with propidium iodide are shown in 
Plate 3.14. It seems therefore that the fluorescent product from 
the reaction of GGT with the substrate does not remain associated
Fig 3.14 Flow cytometric analysis of JB1 cells stained for 
GGT using the substrate yGMNA.
Fig 3.15 Flow cytometric analysis of BL9L cells stained for 
GGT using the substrate yGMNA.
Fig 3.16 Flow cytometric analysis of a mixed population of 
JB1 and BL9L cells stained for GGT using the substrate yGMNA.

Plate 3» M
Hepatoc.ytes from an AFB f^ed animal stained for DM with 
propidium iodide and for GGT with the substrate GMNA (x 1370)*
with the cell that exhibits enzyme activity, but is distributed 
throughout the cell population.
Flow cytometric analysis of cells stained by this method 
could not distinguish two separate fluorescence populations.
(g) Summary
In the adult male rat liver GGT activity is normally
/
confined to the bile duct cells. Feeding the rats with AFI^ 
contaminated diet progessively induces some of the hepatocytes to 
express GGT. This seems to be an early change during the 
carcinogenic process, since animals showing the first signs of 
GGT positive cells appear after 3 to 4 weeks feeding with 4 ppm 
AFB1# It requires over 3 weeks feeding with AFB^ at 4 ppm to 
induce neoplasia in Fischer 344 rats (Neal and Butler, 1978).
The model cell lines exhibit large differences in GGT 
activity. This could be demonstrated microscopically by both 
histochemical staining and by staining with a fluorogenic 
substrate. When the two cell lines were separately examined in 
the flow cytometer following addition of the fluorogenic 
substrate yGAMC and yGMNA, differences in the fluorescence 
intensities of the two types of cells were obtained. However when 
a mixed population of the two types of cells were stained with 
either substrate and were then analysed in the flow cytometer, 
two populations of differing fluorescence intensities could not 
be distinguished. It appears that the solubility of the 
fluorescent products of the reaction of both substrates with GGT 
results in the fluorescent species being distributed amongst all 
the cells in the population. To exploit the differences observed 
in GGT activity to distinguish and quantitate cells positive and 
negative for the enzyme , it would be necessary to obtain 
subtrates whose reaction products are insoluble and remain 
associated with the enzyme positive cell. An alternative method
of distinguishing GGT positive from negative cells would be to 
use an antibody specific for the enzyme and this will be 
discussed in Chapter 4.
3.4 Alkaline phosphatase and chemical carcinogenesis
(a) Introduction
/
Several groups have studied the relationship between 
alkaline phosphatase activity (EC 3.1.3.1) and neoplasia in 
rodent liver.
Early studies of Emmelot et al. (1964), and Emmelot and Bos 
(1969), showed that increases in alkaline phosphatase activity in 
hepatocyte plasma membrane preparations could be observed after 
feeding rats 4-dimethylaminoazobenzene. However the degree of 
increase was affected by the substrate used and the assay 
conditions.
An histochemical study of hyperplastic lesions and hepatomas 
in the liver of rats fed 2-fluorenylacetamide conducted by 
Kitagawa in 1971 showed that in the preneoplastic lesions, 
alkaline phosphatase activity was lower than in normal liver, 
however more advanced neoplastic liver lesions showed increased 
activity of the enzyme.
It has been suggested, that increases in alkaline 
phosphatase are not a result of cell transformation, but rather 
are associated with growth per se. Induction of DNA synthesis and 
cell replication by partial hepatectomy or bile duct ligation 
(Novikoff and Essner, 1962, Wootton et_al.,1975) has been 
reported to cause an increase in the enzyme activity at liver 
cell plasma membranes.
Karasaki (1975) found by [*H]thymidine labelling 
proliferative hepatocytes induced during feeding with the
hepatotoxin dimethylaminoazobenzene, and subsequent histochemical 
localisation of alkaline phosphatase, that continuously 
proliferating preneoplastic liver cells exhibit a reduction of 
cytoplasmic alkaline phosphatase activity and a corresponding 
increase in activity along the plasma membrane surface. The 
author suggests that alterations to the Golgi seen during cell 
proliferation may allow transportation of alkaline phosphatase to 
the cell surface. Therefore if alkaline phosphatase does have a
role in the regulation of DNA synthesis, such changes could be
related to abnormal control of cell growth and differentiation.
These reports of increased levels of alkaline phosphatase in
the liver after feeding carcinogens, are of interest in this
study as fluorescent substrates to phosphatases are available, 
and using these, cells which show activity can be distiguished 
from enzyme negative cells in the flow cytometer. This was 
demonstrated by Watson et al. (1979) and Haskill et al. (1983) 
using the substrates 3-0-methyl fluorescein phosphate and 
flavone-3-diphosphate, respectively. Watson et al. stained mouse 
mammary tumours for alkaline phosophatase for analysis in the 
flow cytometer. 3-0-methyl fluorescein phosphate is ionised at 
physiological pH and would not be expected to penetrate the cell 
without prior dephosphorylation by membrane phosphatases. 
Microscopic observation led the authors to conclude that the ring 
of fluorescence observed corresponding to the cell membrane was a 
result of product formation at the cell surface and some of the 
fluorescent product remaining associated with the plasma 
membrane•
The possible link between the neoplastic state and the level
of activity of alkaline phosphatase is therefore open to study 
using flow cytometric analysis. In this section the level of 
alkaline phosphatase in the JB1 and BL9L cell lines was examined 
both quantitatively and by flow cytometric analysis, and the 
possible changes in enzyme activity in the livers of rats fed 
AFB^ investigated.
(b) Histochemical staining of tissue sections and cell lines for 
alkaline phosphatase
The alkaline phosphatase activity of JB1 and BL9L cells was 
demonstrated histochemically by staining the cells as described 
in Chapter 2.5 (b).
A monolayer of JB1 and BL9L cells is shown under brightfield 
illumination in Plate 3.15. After staining for alkaline 
phosphatase, the JB1 cells stain red whereas the BL9L cells show 
no positive staining (Plate 3.16).
Acetone fixed sections of liver from rats fed aflatoxin B^ 
for 10 weeks and from control animals were also stained for 
alkaline phosphatase using the histochemical stain. The bile 
ducts showed positive staining in both control and fed livers 
(Plates 3.17 and 3.18). However control livers showed no 
parenchymal staining (Plate 3.19) whilst fed liver sections, 
stained for activity, showed a few areas of cells where distinct 
membrane staining could be seen (Plate 3,20). The number of such 
areas showing alkaline phosphatase activity was much smaller than 
the number of areas showing GGT activity.
Sections treated with 15% acetic acid for 15 min to 
inactivate alkaline phoshatase showed no staining whatsoever.
Frozen sections were also stained for alkaline phosphatase 
activity, but no more positive staining areas could be observed 
than when acetone fixed sections were used.
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Plate J .15
A mixed culture of JB1 and EL9L cells under brightfield  
illumination (x 448).
P la te  3 .1 6
Admixed culture of JB1 and BL9L cells stained for alkaline 
phosphatase ac tiv ity  (x 448) .
1'4*
P la te  3 .17
L iv e r  s e c t io n  from  a c o n t ro l r a t  show ing b i le  duc ts  s ta in in g  
p o s i t i v e ly  f o r  a lk a l in e  phosphatase a c t i v i t y  ( x  1 4 0 ).
Plate 3.18 -
Liver section from a rat fed 4 ppm AFB^  for 10 weeks, showing
bile  ducts staining positively for alkaline phosphatase activ ity  
(x 140)
Plate 3.19
Liver section from a control ra t showing no parenchymal cells  
staining positively for alkaline phosphatase activ ity  (x 140).
Plate 3.20
Liver section from an AFB^  fed rat showing some hepatocytes 
staining positively for alkaline phosphatase activ ity  (x 140).
(c) Quantitation of alkaline phosphatase activity in cell lines
The alkaline phosphatase content of JB1 and BL9L cells was 
quantitated by the ability of cell sonicate to hydrolyse 
p-nitrophenyl phosphate as described in Chapter 2.4 (b).
Measurement of the amount of enzyme in the two cell lines 
gave the following result:
JB1 13.31+1.18 nmoles p-nitrophenol/10* cells/min
BL9L 0.83+0.12 nmoles p-nitrophenol/10* cells/min
These results are the means and standard errors of 8 
measurements where 2 plates of cells were pooled for each 
measurement.
Variation in the amount of alkaline phosphatase for both 
cell types appeared to depend on the degree of confluency of the 
cell. The more confluent the plate of cells, the lower the 
concentration of alkaline phosphatase.
However the amount of alkaline phosphatase was always 10-20 
times greater in JB1 cells compared with BL9L cells.
(d) Fluorescent staining for alkaline phosphatase
Watson et al. (1979) used a fluorogenic substrate for 
alkaline phosphatase to stain mouse mammary cells for analysis in 
the flow cytometer.
This substrate, 3-0-methyl fluorescein phosphate (MFP), was
employed to determine if differences in the alkaline phosphatase 
activities of the two cell lines and of hepatocytes isolated from
control and aflatoxin fed animals could be distinguished in
/
the flow cytometer.
JB1 and BL9L cells were stained for enzyme activity as 
described in Chapter 2.6 (c).
BL9L cells showed only a background dull green fluorescence 
too faint to be photographed, however JB1 cells emit bright green 
fluorescence after staining. A photograph of a mixed culture of 
JB1 and BL9L cells stained for alkaline phosphatase using this 
fluorescent substrate is shown in plate (3.21).
Dewaxed acetone fixed sections of AFB^ fed rat liver and 
control rat livers were similarily stained using this fluorescent 
substrate, however no differences in the staining of such 
sections from treated animals were detectable above the 
background dull green fluorescence of the control animal 
sections.
(e) Flow cytometric studies of alkaline phosphatase content
JB1 and BL9L cells were stained for alkaline phosphatase for 
flow cytometric analysis as described in methods. The results of 
this analysis are shown in cytograms and histograms in Figs 3.17 
and 3.18.
Almost complete separation of JB1 and BL9L cells could b£ 
achieved using this fluorescent staining method.
Hepatocytes derived from control and AFB^ fed animals were 
then stained for alkaline phosphatase using this fluorescent
Plate 3.21
A mixed culture of JB1 and BL9L cells stained for alkaline 
phosphatase ac tiv ity  with the substrate 3- 0-inethyl fluorescein 
phosphate (x 70).
substrate. The results are shown in Figs 3.19 and 3.20. The cells 
in region 1 were identified as being dead cells, as cells killed 
by incubation with CCl^ from both control and treated animals had
t
very low fluorescence intensities. The viable cells from the 
control animal show higher mean fluorescence intensity than those 
from the A'c£/ jeA animal. This was repeated on several occasions 
using animals which had been fed AFB^ contaminated diet for 
differing periods and the same result was obtained each time.
Fig 3.17 Flow cytometric analysis of JB1 cells stained for
alkaline phosphatase activity with the fluorogenic substrate 
3-0-methyl fluorescein phosphate.
Fig 3.18 Flow cytometric analysis of BL9L cells stained for
alkaline phosphatase activity with the fluorogenic substrate 
3-0-methyl fluorescein phosphate.
Fig 3.19 Flow cytometric analysis of control rat hepatocytes
stained for alkaline phosphatase activity with 3-0-methyl
fluorescein phosphate.
Fig 3.20 Flow cytometric analysis of hepatocytes from an AFB1 
fed animal, stained for alkaline phosphatase activity with
3-0-methyl fluorescein phosphate.
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(f) Summary
Reports of carcinogen feeding affecting the levels of 
alkaline phosphatase in rat liver (Emmelot and Bos, 1969, 
Karasaki, 1975) suggested that this might be another marker for 
preneoplastic cells.
Sections of liver from control rats and animals fed AFB^ 
were fixed and stained histochemically for activity of the
enzyme. In addition to the positive staining of the bile duct
cells of both control and AFB^ fed rats, small areas of positive 
membrane staining were observed in liver sections from AFB^ fed 
animals, although no positive staining hepatocytes were found in 
sections from control rat liver. Cells from the two cell lines 
were also stained for alkaline phosphatase activity, and JB1
cells (hepatoma derived) were positive for the enzyme whereas
BL9L cells were negative. The enzyme activity was quantitated in
the two types of cell and the JB1 cells were found to have
between 10 and 20 times the activity of BL9L cells. The cell line
system was therefore an appropriate model for analysis of this
parameter in the flow cytometer. Cells from these two cell lines,
-tW>se
andy^isolated from control and AFBj fed animals were then stained 
with a fluorescent substrate for the enzyme and assayed flow
cytometrically.
In accordance with the histochemical staining, considerable 
differences were observed in the fluorescent staining of the cell 
lines, JB1 cells showed much higher fluorescence intensites than 
the BL9L cells. However when the system is applied to primary 
hepatocyte suspensions isolated from control and AFB^ fed
animals, the population of viable cells present in the 
preparations isolated from AFB^ fed animals showed lower mean 
fluorescence intensity than did the corresponding cells from a 
control animal.
Kitagawa (1971) has reported lower alkaline phosphatase 
activity in preneoplastic cells from rats fed 
2-fluorenylacetamide (2-AAF). However, it does not appear that 
this can be the explanation of the anomaly encountered in the 
present study, as the flow cytometric results are contradictory 
with those from histochemical staining of liver sections.
The lack of correlation between the histochemical and 
fluorescent detection of enzyme activity in hepatocytes from 
control and AFB1 fed animals contrasts with the situation using 
the cell lines where both methods of detection of enzyme activity 
were in agreement. The unexpected result obtained when 
hepatocytes from control and carcinogen fed rats were 
fluorescently stained for alkaline phosphatase may be the result 
of some constituent, present in the primary hepatocytes, 
quenching the fluorescence of the product formed by the enzymic 
reaction. Alternatively some other enzyme may be reacting with 
the substrate resulting in the fluorescent product being formed 
to a greater extent in the cells from control animals compared to 
the AFB1 fed animals.
Therefore it appears that this marker could be useful if an 
alternative fluorescent probe could be obtained which did not 
have these associated difficulties.
3.5 Guanidinobenzoatase: an enzyme associated with tumour cells
(a) Introduction
f
The ability of tumour cells to invade into normal tissue and 
form metastases distant from the primary site is generaly 
considered to be the major cause of mortality due to cancer. For 
this reason, many groups have examined tumour cells to determine 
the properties which have been acquired to allow this 
infiltration.
The increase in protease production at the plasma membrane 
of transformed cells has been suggested as a possible mechanism 
of invasiveness. The effect of tumour cell protease production on 
the normal extracellular tissue matrix has been examined (Liotta 
et al.. 1980, Jones and DeClerck, 1980) and, in addition, the 
ability of some cancer cells to cause host cell cytolysis has 
been suggested to result from the action of trypsin-like serine 
proteases (DiStefano et al.. 1982).
Steven and Al-Ahmad (1983) reported the presence of a 
trypsin-like enzyme in the ascitic plasma surrounding Ehrlich 
ascites tumour cells and in normal mouse serum. This enzyme 
differs from trypsin in that it will continuously cleave
4-nitrophenol-p-guanidinobenzoate and 4-methylumbelliferyl-p- 
guanidinobenzoate (Coleman et al.. 1976) which are used as
active-site titrants of trypsin. For this reason Steven and 
Al-Ahmad (1983) called the enzyme guanidinobenzoatase.
In a subsequent paper, Steven et al. (1985) described the 
preparation of a number of fluorescent probes for the active site
of this enzyme. These probes could be used to stain cells 
possessing the enzyme in sections of fixed tissue. 
Guanidinobenzoatase was found to be present on a number of types 
of tumour cells and also in some normal cells such as squamous 
epithelial cells and foetal cells. Most of the normal cells which 
show positive staining are, however, migratory in nature. Many 
normal tissues do not stain positively for the enzyme for example 
breast tumour cells show fluorescence after staining for the 
enzyme while no fluorescence is emitted by normal breast tissue. 
Similarly bladder tumour cells can be clearly distinguished 
against the normal cells when stained for guanidinobenzoatase 
(Steven et al.. 1985).
The ability to probe for the enzyme guanidinobenzoatase by 
fluorescent means suggests that it may be possible to distinguish 
tumour cells from normal cells using flow cytometry. Accordingly 
sections of liver derived from normal and AFB^ fed rats were 
stained for the enzyme, as were the two liver cell lines, using 
two of these fluorescent probes.
The two probes used to stain fluorescently for 
guanidinobenzoatase were 9-aminoacridine and N«-dansyl- 
homoarginine both of which bind to the active site of the enzyme 
and are competitive inhibitors. Fluorescence emission alters 
according to the concentration of 9-aminoacridine used to stain 
tissue sections, as this probe will undergo molecular stacking at 
the active centre of the enzyme. N«-dansyl-homoarginine emits 
light maximally at 520nm when excited by UV light. When bound to 
cells the emission maximum drops to 340nm.
(b) Staining tissue sections for guanidinobenzoatase
Sections of liver from rats fed AFB or control diet were
t *
stained for the enzyme guanidinoabenzoatase with 9-aminoacridine 
as described in Chapter 2.6 (d). The sections of liver were
either fixed in buffered formalin or were frozen sections. Cold 
acetone fixed sections showed no staining. The results are shown 
in Plates 3.22 and 3.23. In contrast to the result reported by 
Steven et al. (1983) for other tissue types, the normal liver 
tissue shows considerable background yellow fluorescent staining 
of the cell membrane. The sections from AFB.^  fed animals showed 
areas where cells exhibited a brighter fluorescence than the 
surrounding tissue, however these areas were not so numerous or 
of the same size as GGT positive foci found in sections from the 
same animals. No difference in staining was found between 
formalin fixed and frozen sections.
JB1 and BL9L cells grown on coverslips and fixed in formalin 
were also stained with 9-aminoacridine and are shown in Plates 
2.24 and 2.25. The JB1 cells showed a greater fluorescence 
intesity than the BL9L cells.
(c) Staining whole cells for guanidinobenzoatase
Cell lines and hepatocytes derived by collagenase perfusion 
were stained for guanidinobenzoatase using Noc-dansyl-homoarginine 
as this is more suitable for unfixed cells than 9-aminoacridine 
(F.S. Steven, personal communication) as described in Chapter 2.6
Plate 3.22
Liver section from a control animal stained for guanidinobenzo­
atase with 9-aminoacridine (x 1370).
Plate 3.23
Liver section from an AIB, fed animal stained for guanidino- 
benzoatase with 9-aminoacridine (x 1370).
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Plate 3.24
JB1 cells stained for guanidinobenzoatase with 9-aminoacridine 
(x 1370).
Plate 3.25
BL9L cells stained for guanidinobenzoatase with 9-aminoacridine 
U  1370).
Figs 3.21 and 3.22 show JB1 and BL9L cells stained for 
guanidinobenzoatase using this fluorescent probe. The staining 
patterns are different, with the JB1 cells having a higher mean 
fluorescence intensity than the BL9L cells. However the overlap 
in fluorescence emitted by the two types of cells is probably too 
great for successful separation on this parameter. A filter 
specific for the emission wavelenght may improve resolution of 
the fluorescence peaks. Hepatocytes derived from a control 
Fischer rat and an animal fed 1 to 2 ppm AFB1 in the diet for 10
weeks were also stained for the enzyme using
N^-dansyl-homoarginine. There is a sub-population of cells 
amongst those derived from the AFB.^  fed animal which show a 
higher mean fluorescence intensity than the main population. 
Around 25% of the total population show this greater staining
intensity (Fig 3.23). Only a very few cells from the control 
animal stain with this degree of fluorescence intensity (Fig
3.24).
Fig 3.21 Flow cytometric analysis of JB1 cells stained for 
guanidinobenzoatase using the fluorescent probe N«-dansyl- 
homoarginine.
t
Fig 3.22 Flow cytometric analysis of BL9L cells stained for 
guanidinobenzoatase using the fluorescent probe N«-dansyl- 
homoarginine.
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Fig 3,23 Flow cytometric analysis of hepatocytes derived from 
a rat fed 1 to 2 ppm AFB^  ^ for 10 weeks stained for 
guanidinobenzoatase with N^-dansyl-homoarginine,
Fig 3.24 Flow cytometric analysis of hepatocytes derived from 
a control animal stained for guanidinobenzoatase with
N^-dansyl-homoarginine
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(d) Summary
The importance of tumour associated protease activity in 
terms of malignant spread has already been refered to. The 
development of fluorescent probes for a tumour associated 
trypsin-like enzyme, guanidinobenzoatase, could provide important 
tools for the analysis of the malignant potential of tumour cells 
in the flow cytometer. In addition this could lead to the 
separation of neoplastic cells of varying degrees of malignancy 
from each other and from normal cells. As the probes for 
guanidinobenzoatase have been reported to be immobilised by 
binding to the active site of the enzyme, the problems of 
solubility of the fluorescent product, encountered using 
fluorogenic substrates for GGT and alkaline phosphatase, would 
presumably not be arise in this case.
Sections of rat liver from control and AFB^ fed animals were 
stained for the enzyme using the probe 9-aminoacridine. Sections 
from both normal and AFB1 fed animals showed considerable 
background yellow fluorescence, but in addition some areas of 
brighter fluorescence could be observed in the liver sections 
from carcinogen-treated animals. The reasons for this high 
background are not clear. Some non-hepatic normal cells have been 
reported to exhibit this enzyme activity but this has usually 
been associated with a migratory nature. However, despite the 
background staining, it did appear using the liver sections, that 
it is possible to detect, fluorimetrically, areas of increased 
guanidinobenzoatase activity resulting from feeding the 
hepatocarcinogen.
Whole cells from the two cell lines and also derived by 
collagenase perfusion from the livers of control and AFB^ fed 
Fischer 344 rats, were examined for the presence of
guanidinobenzoatase using a different fluorescent probe, 
N®-dansyl-homoarginine. Differences in the degree of fluorescent 
staining were observed between the JB1 and BL9L cells with the 
tumour-derived cells exhibiting the higher levels. In agreement 
with the results of the fluorescent staining of the liver 
sections, a population of highly fluorescent cells was
distinguished amongst he patocytes derived from animals fed AFB^ 
contaminated diet which was not observed in hepatocyte
preparations from control animals. These results suggested that
the Ntt-dansyl-homoarginine was staining for a preneoplasia or 
neoplasia associated enzyme.
A high background staining, observed when using 
9-aminoacridine on liver sections, was not encountered when the 
isolated cells or cell lines were stained with 
N«-dansyl-homoarginine and the fluorescence quantitated in the 
flow cytometer. This may have been the result of more extensive 
washing being achieved by the centrifugation procedure used when 
preparing the cell suspensions for flow cytometry, or 
alternatively the 9-aminoacridine may bind nonspecifically to 
some other component of liver cells. Fixation in formalin did not 
affect the degree of background staining, as frozen sections 
showed the same effect. The explanation of this phenomenon 
requires further investigation. However the results from this 
study indicate that staining for the trypsin-like tumour 
associated protease, guanidinobenzoatase, deserves further
examination by flow cytometric analysis. It could also be of use 
in sorting possible populations of differing degrees of 
malignancy but this clearly requires further study.
3.6 Induction of resistance to adriamycin by aflatoxin
(a) Introduction
Adriamycin is one of a group of anthracycline antibiotics 
isolated from the Streptomyces species. These anthracycline 
antibiotics were found to have an antileukaemic action, and
adriamycin is now widely employed as a chemotheraputic agent
(DiMarco, 1975). The drug has been used as a single agent or in 
combination chemotherapy to treat, with varying degrees of 
response, a range of different cancers including leukaemias,
breast cancer, hepatocellular carcinoma and small cell carcinoma 
of the lung (Crooke 1981).
Since the anthracyclines have been used as anticancer 
agents, a considerable amount of work has been performed to 
ascertain the mechanism of cytotoxicity. For some time 
cytotoxicty was attributed to the ability of the drug to bind, by 
intercalation, to DNA (DiMarco, 1971). This intercalation was 
thought to inhibit DNA and RNA polymerase activity thereby 
blocking mitosis and preventing tumour cell proliferation 
(Goodman et al.. 1977). However no correlation has been found
between the binding affinities of a number of anthracyclines to 
DNA and their antitumoral activity (Aubel-Sadron and
Londos-Gagliardi, 1984).
Another proposed mechanism has been catalysis of the 
anthracycline to a free radical form (Bachur et al.. 1979, 
Doroshow and Reeves, 1981) causing degradation of the DNA or 
inducing lipid peroxidation.
As the most important cause of treatment failure in cancer 
chemotherapy is due to the development of resistance to the drug 
by the malignant cells, a number of groups have studied 
differences in the effect of anthracycline on normal and 
malignant cells.
Differences found in the intracellular drug concentrations 
of cells resistant and sensitive to anthracyclines led to the 
proposition of decreased influx and/or increased efflux of the 
drug being the mechanism of resistance (Inaba and Johnson, 1978, 
Inaba et al.. 1979, Skovsgaard 1978). However a recent study 
(Siegfried et al.. 1983) has shown that the intracellular content 
of daunorubicin is not directly related to the varying resistance 
of sublines of Sarcoma 180 cells.
An increasing amount of evidence is appearing to support the 
concept that the structure of the plasma membrane itself may 
determine the cells resistance or sensitivity to the 
anthracyclines. It has been found that adriamycin does not need 
to penetrate the cell to exert its cytotoxic effect (Tritton and 
Yee, 1982, Zokes et al. 1982). If the drug is immobilised on an 
inert support of agarose or polyglutaraldehyde beads it can 
retain its cytotoxic effect on murine cells in culture.
In addition drug bound to an inert susbstrate in this way is 
more cytotoxic to a cell population which shows resistance to the 
free drug. The authors explain this as the result of multiple and 
repititious interactions of bound drug with the cell surface 
resulting in membrane perturbation.
The structure of adriamycin - a relatively hydrophobic 
aromatic ring structure with a positively charged side group -
(Fig 3.25) suggests an affinity for lipid bilayers, and therefore 
the cell membrane as a likely site of action. Adriamycin has been 
shown to affect the cell surface in a number of ways. Low 
concentrations of adriamycin cause an increase in the 
agglutination of Sarcoma 180 cells by Concanavalin A (Murphee 
et al.. 1976). Adriamycin has also been shown to increase the 
glycosylation of surface proteins in P388 cells (Kessel, 1979), 
and to regulate upwards the numbers of growth factor receptors in 
3T3 and Hela cells (Zuckier and Tritton, 1983).
In addition, alterations in plasma membrane composition seem 
to be associated with cellular resistance to these drugs. In an 
early study (Riehm and Biedler, 1972), Chinese hamster cells 
resistant to actinomycin D and daunomycin were grown in the 
non-ionic detergent Tween 80. Tween 80 caused a marked 
potentiation of drug effect, suggested to be the result of 
increased permeabililty of the cell membrane to the drug.
The relative membrane fluidities of resistant and sensitive 
cells have been compared for three different cell types (Rintoul 
and Center, 1984, Wheeler et al.. 1982, Siegfried et al.. 1983). 
In each case the resistant cells were shown to have a greater 
degree of membrane fluidity. In two of these studies (Wheeler et 
al.,1982, Siegfried et al.. 1983), there was a correlation 
between the degree of resistance of sublines and the membrane 
fluidity.
Differences in the glycoprotein composition of the membranes 
of sensitive and resistant cells have also been observed (Yee et 
al., 1984, Peterson et_al., 1983, Kartner et al..1983). It is
unclear how the appearance of the glycoproteins reported are
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related to the development of resistance. It has been suggested 
that these proteins may be the products of amplified genes.
Of particular interest with regard to this study, has been 
the work of Carr and Laishes (1981a, 1981b) on the induction of 
resistance to a range of drugs in hepatocytes from 
hepatocarcinogen treated rats. It was found that feeding of 
2-acetylaminofluorene (2-AAF) to rats resulted in the appearance 
of a population of cells resistant to the toxic effects of 
methotrexate, adriamycin, cycloheximide and aflatoxin B^. 
Hepatocytes from untreated rats were sensitive to these agents. 
This was found to be an early phenotypic change with resistance 
becoming apparent after 24 hours of carcinogen feeding, and most 
of the increase in resistance occuring within 1 week of 
continuous feeding.
Differences in the intracellular content of anthracycline 
drugs between resistant cell lines has been reported in several
studies (Inaba and Johnson, 1978, Skovsgaard, 1978, Yanovich and
Taub, 1983) Recently this observation and the fluorescent
properties of the anthracyclines have led to the use of flow 
cytometry as a method of determining the anthracycline content of 
individual cells within a population (Krishan and Ganapathi, 
1980, Durand and Olive, 1981, McGown et al.. 1983, Nooter et al..
1983)
As feeding with 2-AAF gives rise to an adriamycin-resistant 
cell population, it would seem possible that feeding with 
aflatoxin should also have this effect. The resistant
population induced may then exhibit the reduced intracellular 
content of adriamycin as seen in other anthracycline-resistant
cell types. If this were the case, because of the highly 
fluorescent nature of the anthracyclines flow cytometry could be 
used as a means to identify and quantitate such resistant cells.
(b) Toxicity of adriamycin to JB1 and BL9L cells
The hepatoma derived cell line JB1 has been shown previously 
to be resistant to the cytotoxic properties of adriamycin, 
whereas the BL9L cell line is sensitive to the drug (G.E. Neal 
personal communication)•
To confirm these findings, plates of confluent JB1 and BL9L 
cells were incubated overnight with adriamycin in PBS at 0, 0.86, 
1.72, and 4.31 pM
At 0.86 jiM adriamycin the BL9L cells were beginning to show 
signs of cytotoxicity, and the degree of cell damage increased 
with increasing concentrations of the drug (Plates 3.25 - 3.28)
At the highest concentration, a monolayer of still attached cells 
was observed. However, when the very large number of detached 
cells was washed off, these cells also showed signs of 
cytotoxicity (Plate 3.29). At the highest concentration of the 
drug, JB1 cells showed few signs of cytotoxicity (Plates 3.30 and 
3.31).
The viability of JB1 and BL9L cells after treating with 
adriamycin was assayed by incubating the cells overnight with 
concentrations of the drug between 0 and 4.31 nM in complete 
Williams E medium. Cells detached from the dish were retained and 
cells remaining attached to the plastic were removed with 
trypsin. Viability was assayed by trypan blue exclusion. The 
results given in Table 3.4 are the means of duplicate plates.
Adriamycin affects 'both the yield and the viability of the 
BL9L cells to a greater extent than the JB1 cells. The number of 
BL9L cells which detach from the dishes (results not shown)
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Table 3.4 Yields and viabilities of cell lines following 
incubation with adriamycin.
Concentration o'f BL9L
adriamycin nM viable
0 88.6
0.86 69
1.72 55.7
4.31 32.6
cells JB1 cells
yield viable yield
100 77 100
82 69 79
46 76 72
49 65.5 81
Values given are the mean percentages of duplicate plates.
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Cytograms of JB1 and BL9L cells after Incubation with 10 pM 
adriamycin are shown in Figs 3,27 and 3.28. The peak fluorescence 
channel was determined from the fluorescence histogram for each 
sample. A representative graph of peak fluorescence channel 
against incubating concentration is shown in Fig 3.29.
The intracellular content of adriamycin in hepatocytes 
isolated by collagenase perfusion from an animal fed AFB ^ for 16 
weeks and an age-matched control animal were analysed by flow 
cytometry as described in Chapter 2.6 (e). The cells were 
incubated with adriamycin at concentrations between 0 and 25pM. 
The peak fluorescence channel was determined and plotted against 
adriamycin content(Fig 3.30).
From cytograms 3.31 and 3.32 differences can be seen in the 
mean fluorescence of cells from control and AFB^ fed animals. 
There may be two populations of cell with different fluorescence 
intensities amongst the hepatocytes from the AFB^ fed animals 
although there seens to be some evidence of two populations of 
slightly different fluorescence intensity in the cells derived 
from the control animal also. The existance of separate 
populations did not alter with the length of time the animal h&d 
been on AFB^ diet, as animals fed AFB^ for between 8 and 16 weeks 
showed very similar patterns. Hepatocytes from a control animal 
killed by incubation with CCl^ have a reduced intracellular 
content of AdR (Fig 3.33). The two populations obtained may 
therefore be a function of the viabilities of the cells after 
incubation with the drug. This does not, however, explain why all 
the cells from the AFB1 fed animal have a reduced fluorescence 
intensity compared to the control animal cells.
Fig 3.27 Flow cytometric analysis of JB1 cells after
incubation with 10 pM adriamycin.
Fig 3.28 Flow cytometric analysis of BL9L cells after 
incubation with 10 pM adriamycin.
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Fig 3.29 Fluorescence emitted by JB1 and BL9L cells following 
incubation with adriamycin.
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Fig 3*30 Fluorescence emitted by hepatocytes derived from 
control and AFB^ fed rats following incubation with 
adriamycin.
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Fig 3.31 Flow cytometric analysis of hepatocytes from a
control rat incubated with 10 pM adriamycin.
Fig 3.32 Flow cytometric analysis of hepatocytes from a rat 
fed 1 to 2 ppm AFB^ for 10 weeks, incubated with 10 pM 
adriamycin.
Fig 3.33 Flow cytometric analysis of hepatocytes incubated
with CC1, before incubation with adriamycin.
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(e) Summary
Reports of the induction of a liver cell population 
resistant to the effects of a number of toxic substances 
including the drug adriamycin, following feeding with the 
carcinogen 2-AAF (Carr and Laishes, 1981a, 1981b), resulted in 
the study of similar effects following feeding with aflatoxin B^.
Initially the toxicity of adriamycin to two liver cell lines 
was examined, and the hepatoma derived line was found to be 
resistant to concentrations 10 times greater than could be 
tolerated by the cell line derived from normal hepatocytes.
The intracellular content of the drug was also considerably 
reduced in the hepatoma derived line as opposed to the 'normal' 
cell line. This was established both by extraction of adriamycin 
from the cells following incubation with the drug and by flow 
cytometric analysis of the cells. There was some variation in the 
effect of the drug on the individual cells of the BL9L 
population. With increasing concentrations of the drug larger 
proportions of the cells detached from the dish and were shown 
not to exclude trypan blue. However even at the highest 
concentration, a small population of cells remained viable 
following incubation with adriamycin.
The intracellular content of cells derived from AFB^  ^ fed 
rats and control animals was also analysed by flow cytometry. The 
cells from control animals gave consistently higher mean 
fluorescence intensity than did the AFB^  ^ fed animal. It was 
anticipated that two populations of differing mean fluorescence 
intensities would be observed amongst the cells of the AFB^ fe(j
animal, corresponding to the normal cells, and the drug resistant 
population. However two distinct populations could not be
resolved and the reasons for this remain unclear. One explanation
/
for the inability to distinguish two populations could be that
feeding of AFI^ causes a change in the response of all the
hepatocytes in the liver to the cytotoxic effects of adriamycin 
and not simply to those cells which are defined to be
preneoplastic. This would therefore cause a difference in the 
intracellular content of the drug in all the cells in the
population from the AFB^ fed animal as compared to the control 
animal. This would result in a decreased mean fluorescence 
intensity of the cells from the animals which have received the 
carcinogen if compared to the fluorescence intensity of the cells 
from a control animal, as is observed following flow cytometric 
analysis.
3.7 Changes in cellular thiol content during liver 
carcinogenesis.
t
(a) Introduction
One of the earliest changes hypothesised to occur during the 
carcinogenic process is the development, in a few hepatocytes, of 
resistance to the cytotoxic properties of carcinogens (Farber, 
1979). If these resistant hepatocytes undergo proliferation, foci 
of altered cells would develop eventually leading to the 
production of neoplastic nodules.
Hepatocytes isolated from rats fed a carcinogenic regime, 
have been reported to have decreased sensitivity to the 
carcinogen. Compounds which have this effect include aflatoxin 
(Judah et al.. 1977), N-nitrosodiethylamine and N-methyl-
N-nitrosourea (Solt et al.. 1980), and 2-acetylaminofluorene,
(2-AAF), (Farber et al.. 1976).
In addition, certain hepatocarcinogens induce cellular 
resistance to other toxic compounds. For example, the feeding of 
2-AAF in the diet to rats results in resistance of their 
hepatocytes to the cytotoxic effects of adriamycin (Carr and 
Laishes, 1981).
Dimethylnitrosamine (DMN) is a carcinogenic and mutagenic 
compound which is microsomally activated mainly in the liver and 
results in alkylation of cellular components such as DNA, RNA and 
protein (Pegg, 1977). Other groups have suggested that there is 
also activation of the carcinogen by monoamine oxidases (Lake 
et al.. 1977). 06-methylguanine is o* product of DNA alkylation
by DMN and is thought to be c \, mutagenic lesion. The liver has 
an enzymic system which is involved in the repair of 
0*-methylguanine lesions in DNA (Pegg and Hui, 1978). These 
enzymes appear to act by the transfer of the alkyl group to a 
protein acceptor site (Mehta et al.. 1981).
It has been observed that pretreatment of rats with a low 
dose of a carcinogen results in an increase in repair of 
0«-methylguanine lesions after administration of an acute dose of 
an alkylating agent such as DMN (Buckley et al.. 1979, Montesano 
et al.. 1980, Chu et al.. 1981). This has therefore been
suggested as a possible mechanism for the development of cellular 
resistance to cytotoxic compounds. The effect has been suggested 
to be the result of induction of a specific system of repair of 
0*-methylguanine lesions or of a general mechanism for repair 
(Buckley et al.. 1979). The latter seems more likely as the
effect is initiated by chemically distinct classes of carcinogen 
which have different mechanisms of action.
Neal et al. in 1981 suggested that increased levels of 
glutathione (GSH) and glutathione S-transferase
(GSH-transferase), in the altered cells induced by AFB^, result 
in these cells being resistant to the toxic effects of the 
carcinogen. These authors showed that GSH is elevated in those 
areas of liver with high levels of GGT, as did Demi and Oesterle 
(1980) on feeding animals with diethylnitrosamine. Neal and Green 
(1983) also studied the effect of AFB^ feeding and partial 
hepatectomy on levels of GSH-transferase. The treatment was found 
to increase the levels of all GSH-transferases, whereas no change 
was found in control animals given partial hepatectomy only.
Kitahara et al. (1984) studied the changes in the molecular 
forms of GSH-transferases during rat hepatocarcinogenesis. These
authors found that a placental form of GSH-transferase which is
/
found only at low levels in normal liver is induced in livers 
having preneoplastic nodules.
Glutathione is known to have a wide range of functions in 
the mammalian cell including involvement in protein and DNA 
synthesis, maintainance of membrane integrity and cytoskeletal 
organisation, and drug biotransformation (Orrenius and Moldeus,
1984). GSH is a strong nucleophile which will react with 
electrophilic carcinogen metabolites to form glutathione 
conjugates. These reactions are catalysed by glutathione 
S-transferase enzymes found in some form in all mammalian tissues 
and usually as a number of isoenzymes (Ketterer et al.. 1983). It 
is generally thought that the multiplicity of enzymes is required 
to deal with the variety of substrates, although they do exhibit 
a high degree of overlap in substrate specificity.
The induction of increased levels of GSH and 
GSH-transferases were selected for examination in this study 
because they are known to undergo alterations in levels during 
AFB1 carcinogenesis and because of the availibility of suitable 
fluorescent probes. Alterations in the levels of GSH and 
GSH-transfserases or in the molecular forms of the 
GSH-transferases in the hepatic cytosol following feeding with a 
carcinogen could provide a means of identifying and quantitating 
preneoplastic cells and could subsequently facilitate separation 
of the preneoplastic cells from the normal population.
Recently, fluorogenic substrates for measuring thiols have
been reported (Curtis and Cowden, 1980, Andrews et al.. 1982, 
Hulbert and Yakubu, 1983). A number of these types of thiol 
substrates were studied by Durand and Olive (1983) as a means of 
identifying cells having elevated levels of thiols using flow 
cytometry.
One of these substrates, monobromobimane, was reported by 
these authors to readily penetrate viable cells, and on reacting 
with thiols is highly fluorescent. In addition the stability of 
the reagents within the cells suggested that binding was 
irreversible.
Monobromobimane (mBrB) reacts with GSH to form a fluorescent 
glutathione conjugate. This reaction proceeds slowly non- 
enzymatically, but at a rapid rate when catalysed by 
GSH-transferases (Hulbert and Yakubu, 1983), and has a broad 
specificity for the GSH-transferases (P.B. Hulbert, personal 
communication).
When this fluorochrome is employed in cell free systems, it 
can be used in the presence of added excess GSH to determine 
glutathione S-transferase levels, or in the presence of added 
excess GSH-transferases to quantitate reduced glutathione levels. 
In intact cell systems such as those required for flow cytometry, 
the lack of penetration of GSH or GSH-transferse enzymes into the 
cell will possibly cause the reaction to be rate limited by 
either the S-transferase levels or the GSH level. However, in the 
cells to be examined in the present study elevated levels of both 
the systems have been reported to be present. Another possible 
limitation could be the rate of entry of mBrB into the cell.
The increases in GSH and GSH-transferases induced in some
hepatocytes by feeding with AFB^ could therefore be determined by
flow cytometric analysis of cells from these animals incubated
with a substrate such as this.
In initial studies of this parameter differences in the
intracellular fluorescence of the two cell lines following
incubation with monobromobimane was observed. The glutathione
content of the cells was quantitated, and the toxicity of the
*
substrate to the cells was also examined.
(b) Staining cell lines for glutathione
JB1 and BL9L cells were grown on 100mm diameter petri dishes 
until almost confluent. The medium was removed and the monolayers 
washed with HBSS pH 7.0. Monobromobimane (mBrB) was made up to 
1 mM in acetonitrile and diluted in HBSS pH7.0 to give a range of 
concentrations between 1 and 20 pg/ml. The mBrB in HBSS was then 
added to the plates of cells and the cells were examined at 
intervals during the incubation period. Control plates of cells 
were treated with acetonitrile only.
The degree of fluorescence emitted by the two cell types
following incubation with mBrB is shown in Table 3.5. The scores 
are for the general appearance of the monolayer although there 
was some variation in the amount of fluorescence in individual 
cells. At all concentrations of the substrate, those cells which 
were floating above the monolayer, were brightly fluorescent, and
were assumed to be dead from their appearance.
(c) Toxicity of monobromobimane to cell lines
After the incubation period with mBrB, the substrate was 
removed, the monolayers were washed 3 times with HBSS and then 
replaced with complete Williams E Medium. The following day, the 
effect of the substrate on cell viability was assessed 
subjectively by the degree of detachment of the cells from the 
monolayer, and the refractile nature of the cells. This
assessment is shown in Table 3.6.
The mBrB does not appear to be toxic to either cell type at
Table 3.5 Fluorescence emitted by cells following incubation 
with monobromobimane
Concentration of 
mBrB (|ig/ml)
Degree of cellular fluorescence 
JB1 BL9L
0
1
2.5
5
10
20
+
++
+++
- = no fluorescence, + = faint fluorescence,
++ = bright fluorescence, +++ = very bright fluorescence
Table 3.6 Effect of monobromobimane on cell viability
Concentration of 
mBrB (ng/ml)
Cytotoxicity of mBrB 
JB1 BL9L
0
1
2.5
5
10
20
+
+
++
+
++
+++
+++
- = no effect, + = some cells affected, ++ = many cells affected
+++ = all cells dead
1 pg/ml however some evidence of cytotoxicity is noted in the 
BL9L cells at 2.5 pg/ml. The cytotoxicity of the compound to BL9L 
cells increases with increasing concentration, and at 10 |ig/ml 
has killed all cells exposed to a 30 min incubation. JB1 cells 
are more resistant to the substrates cytotoxic effects.
As the cells which are dead before exposure to 
monobromobimane fluoresce brightly even at very low 
concentrations of substrate, the possibility of membrane 
disruption leading to cell death being required before the drug 
can penetrate into the cell was considered.
The effect of monobromobimane on leakage of lactate 
dehydrogenase (LDH) was therefore assayed as an indication of 
membrane disruption (Story et al.. 1983).
JB1 and BL9L cells were grown on petri dishes until almost 
confluent. The medium was removed, and the monolayers washed with 
HBSS pH 7.0 the cells were then incubated with mBrB in HBSS at 
concentrations from 0 to 45 pg/ml at 37°C. 300 pi aliquots were 
taken from the dishes and asssayed for LDH (Chapter 2.9 (h)) at 
15 min intervals from 0 to 60 min. These readings were then 
compared to the amount of LDH measured in a comparable aliquot of 
sonicate of each cell type.
There was no apparent increase in leakage of LDH from the 
cells during the period of incubation over the range of 
concentrations of mBrB, although the cells did emit fluorescence 
to similar degrees as shown in Table 3.5. After the 60 min 
incubation time, the cells did not appear to be affected 
adversely by the compound, however after 2-3 hours there were 
signs of cytotoxicity particularly at the higher concentrations
of mBrB.
Therefore a small degree of membrane damage may be required 
for penetration of mBrB into the cell, but fluorescence is 
emitted following reaction with thiols before signs of 
cytotoxicity are apparent. Greater resistance to the cytotoxic 
effects of the drug could possibly result in a lower 
intracellular content of mBrB giving low fluorescence. However 
this is not the reason for the differences in fluorescence 
observed between the JB1 and BL9L cells, as the JB1 cells show 
greater resistance to cytotoxicity but also show greater 
intracellular fluorescence following incubation with the drug.
(d) Quantitation of glutathione and glutathione S-transferase in 
cell lines
The amount of reduced glutathione in JB1 and BL9L cell was 
assayed as described in Chapter 2.4 (d).
Three plates of cells of each type were assayed on each 
occasion and the values below are the means and standard errors 
of 4 sets of triplicate measurements made on separate occasions.
JB1 0.0260 + 0.0025 pmoles GSH/10« cells
BL9L 0.0151 + 0.0025 pmoles GSH/106 cells
Monobromomobimane can be used to measure the relative 
amounts of glutathione S-transferase in the two cell lines. 
Cytosolic GSH-transferase is estimated by incubating cell
sonicate with excess GSH and mBrB and comparing the rates of 
fluorescent product formation. Cells were diluted to give the 
same number per ml and rates were directly compared. On each
t
occasion when GSH-transferase was measured there was 4-5 times as 
much cytosolic enzyme in the JB1 cells as compared to BL9L cells. 
Conditions can be created where mBrB is limiting and using these 
conditions the amount of fluorescence due to formation of 
GSH-conjugate produced can be used as a standard in quantitating 
transferase activity using mBrB as a substrate. From this it can 
be determined that JB1 cells have sufficient GSH-transferase to 
allow conjugation of 1.11 + 0.47pmoles mBrB/min/106 cells, and 
BL9L cells will catalyse the conjugation of 0.22 + O.lOpmoles 
mBrB/min/106 cells.
(e) Flow cytometric analysis of cells stained with 
monobromobimane
JB1 and BL9L cells grown on petri dishes were removed with 
trypsin and stained for thiol compounds with monobromobimane as 
described in Chapter 2.6 (f). Analysis of JB1 and BL9L cells
shows that a large population of JB1 cells emit a high mean 
fluorescence intensity. There is also a population which are not 
fluorescent (Fig 3.34). BL9L cells have a much lower mean 
fluorescence intensity, however it is not possible to determine 
if there are two populations, one non-fluorescent, and one with 
low fluorescence emission at the gain on the photomultiplier tube 
necessary in this experiment. (Fig 3.35).
Hepatocytes from control and AFB1 fed animals were also
stained with mBrB. Hepatocytes from a control rat and an animal 
fed AFB^ at 1-2 ppm for 13 weeks stained with the compound are 
shown in Figs 3.36 and 3.37. Samples of both types of cells show 
two populations, one with very low fluorescence intensity, and 
one with higher fluorescence intensity. There are a greater 
proportion of cells with the higher fluorescence intensity 
amongst the cell population from the AFB.^  fed animal.
It is not possible to determine the individual contributions 
of GSH and GSH-transferases to the total fluorescence emission 
observed when using the mBrB staining for flow cytometric 
analysis.
Fig 3.34 Flow cytometric analysis of JB1 cells incubated with 
monobromobimane.
Fig 3.35 Flow cytometric analysis of BL9L cell incubated with 
monobromob imane.
Fig 3.36 Flow cytometric analysis of hepatocytes from a rat 
fed 1 to 2 ppm AFB^ for 13 weeks, incubated with 
monobromobimane.
Fig 3.37 Flow cytometric analysis of hepatocytes from a 
control rat incubated with monobromobimane.
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(f) Summary
Monobromobimane was used as a substrate for cellular thiols 
to measure quantitatively differences in the concentration of 
glutathione and the enzyme which catalyses the reaction, 
glutathione S-transferases in two cell lines. It was found that 
the hepatoma-derived cell line (JB1) had greater concentrations 
of both GSH and GSH-transferase per cell than did the 
normal-derived cell line (BL9L). In addition, monobromobimane was 
used as a fluorescent stain for cellular thiols allowing these 
two cell lines to be disinguished in the flow cytometer. Two 
populations having differing mean fluorescent intensities could 
be observed in a suspension of JB1 cells. One subpopulation was 
essentially non-fluorescent whilst the other has a high mean 
fluorescence intensity. Histochemical staining for GSH (Smith 
et al... 1979), when the JB1 cell line was first established, 
showed all cells to have approximately equal amounts of 
glutathione (G.E. Neal, personal communication). This suggests 
that during subculturing a subpopulation of cells with a lower 
content of glutathione has become established. The presence of a 
sub-group of cells with lower GSH levels within the JB1 cell 
population would result in the average GSH quantitated per cell 
being artificially low. This would be in agreement with the much 
larger difference in fluorescence intensity observed between the 
subpopulation of JB1 cells containing higher levels of GSH and 
the BL9L cells when flow cytometric analysis is conducted, as 
compared with the differences observed when biochmical analysis 
of the 2 cell lines was carried out.
Monobromobimane was also used for staining hepatocytes 
isolated by collagenase perfusion from normal rats and animals
fed AFB1. There is a wide variation in the degree of staining of
$
cells from both control and experimental animals, which was 
expected since the GSH content of cells varies across the liver 
lobule (Smith et al.. 1979). However there are a greater number 
of cells emitting high fluorescence intensity in the population 
derived from the AFB^  ^ fed animal, which presumably correspond to 
the GGT positive cells (Neal et al.. 1981).
Chapter 4 Antibodies to transformed cells
4.1 Introduction
In Chapter 3, a number of different features of transformed 
cells were examined and the possibility of exploiting these 
features to allow preneoplastic cells to be identified by means 
of flow cytometry was considered. A variety of problems were 
encountered. Fluorescent substrates for enzymes tend to be 
soluble and therefore do not remain associated with the cells 
having the enzyme but are distributed throughout the medium and 
apparently become associated with all the cells in the 
population.
Fluorescent probes may bind non-specifically to other 
cellular components. Other compounds, which can specifically mark 
either the normal or transformed population, require the cell 
membrane to be damaged before they can penetrate into the cell, 
or are themselves cytotoxic.
Antibodies specific for cell surface components have none of 
these associated problems although there are penetration problems 
when non-surface antigens are to be identified by antibodies. 
They can be easily tagged directly or indirectly with a range of 
different fluorochromes. With adequate blocking, non-specific 
binding can be almost eliminated, and although the antibodies 
cannot be removed from the cell and allow it to remain viable, 
the cells can be cultured * after being marked as the antibody and 
its fluorescent tag will be internalised and broken down or 
exocytosed. Monoclonal antibodies have been widely used in the
analysis of subsets of lymphocytes as they have become 
commercially available.
For the purposes of distinguishing transformed cells amongst 
the normal population, a monoclonal antibody to a tumour specific 
cell component would possibly be the most potentially useful 
marker.
In this chapter, several attempts to produce an antibody 
specific for transformed cell surface proteins are described. 
Also the properties of a polyclonal antibody to GGT and a 
monoclonal antibody to a surface antigen whose appearance seems 
to have some association with the carcinogenic process have been 
examined•
4.2 Attempts to produce antibodies specific for transformed 
cells.
(a) Immunisation with whole cells
The data given in Chapter 3 suggest that there is a wide 
variety of different enzymes associated with transformed cells 
which are not present or are present in much reduced amounts in 
normal liver cells. The ease with which antibodies can be 
fluorescently tagged either directly or indirectly, that is, by 
means of a second antibody conjugated to a fluorescent compound 
and therefore allow flow cytometric analysis of those cells 
binding antibody, suggested that production of an antibody 
specific for an antigen on the plasma membrane of hepatoma cells 
would probably be a suitable method for sorting transformed cells 
from the normal population.
JB1 cells were grown on petri dishes and harvested by 
scraping with a rubber policeman into PBS. The cells were then 
disrupted by ultrasonicating (1 Amp for 20s), and the protein 
concentration estimated and adjusted to 1 mg/ml. 0.5 ml of the 
JB1 cell sonicate was emulsified with 0.5 ml of complete Freund's 
adjuvent and injected into a New Zealand White rabbit, 0.25 ml 
given in each limb. Similar cell preparations in incomplete 
Freund's adjuvent were given 1 week and 2 weeks after the first 
injection. At 4 weeks, the animal was test bled by collecting 
around 10 ml of blood from the ear vein. From this serum was 
prepared.
The serum was tested for antibodies against JB1 cell
sonicate by Immunoelectrophoresis as described in Chapter
2.7 (a).
No precipitin lines were observed. Further booster 
injections of 0.5 mg of JB1 cell sonicate in adjuvent and
subsequent test bleeds did not give a positive reaction by
immunoelectrophoresis or Ouchterlony diffusion (Chapter 2.7 (b)).
The reason for this lack of detectable antibody reaction 
against the injected cells, may have been that a large number of 
antigens each in very small quantities was being presented to the 
animal. In view of the fact that antibodies to cell surface 
membrane antigens will allow identification and analysis of 
viable cells in the flow cytometer, methods of partially
purifying some of these JB1 surface antigens were considered.
(b) Immunisation with proteins derived by papain digestion
GGT is considered to be a marker for preneoplastic cells. It 
is a surface protein, and its activity can be easily assayed. The 
preparation of a solution of cell surface proteins including GGT 
for use as a partially purified antigen preparation was therefore 
indicated. One of the initial steps in a method of purification 
of GGT involves solubilisation of the hydrophobic moieties of 
membrane proteins by incubation of GGT positive cell membranes 
with papain solution (Meister et al.. 1981). GGT activity is
retained in the hydrophobic portion of the peptide released by 
this treatment. JB1 cells were grown on petri dishes and treated 
with papain as described in Chapter 2.10 (a). After desalting, 
the supernatant was collected and concentrated by lyophilisation.
Protein was estimated in the concentrated samples, and adjusted 
appropriately.
The GGT activity in the supernatant obtained was measured as 
described in Chapter 2.4 (a) (i), and the percentage removed
calculated. The yield of GGT increased with increasing length of 
incubation, and also with the concentration of papain used (Table 
4.1).
Although no measurable GGT activity was obtained in the 
supernatant of BL9L cells, it was confirmed by protein estimation 
(Chapter 2.9 (a)) that similar amounts of surface protein were 
removed by papain treatment of these cells as were obtained from 
JB1 cells.
A New Zealand White rabbit was immunised with 500 pg and 4 
Balb/c mice with 50 pg protein from papain digestion of JB1 cells 
on 3 occasions at weekly intervals as described in Chapter
4.2 (a). The serum obtained by test bleeding was tested for 
reactivity against papain digest of JB1 cells by 
Immunoelectrophoresis.
Only one precipitin band was observed and that was towards 
the negative electrode when antiserum from the rabbit and the 
mice were assayed. This was unexpected because many bands should 
have been observed corresponding to the different proteins in the 
papain digest. It was suspected that this band was in fact 
precipitation of papain with antipapain antibody.
This was confirmed when a second set of 
Immunoelectrophoresis plates were set up, two of which had 4 pg 
papain in the well and the rabbit antiserum in the trough. The 
same precipitin line appeared. Therefore the only detectable
J.7A
Table 4.1 %GGT obtained from JB1 cells following incubation 
with papain
Concentration of 
papain (mg/ml)
Length of 
incubation (h)
%GGT obtained 
from JB1 cells
0.5
0.5
0.5
0.6
1
1
1
1.5
4.5 
4
4
1.5
3
4
14
43.8
40
20
29
23
33.5
reaction was against papain.
Papain digest of JB1 cells was electrophoresed and then the 
gel was stained histochemically for GGT. An area of pink stain
r
was observed towards the positive electrode. Therefore active 
enzyme was being injected into the animals, but presumably not in 
sufficient quantity to give a detectable reaction.
Booster injections of the rabbit and mice did not give any 
bands other than the papain band.
Methods of removing the papain from the papain digest 
supernatant prior to its use as an antigen had then to be 
considered. Since papain is highly immunogenic, one approach 
would be to raise an antibody to papain, and then papain in the 
JB1 cell digest could be removed by immunoprecipitation.
Antibody to papain was raised in a New Zealand Yttiite rabbit 
and 4 Balb/c mice.
As papain can cleave immunoglobulin its activity would have 
to be inhibited before carrying out the immunoprecipitation. This 
was achieved by preincubating papain with p-chloromercuribenzoate 
(PCMB) (Finkle and Smith, 1958). 10 pg of papain were
preincubated with PCMB at a final concentration of 0.25 mM for 15 
min. The inactivated papain was then immunoprecipitated with the 
rabbit or mouse antipapain antiserum (Chapter 2.7 (d)). The
inhibition of papain activity by PCMB was found to be completely 
reversed by a concentration of 5 mM cysteine. Therfore the degree 
of papain precipitation was measured by assaying by the 
fluorimetric method (Chapter 2.9 (e) (ii)). It was found that
only the highest concentration of antiserum resulted in any 
reduction of papain activity. Prom this it was calculated that
100 pi of serum would be required to precipitate 10 pg of papain. 
Therefore to remove the papain from a papain digest supernatant 
of just one 100 mm petri dish of JB1 cells would require around 
25 ml of serum.
This was not feasible. Attempts to raise the titre of the 
antibody by further injections were not succesful.
(c) Immunisation with GGT band from an agarose gel
An alternative method of raising antibody to JB1 surface 
protein was attempted. The papain digest of JB1 cells was 
resolved by electrophoresing through a 0.1% Triton X-100, 10% 
polyacrylamide gel. This is a non-denaturing gel and so enzyme 
activity should be retained. Samples of the JB1 cell papain 
digest were run in all lanes. After electrophoresisng one lane 
was cut from the gel and stained for GGT by the histochemical 
method. An area staining pink was observed and the corresponding 
part of the remaining unstained gel was removed and retained. The 
GGT containing strip of gel was stored at -70°C until required. A 
portion of the gel was homogenised in an Ultra-turrax and 
combined with complete Freund's adjuvent and used to immunise 3 
Balb/c mice. Two further immunisations in incomplete Freund's 
adjuvent were given at weekly intervals. The mice were test bled 
and serum prepared. This was tested in an Ouchterlony plate 
against some partially purified GGT. No precipitin lines were 
observed.
It was thought possible that the Ouchterlony assay was not 
sensitive enough to pick up a small degree of antibody
production, therefore an immunoprecipitation reaction was 
conducted using a range of dilutions of mouse serum (Chapter 2.7
(d)). No reduction in the enzyme activity as measured 
fluorimetrically was observed following the immunoprecipitation 
reaction.
It seems that again, the amount of antigen being presented 
is too small for an antibody reaction to be detectable, or that 
the antigen is not strongly immunogenic and so a response cannot 
be detected.
4.3 SDS-PAGE of cellular membrane proteins
To examine the differences in the protein composition of the 
membranes of the two cell lines, papain digests were prepared and 
the proteins compared by sodium dodecyl sulphate polyacrylamide 
gel eletrophoresis, SDS-PAGE, and autoradiography.
JB1 and BL9L cells were grown to near confluency and were 
treated with papain as described above.
The supernatant obtained after papain treatment of the cells 
was concentrated by lyophilisation and reconstituted in a small 
volume. Appropriate amounts of the papain digests were then 
boiled in sample buffer, and electrophoresed in a polyacrylamide 
gel as described in Chapter 2.9 (f).
The first gels were stained with Page Blue 83, however only 
a very few bands were visible in the papain digests, and so 
subsequently the gels were silver stained to give greater 
sensitivity.
An example of a silver stained gel of JB1 and BL9L cell
surface proteins obtained by papain digestion is shown in Plate
4.1.
A sample of medium in which the cells were grown is shown in 
lane 1, to exclude the possibility of serum proteins 
contaminating the cell digestion supernatants. Lanes 2 and 5 show 
samples of the papain solution used to treat the cells. The 
sample in lane 2 was incubated at 37°C for 3 hr to examine if 
there was breakdown of the enzyme or its impurities. Lane 3 shows 
protein from BL9L cells following treatment and lane 4 protein 
from JB1 cells. Lane 6 contains the molecular weight markers.
The band patterns of the JB1 and BL9L supernatants are very 
similar. There are only a few very faint bands visible in the 
high molecular weight region ie above 30 kD. Although
fragments of surface proteins should be antigenic and therefore 
be of use in raising antibodies to surface protein the reasons 
for the lack of high molecular weight proteins was unclear. For 
example the heavy molecular weight subunit of GGT is 46. 1 kD.
The lack of high molecular weight proteins obtained after 
papain treatment might be due to further breakdown of the 
proteins by the protease on storage. Therefore conditions to 
inactivate papain were considered. Protease inhibitors could be 
used, however since pH is a relatively easy parameter to control, 
and the papain becomes inactivated at low pH, this method was 
used in the first instance. It was found that the enzyme activity 
drops dramatically at pH 5.0 to less than 5% of the activity of 
the enzyme at pH 7.5. So preparations of proteins from cell lines 
produced by papain digestion could be adjusted to pH 5.0 and 
therefore further digestion of the polypeptides should not occur.
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It was also considered possible that the absence of high 
molecular weight proteins on the gels might be artefactual due to 
the presence of high concentrations of PBS causing interference 
in the running of the protein bands on the gel.
In order to examine this possibility, surface protein 
fractions was prepared from the 2 cell lines as before and then 
adjusted to pH 5.0 with acetic acid to inactivate papain. 
Aliquots of the supernatants were then dialysed against 0.05 M 
acetate buffer pH 5.0 to remove PBS and to prevent further 
digestion of the proteins by papain. The samples were then 
concentrated by lyophilisation and reconsituted in distilled 
water. The samples were then subjected to SDS-PAGE. No 
differences could be found between the samples before and after 
dialysing, so PBS is not disrupting the protein band pattern.
The band pattern was very similar to that shown in Plate
4.2. There were again only a few very faint bands in the high 
molecular weight region, so papain does not seem to be breaking 
down the polypeptides after initial cleavage from the membrane.
The reason for being unable to visualise high molecular 
weight proteins may be simply because each protein is present in 
such low concentrations that the staining method is not sensitive 
enough. A more sensitive method would be to radioactively label 
the cellular proteins prior to papain treatment. Autoradiography 
could then be performed on the polyacrylamide gel, and most of 
the proteins cleaved from the membrane should then be apparent. 
In addition the papain proteins will not be labelled and will 
therefore not show on the autoradiograph, and so the proteins 
from the JB1 and BL9L cells should be more clearly defined.
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4.4 Autoradiography of labelled cell proteins
/
In addition to examining the proteins removed from the cell 
surface by papain, it was decided to examine also those proteins 
which are being secreted into the medium. An experiment designed 
to measure the amount of GGT found in tissue culture medium after 
two hours incubation with JB1 cells revealed that around 2% of 
the cellular GGT is released into the medium during this period.
Accordingly, JB1, BL9L and BL8L (Judah et_al., 1977) cells 
were incubated with 14.44 mCi/ml [*5S]methionine in serum-free 
medium containing 5 pH methionine for 1,3, and 6 hours and the 
medium was removed and retained prior to incubation of the cells 
with papain. Also JB1, BL9L and BL8L cells were lysed subsequent 
to labelling with [*5S]methionine for examination of the total 
cellular protein. Details of the experimental procedure are 
presented in Chapter 2.8 (b).
The result is shown in Plate 4.3. This is the autoradiograph 
obtained after resolution of the proteins obtained by SDS-PAGE.
Lanes 16,17 and 18 show the total labelled cellular protein 
of JB1, BL9L and BL8L cells respectively. It is particularly 
interesting that the banding pattern of the JB1 cells is so 
similar to that of the other two cell types. This was surprising 
as the morphology of the JB1 cells is quite different from the 
BL9L cells.
The proteins obtained by papain digestion, lanes 13 and 14, 
are not very clearly defined, with very few bands visible from 
papain treatment of BL9L cells. The reason for this lack of bands
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Plate 4.3 Autoradiograph of JB1, BL9L and BL8L cell protein.
Reading plate from left to right:
Lane 1 JB1 cell medium after 1 hours incubation 
Lane 2 BL9L cell medium after 1 hours incubation 
Lane 3 JB1 cell medium after 3 hours incubation 
Lane 4 BL9L cell medium after 3 hours incubation 
Lane 5 BL8L cell medium after 3 hours incubation 
Lane 6 JB1 cell medium after 6 hours incubation 
Lane 7 BL9L cell medium after 6 hours incubation 
Lane 8 Control medium
Lane 9 JB1 cell papain supernatant after 1 hours incubation 
Lane 10 BL9L cell papain supernatant after 1 hours incubation 
Lane 11 JB1 cell papain supernatant after 3 hours incubation 
Lane 12 BL9L cell papain supernatant after 3 hours incubation 
Lane 13 JB1 cell papain supernatant after 6 hours incubation 
Lane 14 BL9L cell papain supernatant after 6 hours incubation 
Lane 15 Control papain supernatant 
Lane 16 JB1 cell lysis supernatant 
Lane 17 BL9L cell lysis supernatant 
Lane 18 BL8L cell lysis supernatant

is not clear, as radioactive counting of the sample suggested 
that there should have been sufficient labelled protein applied 
to the gel. However there is some smearing and it seems that some 
label has been retained on top of the gel.
Of greatest interest, are the differences in the proteins 
secreted into the medium by the two cell lines. Lanes 6 and 7 
show protein in the medium after incubation with JB1 and BL9L 
cells for 6 hours. There are a number of bands shared by the two 
cell lines and there are a considerable number of bands which are 
unique for each cell type. In addition there are proteins 
associated with the cells which are in greater quantity in one 
cell as opposed to the other.
From the protein banding patterns seen when the JB1 and BL9L 
cells are lysed it would seem that the possibility of raising an 
antibody specific for the transformed cell line using 
unfractionated total protein would be remote. However in view of 
the differences in the secreted proteins involved these 
techniques would perhaps be a way of obtaining an antigen 
preparation for the raising of antibodies.
As JB1 cells appeared both to synthesise greater amounts of 
protein, and to secrete more protein as compared with BL9L cells, 
a more rigorous experiment was performed to determine if this was 
in fact the case.
JB1 and BL9L cells were incubated with [*5S]methionine for 
periods of 2,4,6,8 and 10 hours. After the appropriate time 
point, the medium was removed and retained and, after washing 
with PBS, papain at lmg/ml was added and incubated with the cells 
for 2 hours. Supernatant from the papain treated cells was
collected. The samples obtained were prepared for radioactive 
counting as described in Chapter 2.8 (b).
The total cellular incorporation of [35S]methionine was also 
measured at each time point by scraping cells off the dish into 1 
ml PBS and adding 2 ml of 10% TCA before being treated in the 
same way as the other samples.
Cells were removed as described above from control plates 
incubated for 4 hours with unlabelled medium, and medium 
containing [35S]methionine incubated for 4 hours at 37°C were 
also counted for radioactive incorporation to determine 
background levels.
Cell counts were made of 3 plates of each cell type and 
protein was estimated (Chapter 2.9 (a)).
The results are shown in Figs 4.1, 4.2. The first two graphs 
show incorporation of [3*S]methionine into secreted proteins and 
papain cleaved membrane proteins expressed as dpm per 106 cells. 
The second two graphs show the results expressed as dpm per mg of 
protein.
Although there seems to be greater protein synthesis 
occuring per cell, in the JB1 population, this results from the 
greater amount of protein in each cell as compared with the BL9L 
cell protein content. 106 JB1 cells have 0.9 mg protein whereas 
106 BL9L cells have only 0.35 mg protein.
Both the amount of protein secreted into the medium by the 
cells and the protein cleaved from the surface of the cells by 
papain digestion increase with increasing incubation time.
Fig 4.1 Radioactive incorporation into secreted proteins
(----) and papain-cleaved membrane proteins ( - - - - )
following incubation of JB1 and BL9L cells with medium 
containing [*5S]methionine. Results expressed as dpm/10* 
cells.
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Fig 4,2 Radioactive incorporation into secreted proteins
(----) and papain-cleaved membrane proteins (- - - -)
following incubation of JB1 and BL9L cells with medium 
containing [**S]methionine. Results expressed as dpm/mg
protein.
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4,5 Use of a monoclonal antibody to a tumour-derived cell line
(a) Histochemical staining of tissue sections and cell lines
A monoclonal antibody (MRC TU/J1) has been raised against 
the tumour-derived cell line JB1 (Manson et al.. 1984). This 
antibody has been characterized by histochemical staining of 
liver sections from normal and aflatoxin fed animals. Bile 
duct epithelium from both normal and AFB^ fed animals react 
positively with the antibody. Normal liver sections show membrane 
staining, and the degree of staining appears to increase with 
increasing age of the animal.
Staining of AFB1 fed animal liver sections, shows a greater 
degree of heterogeneity. Some areas, positive for GGT in serial 
sections were negative, positive or heterogenous when stained for 
the antibody.
This antibody is therefore recognising an antigen whose 
expression is in some way affected during the carcinogenic 
process.
It was of interest, to determine if these changes could be 
identified by fluorescently staining isolated hepatocytes for the 
enzyme and analysing in the flow cytometer.
First a mixed culture of JB1 and BL9L cells were stained 
histochemically with the antibody as described in Chapter 2,7 (e) 
(ii). Also, sections of liver from control and AFB1 fed animals 
were stained for the presence of antigen. Plate 4.4 shows a mixed 
culture of JB1 and BL9L cells histochemically stained. As 
expected the JB1 cells stain positively, however the BL9L cells
are completely negative with respect to antibody reactivity. 
Plate 4.5 shows a section of liver from a normal Fischer 344 rat 
aged around 10 weeks. There is a generalised staining of the 
tissue with increased staining in the periportal regions. Liver 
from an animal fed AFI^ for 7 weeks at 4 ppm stained for MRC 
TU/J1 is shown in Plate 4.6. There is some variation in the 
staining on the tissue and some areas which are negative. Other 
areas (not shown) were intensely stained. Plate 4.7 is a higher 
power photograph of the same section showing the antibody to be 
associated with the hepatocyte membrane.
(b) Flow cytometric analysis of cells stained with MRC TU/J1
JB1 and BL9L cells were stained for presence of the antigen 
(Chapter 2.6 (g)). In this case the second antibody was
conjugated to FITC and the cells were analysed by flow cytometry.
Figs 4.3 and 4.4 show JB1 and BL9L cells stained with MRC TU/J1. 
BL9L cells show a very low mean fluorescence, and the JB1 cells a 
higher mean fluorescence. This was the result expected on the 
basis of histochemical staining.
Cells isolated by collagenase perfusion from control and 
AFBj^  fed animals were stained in suspension for reactivity with 
the antibody (Chapter 2.6 (g))• In this case the second antibody 
was conjugated to FITC, and the cells were analysed in the flow 
cytometer. Hepatocytes from both normal and AFB^ fed rats were
also incubated with Williams E Medium to replace the tissue
culture supernatant containing antibody, before following the 
remaining staining schedule. These cells could then give an
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Plate 4*4 -
A mixed culture of JB1 and BL9L cells stained immunohisto­
chemically with MRC TU/J1 (x 56) .
Plate 4.5 ~
Liver section from a control animal stained immunohistochemically 
with MRC TU/J1 (x 56).
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Plate 4*6
Liver section from an APB^  fed animal stained imnmnohisto­
chemically with MRC TU/J1 (x 56).
Plate 4.7
Liver section from an AFB^  fed animal stained iramunohisto­
chemically with MRC.TU/J1 (x 140)•
indication of the levels of any non-specific staining which may 
occur during the procedure.
Fig 4.5 shows staining of hepatocytes from a control animal.
/
These cells have a higher mean fluorescence intensity than the 
BL9L cells. The cells from the AFI^ fed animal (Fig 4.6), form 
two populations one having a similar mean fluorescence to the 
stained BL9L cell, and one having a much greater mean 
fluorescence intensity. Controls where normal WEM was used to 
replace the tissue culture supernatant containing the primary 
antibody showed only low levels of emitted fluorescence.
Amongst the cells derived from an AFB1 fed animal, a 
population of cells negative for the antigen was expected from 
histochemical staining of the sections. This was not observed but 
it may have been the result of the low level of non-specific 
staining, which does occur as a result of using a second antibody 
conjugated to FITC, causing an overlap between negative and 
positive cells.
4.6 Staining with polyclonal antibodies to GGT
Two polyclonal antibodies to GGT were studied for their 
reactivity against sections of liver from AFB^ fed animals (Tsao 
and Curthoys, 1980, Murphy et al.. 1984).
Sections of liver were stained immunohistochemically for 
antigen (Chapter 2.7 (e) (ii)) and sections of the same liver 
were stained for GGT by the histochemical stain of Rutenberg 
(Chapter 2.5 (a)).
Both of these antibodies stained faintly only very small
Fig 4.3 Flow cytometric analysis of JB1 cells stained immuno-
histochemically with monoclonal antibody.
Fig 4.4 Flow cytometric analysis of BL9L cells stained 
immunohistochemically with monoclonal antibody MRC TU/J1.
Fig 4.5 Flow cytometric analysis of hepatocytes from a
control animal stained immunohistochemically with monoclonal 
antibody MRC TU/J1.
Fig 4.6 Flow cytometric analysis of hepatocytes from an
animal fed AFB^  ^stained immunohistochemically with monoclonal 
anti- body MRC TU/J1.
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areas of hepatocytes. The staining was associated with the cell 
membrane, Plate 4.8 shows staining of such a tissue section with 
the antibody made by Murphy et al. (1984),
It seems therefore that this antibody is not reacting with 
all GGT in the liver sections. It is perhaps only reacting with 
certain of the isoenzymes of GGT.
As there were so few cells showing positive staining after 
immunohistochemistry with these antibodies, it would be very 
difficult to determine differences between control and AFB^ fed 
animals by flow cytometric analysis.
Plate 4.8
Liver section from an fed rat stained iramunohistochemically
with a polyclonal antibody to GGT (Murphy et a l. , 1984) (x  140).
4.7 Summary
Antibodies are widely used in the flow cytometric analysis 
o£ a large range of cellular features. The commercial 
availability of monoclonal antibodies, and an increasing number 
of fluorochromes with differing spectral characteristics, has 
permitted flow cytometric analysis and subsequent sorting of 
subpopulations to be conducted with relative ease.
In this chapter, attempts were made to produce an antibody 
specific for the surface features of hepatoma cell lines. These 
attempts were unsucessful although the reason for the lack of 
success is unknown. The experience of others has suggested that 
GGT may not be stongly immunogenic (M. Manson, personal 
communication), however, as discussed in Chapter 3, there are a 
large number of other phenotypic changes induced in the hepatoma 
cells, and these should have given some immunologic reaction. It 
is perhaps possible that the animals used may not have reacted as 
expected as occasionally an animal is found not to respond 
immunogenically to a presented antigen although the reasons for 
such a lack of response are unknown.
A number of antibodies reported to be specific for antigens 
which appear during the process of carcinogenesis were also 
examined. One of these MRC TU/J1, reacts with an unknown antigen 
whose expression seems to be related to the carcinogenic process. 
Some differences in staining of hepatocytes from an AFBj fed rat, 
as compared to a control animal, were observed when MRC TU/J1 was 
used in conjunction with a flow cytometer. Further work in this 
area, for instance, sorting of the cells showing a high level of
220
staining, may give more information as to the antigen and its 
expression during carcinogenesis.
The problems discussed in Chapter 3 related to the use of 
fluorescent substrates for enzymes, and other fluorescent dyes, 
i.e. solubility of products, and toxicty of some substances, 
suggest that if suitable antibodies are available, these may be 
used with greater ease in flow cytometric studies. However there 
are problems associated with the use of antibodies which should 
also be considered. If cells are sorted by tagging with an 
antibody and then used in functional studies, the effects of 
bound antibody must be considered. For example, the bound 
antibody and associated fluorochrome may affect the functioning 
or turnover rate of the protein with which they are associated. 
However such disadvantages, in most cases, do not outweigh the 
advantages of using antibodies in flow cytometric studies of many 
different aspects of cellular structure and function.
Chapter 5 Effect of growth factors on hepatocyte DNA synthesis 
in vitro and in vivo
/
5.1 Introduction
Primary cultures of adult rat hepatocytes under normal 
culture conditions show only very low levels of DNA synthesis. 
However it has been shown that the addition of epidermal growth 
factor (EGF) to the culture medium stimulates synthesis of DNA, 
with insulin having a synergistic effect (Richman et al.. 1976, 
Michalopolous et al.. 1982). Hence EGF has been one of the 
factors implicated in in vivo liver growth following partial 
hepatectomy. Other serum factors have also been shown to
stimulate hepatocyte proliferation (Miehalopoulos, 1984).
Bucher et al. (1977), looked at the effect of EGF alone and 
in combination with insulin and glucagon on DNA synthesis of 
hepatocytes in vivo. This was achieved by continuous infusion of 
hormones and subsequent injection of [3H]thymidine. The 
incorporation of [3H]thymidine into the cellular DNA could then 
be evaluated. From this data, it was established that EGF
stimulated DNA synthesis in liver cells in vivo, and that insulin 
and glucagon enhance this activity. As EGF receptors have been 
found in liver membrane preparations (Moriarity and Savage, 
1980), there is further evidence for a regulatory function of EGF 
in liver growth.
In addition to the mitogenic response induced by EGF,
cellular differentiation also appears to be stimulated. Infusion 
of foetal mammals with EGF causes more rapid maturation of a
number of organs (Gospodarowicz, 1983).
Growth factor receptors have been shown to exhibit tyrosine
kinase activity, for example, the binding of epidermal growth
/
factor to its receptor has been shown to activate protein 
phosphorylation by the receptor protein (Buhrow et al.. 1982, 
Erhart et al.. 1983). However activation of the EGF-receptor 
kinase does not always result in the synthesis of DNA. Gregoriou 
and Rees (1984), suggest that phosphorylation may only be one of 
a number of signals which ultimately leads to cell division.
Other authors have shown that the aggregation and 
internalisation of the EGF-receptor complex may be as important 
in EGF stimulated DNA synthesis as the initial binding of the 
hormone (Beardmore and Hopkins, 1984).
The passage of normal cells through the cell cycle is under 
the control of exogenous factors. However transformed cells have 
the ability to divide without the presence of these exogenous 
factors. Oncogene products have been implicated as the 
stimulators of transformed cell replication since structural 
homology between such products and purified growth factors has 
been found. For example the gene product of simian sarcoma virus, 
a p28s‘s dimer is structurally very similar to one of the two 
polypeptide chains of platelet-derived growth factor suggesting 
that the virus has acquired cellular sequences from the gene 
coding for this polypeptide (Heldin and Westermark, 1984). It is 
thought that such viral gene products interact with the growth 
factor receptors to induce cell division. However it is not clear 
if the growth factor homologue must be secreted in order to 
interact with the cells receptor, or if there is a mechanism
allowing intracellular interaction of the factor with the 
receptor.
In normal cells, phosphorylation of tyrosine residues is a
/
very uncommon protein modification. However cells transformed 
with Rous sarcoma virus contain high levels of phosphotyrosine in 
protein.
The product of the src gene, the gene responsible for cell 
transformation by avian sarcoma virus, is pp60src, and has been 
identified as a protein kinase (Maness et al.. 1979). Erikson 
et al. (1979) suggest that increased tyrosine phosphorylation of 
one or more cellular polypeptides may alone be responsible for 
transformation by Rous sarcoma virus, although there is no 
evidence of increased phosphotyrosine levels in cells transformed 
with a number of other viruses (Sefton et al.. 1980).
The role of growth factors during normal cell growth and 
during neoplastic proliferation is not yet clear. However 
evidence of growth factor regulation during cellular DNA
s'
synthesis can be found in all examined cases of cellular 
proliferation. Normal cell proliferation appears to require 
exogenous growth factors whereas transformed cells appear to have 
the ability to produce their own endogenous growth factors. In 
most cases these are similar enough to act via the same receptor 
molecules.
Cell proliferation and therefore DNA synthesis is required 
during chemical carcinogenesis, and would appear to be an early 
change associated with the process of neoplasia (Cayama et al.. 
1978). The ability to identify those cells which have begun 
synthesis of DNA as a result of stimulation with a carcinogen may
give more information with respect to the changes taking place. 
Similarly, normal cells induced to proliferate and undergo other 
changes in growth characteristics by the addition of exogenous 
growth factors may give further insight into the nature of normal 
and abnormal growth.
Recently a flow cytometric technique has been developed 
allowing cells in S-phase to be readily identified and the number 
in the whole cell population quantitated (Dean et al.. 1984). 
This method involves incubating cells with bromodeoxyuridine 
(BudR) causing the S-phase cells to take up the nucleoside. A 
monoclonal antibody is then employed to stain cells for BudR and 
total DNA content is stained with propidium iodide.
The possible importance of specific stages of the cell cycle 
in the carcinogenic process has been referred to previously in 
the studies on ploidy changes. In a study of changes in liver 
carcinogenesis using a flow cytometer it would be desirable to 
apply the BudR technique to hepatocytes. The cell model system 
used in studying other phenotypic changes was not appropriate in 
this case as there is continual DNA replication in both 
immortalised cell lines. Therefore advantage was taken of the 
effect of EGF on DNA synthesis in hepatocytes refered to above in 
developing in vitro systems. From these in vitro systems, 
conditions were derived for the examination of cell proliferation 
in animals fed AFB^
If primary cultures of liver cells alone or in the presence 
of EGF are incubated with BudR and subsequently stained for 
incorporation of the nucleoside, it should be possible to 
determine the proportion of cells which are stimulated by the
growth factor into cell division, and also which of the ploidy
groups are affected.
In addition if cells which are in a proliferative state
in vivo can be tagged with BudR, it may be a method for
identifying cells in the early stages of neoplasia.
The data presented in this chapter are the results of some 
work in these areas, and although the study is essentially
preliminary^ )^ive some indication of the potential of this method 
for looking at growth-related phenomena in rat liver cells.
5.2 Studies of DNA synthesis by BudR incorporation
(a) Effect of EGF on primary cultures of hepatocytes
An investigation was conducted to establish if DNA synthesis 
induced by EGF in primary cultures of rat hepatocytes could be 
detected by incorporation of 5-bromo-2*-deoxyuridine (BudR) into 
newly synthesised DNA.
Hepatocytes were isolated from Fischer 344 rats by 
collagenase perfusion as previously described (Chapter 2.3 (c)). 
These were plated out onto 150 mm petri dishes and incubated as 
described in Chapter 2.10 (b)). After an appropriate incubation 
time, the cells were then harvested and fixed in ethanol. The 
fixed cells were stained for DNA and BudR incorporation (Chapter
2.7 (e) (i)).
The cells were then analysed by flow cytometry. Fig 5.1 
shows the cytogram of primary hepatocytes which have been 
incubated with EGF and BudR as described above. The cells in 
region 1 are fluorescing green and have therefore incorporated 
BudR. These comprise 27% of the total cell population. The cells 
in Fig 5.2 are hepatocytes in primary culture which have had no 
EGF added to the medium. They were stained exactly as those cells 
shown in Fig 5.1. Very few (3%) cells have incorporated BudR into 
their DNA.
Fig 5.1 Flow cytometric analysis of primary hepatocytes 
incubated with EGF and BudR and stained immunohistochemically 
for BudR incorporation.
Fig 5.2 Flow cytometric analysis of primary hepatocytes 
incubated with BudR and stained immunohistochemically for 
BudR incorporation.

(b) Initiation of DNA synthesis in rat hepatocytes following 
incubation with EGF.
Cells were isolated from a Fischer rat and plated out as 
described above. After 3 hours in culture the medium was changed 
and EGF (20 ng/ml) was added to one group of plates, another 
group having only fresh medium.
At 2 hourly intervals between 16 and 34 hours after the 
addition of EGF, [*H]thymidine (1 mCi/ml) was added to each of 
two plates from each group.
After a 1 hour incubation with [8H]thymidine, the cells were 
washed and [3H]thymidine incorporation determined as described in 
Chapter 2.8 (c).
From the result shown in Fig 5.3, it was established that 
synthesis of DNA was initiated between 18 and 20 hours after the 
addition of EGF.
(c) Monitoring progression of hepatocytes through cell cycle.
The progression of cells which were synthesising DNA, as a 
result of incubation with EGF, could be monitored as they passed 
through S-phase to G2 before division and return to Gl. This was 
achieved by treating primary cultures of hepatocytes with EGF, 
(20 ng/ml) for 18 hours when BudR was added for periods of time 
from 2 to 6 hours and for 24 hours. The results are shown in Figs 
5.4 to 5.6. In these cytograms, the cells which have undergone 
DNA synthesis have incorporated BudR and are fluorescing green. 
The DNA synthesising diploid population can be observed to
Z3U
Fig 5.3 Radioactive incorporation into primary hepatocytes in
culture, untreated, (- - ---) or with the addition of EGF
(----), when incubated in medium containing [*H]thymidine.
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Fig 5,4 Flow cytometric analysis of hepatocytes in culture 
treated with EGF for 18 hours and then BudR added for 2 hours 
before harvesting and staining for BudR incorporation.
Fig 5,5 Flow cytometric analysis of hepatocytes in culture
treated with EGF for 18 hours and then BudR added for 4 hours
before harvesting and staining for BudR incorporation.
Fig 5.6 Flow cytometric analysis of hepatocytes in culture 
treated with EGF for 18 hours and then BudR added for 6 hours 
before harvesting and staining for BudR incorporation.
Fig 5.7 Flow cytometric analysis of hepatocytes in culture
treated with EGF for 18 hours and then BudR added for 24
hours before harvesting and staining for BudR incorporation.
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progress through S-phase with time, eventually returning to the 
original diploid state (Fig 5,7),
t
(d) Staining proliferative cells induced by partial hepatectomy.
To establish the conditions required to examine cell divison 
in vivo by BudR incorporation, division was induced in a 
population of rat liver cells by performing a 2/3 partial 
hepatectomy (Chapter 2.2), Around 16 hours after the hepatectomy, 
the animals were injected intra-peritoneally with 0,5 ml of 50 mM 
BudR. Control animals not subjected to the hepatectomy were 
similarly injected. This dose was repeated at hourly intervals 
giving a total of 9 injections.
The following day, cells were isolated by collagenase 
perfusion, washed in PBS and fixed in ethanol. The fixed cells 
were stained for BudR incorporation as previously described.
Fig 5.8 shows flow cytometric analysis of cells from the
hepatectomised rat after staining for BudR incorporation. Fig 5.9
shows cells from the control animal.
The considerable number of cells, from the hepatectomised 
rat showing green fluorescence (approximately 40%) reveals that 
this dose of BudR was effective in monitoring cells which were 
synthesising DNA.
(e) Liver cell proliferation induced by AFB^ feeding.
A Fischer rat fed AFB^ at l-2ppm for 9 weeks was injected
i.p. with 0.5 ml of 50 mM BudR during the course of 10 days with
Fig 5.8 Flow cytometric analysis of hepatocytes from a rat 
treated with BudR in vivo before partial hepatectomy, and 
stained for BudR incorporation.
Fig 5.9 Flow cytometric analysis of hepatocytes from a rat 
treated with BudR in vivo, and stained for BudR incorpor­
ation.
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2 injections given on alternate days, and on day 11 a total of 6 
injections, at hourly intervals, of the same dose were given. On 
day 12 liver cells were isolated by eollagenase perfusion, having 
first tied off and retained a lobe for histological staining.
Isolated liver cells were fixed and stained for BudR 
incorporation as previously described.
Fig 5.10 shows an isometric display of cells from the AFB^
fed animal and Fig 5.11 cells from the control animal. The
percentage of cells from the AFB^ fed animal showing fluorescence 
is 17%.
The sections of liver taken from the same animals were fixed 
in cold acetone. These were then stained for GGT (Chapter 2.5
(a)), and for BudR incorporation (Chapter 2.7 (e) (i)).
Plates 5.1, 5.2, 5.3 and 5.4 show, respectively, GGT
staining of control and fed animal sections, and BudR staining 
from the same portions of liver. The sections from AFB^ fed
animals have many cells positive for GGT, and also large numbers 
of cells which have incorporated BudR.
Fig 5.10 Flow cytometric analysis of hepatocytes from an AFB1 
fed rat injected with BudR in vivo, stained for BudR 
incorporation.
Fig 5.11 Flow cytometric analysis of hepatocytes from a 
control rat injected with BudR in vivo, stained for BudR 
incorporation.
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Plate 5.1
Liver section from a control animal stained histochemically 
for GGT activ ity  (x  140)*
Plate 5.2
Liver section from an fed rat stained histo chemically
for GGT activ ity  (x 140).
Liver section from a control rat stained immunohisto- 
chemically for BudR incorporation (x 140).
Plate 5.4
Liver section from an AFB^  fed rat stained immune histo chemically 
for BudH incorporation (x 140).
5.3 Summary
The induction of DNA synthesis in primary cultures of liver 
cells was studied by using the technique of incorporation of BudR 
into newly synthesised DNA, and staining of the BudR-containing 
cells with an antibody to the nucleoside. These could be observed 
by means of fluorescence tagging and flow cytometric analysis.
The time of initiation of DNA synthesis after addition of 
EGF to the culture medium was determined by pulsing cells at 2 
hourly intervals with [*H]thymidine and establishing the point at 
which the number of counts per mg of protein begins to rise. From 
this it was possible to monitor the DNA synthesising population 
passing through the cell cycle and returning to Gl. These studies 
were conducted to determine the conditions for staining those 
cells which had incorporated BudR.
To establish a method for studying liver cell division 
in vivo, animals subjected to hepatectomy and dosed with BudR had 
cells stained with anti-BudR and these were then compared with 
cells from control animals. It was possible to observe those 
cells which had undergone proliferation, and quantitate them as a 
percentage of the whole population.
This protocol was then adapted to examine the proliferative 
effect of AFB1 on the liver cell population. In this case a group 
of cells containing BudR could be identified amongst the 
population derived from the AFB^ fed animal. Only a very few 
cells from the control animal were positively stained. The flow 
cytometric analyses were verified by immunohistochemical 
observation of the cells containing BudR.
Chapter 6 Phenotypic changes in ras transformed cells
6.1 Introduction
In Chapter 3, a number of phenotypic features were examined 
in normal and transformed hepatocyte cell lines, and in liver 
cells from normal and aflatoxin B1 fed animals.
To date, it is still unknown which transforming genes are 
responsible for the changes in phenotypic and growth control in 
both JB1 and neoplastic hepatocytes.
One approach to this problem, was the examination of cells 
transformed by an oncogene - activated ras. Transformed cells 
were obtained by transfection of BL8L cells (Judah et al.. 1977) 
with activated ras in conjunction with a drug resistance marker 
gene (S.Sinha, personal communication). Some of the phenotypic 
markers discussed in Chapter 3 were examined in one of the cell 
lines successfully transformed by this transfection method, named 
EDI. The results were compared with those obtained when JB1 and 
BL9L cells were studied.
6.2 Flow cytometric analysis of EDI cell phenotype
(a) GGT content of EDI cells
Histochemical staining of EDI cells for GGT revealed that 
there was considerable heterogeneity in the content of enzyme 
between the cells of the EDI population, although morphologically 
the cells were very similar (S. Sinha, personal communication). 
The GGT content of the cells was assayed flow cytometrically by 
staining with the substrate yGAMC. The degree of staining was 
compared with that of JB1 and BL9L cells. Fig 6.1 shows that the 
EDI cells have a lower mean fluorescence intensity than that of 
the JB1 cells Fig 6.2, and a higher mean fluorescence intensity 
than the BL9L cells Fig 6.3. This method of staining effectively 
gives an average of the GGT content of the cells within the 
population, as has been previously discussed (Chapter 3.3). 
However there is some indication of induction of GGT synthesis 
following introduction of the activated ras genes into the BL9L 
cells.
(b) Guanidinobenzoatase content of EDI cells
The concentration of surface guanidinobenzoatase was assayed 
in EDI cells by staining with the substrate 
Noc-dansyl-homoarginine as described in Chapter 2.6 (d). Figs 6.4, 
6.5, and 6.6 show JB1, BL9L and EDI cells stained for the 
presence of the enzyme.
As reported in Chapter 3.3, JB1 cells show a much higher
Fig 6.1 Flow cytometric analysis of EDI cells stained for GGT
activity with the fluorogenic substrate yGAMC.
Fig 6.2 Flow cytometric analysis of JB1 cells stained for GGT 
activity with the fluorogenic substrate yGAMC.
Fig 6.3 Flow cytometric analysis of BL9L cells stained for 
GGT activity with the fluorogenic substrate yGAMC.
Fig 6.4 Flow cytometric analysis of JB1 cells stined for
guanidinobenzoatase with the fluorescent probe N^-dansyl-
homoarginine.
Fig 6*5 Flow cytometric analysis of BL9L cells stained for
guanidinobenzoatase with the fluorescent probe Na-*dansyl-
homoarginine.
Fig 6.6 Flow cytometric analysis of EDI cells stained for
guanidinobenzoatase with the fluorescent probe N«-dansyl-
homoarginine.
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degree of fluorescent staining than do the BL9L cells which show 
very little staining. EDI cells also show very little staining 
for the enzyme, and the population appears more homogeneous than 
the BL9L cells with very few cells showing fluorescence above 50 
units.
There seems therefore to be very little induction of 
guanidinobenzoatase in the ras transformed cells.
(c) EDI cells and resistance to adriamycin
EDI cells were assayed flow cytometrically for intracellular 
adriamycin content following incubation with the drug (Chapter 
3.6 (d)). Again results were compared with those obtained from 
similar treatment of JB1 and BL9L cells.
Following incubation with the drug, the cells were harvested 
and washed. It has been observed that the JB1 cell pellet is 
white, while the BL9L cell pellet is pink in colour, indicating a 
greater intracellular drug concentration, which is confirmed by 
flow cytometric analysis (Chapter 2.6 (e)). EDI cells after
incubation with adriamycin give a white pellet, however the peak 
fluorescence intensity is equivalent to that of the BL9L cells. 
The mean fluorescence intensity is, on the other hand, less than 
that of the BL9L cells, suggesting a smaller degree of 
intercellular variation. (Figures of flow cytometric analysis 
cannot be shown as data was lost due to a faulty tape drive.) It 
may therefore be the case that the BL9L cells which contain the 
greatest amount of drug are responsible for the pink appearance 
of the cell pellet.
6.3 Summary
In this chapter, 3 features of cell transformation as 
previously determined in a highly tumourogenic cell line were 
examined in an activated ras transformed epithelial cell line. 
These cells were found to have elevated GGT as compared to a 
normal epithelial cell line, as was observed in a hepatoma 
derived cell line. Guanidinobenzoatase was not elevated in the 
EDI cells, nor did they show adriamycin resistance. The latter is 
surprising in that the cells already have a gene coding for 
resistance to the drug G418, and some cross resistance to 
adriamycin might have been expected.
In general, EDI cells showed less heterogeneity when stained 
for these characteristics than did the BL9L cells. However this 
is probably a feature of the number of times the BL9L cells had 
been subcultured since their derivation. For this reason and as 
the EDI cells have a drug resistance gene, a cell line derived by 
transfection of BL8L cells with DNA from plasmids having the drug 
resistance gene but not the activated oncogene may have been a 
more suitable control.
There is however, some indication from these results that 
the changes observed during transformation are not induced at the 
same time, nor are they all prerequisites for tumorigenicity. 
Further studies of other cells lines obtained following such 
transfection experiments and of the other phenotypic changes 
which have been observed both in primary hepatoma, and in 
hepatoma cell lines, may give more information as to the sequence 
of events during transformation.
Chapter 7 General discussion
7.1 Flow cytometry - general considerations
The aim of this study was to examine by flow cytometric 
analysis changes known to occur during the early stages of 
hepatocarcinogenesis. Flow cytometric analysis of cell 
populations has the potential to allow the study of several
different parameters in each cell, and quantitate these for each 
cell. Conventional biochemical techniques give only an average 
quantitation for the total cell population, and it is therefore 
not possible to determine if there are subgroups expressing to 
different extents the parameters being studied.
In general the feature to be examined must be fluorescently 
tagged. This can be achieved by using fluorescent dyes, 
fluorogenic substrates, or antibodies conjugated to a 
fluorochrome. Each of these has its advantages and disadvantages. 
Fluorescent dyes are most commonly used for staining 
quantitatively cellular DNA and RNA. However those which are
easiest to use (i.e. ethidium bromide and propidium iodide)
require the cell membrane to be disrupted for penetration. 
Fluorogenic substrates tend to be used in biochemical assays
where a high degree of sensitivity is required and are becoming 
increasingly readily available. Their fluorescent products are 
however, often soluble and will readily pass through the cell 
membranes of both the cells having the enzyme and those lacking 
the enzyme. These substrates are obviously not suitable for flow 
cytometric analysis of a mixed population of enzyme positive, and
enzyme negative cells. Other difficulties encountered are the 
toxicity of some substrates to cells when they have become 
associated with the membrane or have penetrated the cell. This is 
important if it is required to culture the cells subsequently. 
Antibodies conjugated to a fluorochrome are often used and 
particularly when more than one parameter is to be examined. 
Fluorochromes have been developed allowing two antibodies to be 
employed without the necessity of a dual laser excitation system 
which is expensive and technically difficult to achieve. However 
specific antibodies are required and problems may occur regarding 
the functioning of the antigen when an antibody is bound.
In this study, all of these methods of fluorescently 
staining cells were employed according to the particular 
parameter being studied.
The purpose of a flow cytometric approach to studying 
phenotypic changes, was the possibility of sorting cells 
expressing changes in phenotype following treatment with a 
carcinogen. If such cells could be sorted from the normal 
population and kept viable, a number of functional aspects of 
these cells could be studied and compared with those of normal 
cells. Such investigations were beyond the scope of this study 
however the possibilities will be discussed further, later in 
this Chapter.
7.2 Phenotypic changes which take place during aflatoxin B1 
carcinogenesis and which are potentially capable of examination 
by flow cytometry
A number of phenotypic changes were examined in the 
hepatocytes derived from Fischer rats fed aflatoxin B^ and 
compared with the phenotype of hepatocytes from normal animals. 
For most of the parameters, a model system of two cell lines, one 
a hepatoma derived line - JB1, and the other derived from normal 
liver cells - BL9L, was examined first as it proved to be easier 
to handle, and was considerably less expensive than using freshly 
isolated hepatocytes. In addition, the use of animals for 
research is becoming an increasingly sensitive issue and 
therefore the use of model systems not requiring animal 
involvement is desirable.
Changes in the normal development of polyploid cells in rat 
liver have been previously reported following carcinogenic 
treatment (Gonzalez-Mujica and Mathias, 1972, Neal and Butler, 
1978, Styles et al.. 1985). The effect of aflatoxin B^  ^on the 
development of hepatocyte polyploidy was reported by Neal et al. 
in 1976. This study was conducted by separating nuclei by zonal 
centrifugation and quantitating the numbers of nuclei in the 
fractions obtained. This work was confirmed as reported here, by 
staining nuclei from control and fed animals with a
fluorescent dye which binds stoichiometrically to DNA. Analysis 
of stained nuclei by flow cytometry allowed the relative 
proportions of diploid, tetraploid and octaploid nuclei to be 
quantitated. It was found that when the carcinogen was given to
weanling animals the development of polyploid cells was 
repressed. Adult animals, which had an already established
polyploid cell populations showed a reduction in the percentage
/
of tetraploid cells and a corresponding increase in the diploid 
population, on feeding with the carcinogen.
The development of foci of hepatocytes with elevated levels 
of GGT, has frequently been described following treatment of 
animals with carcinogens for relatively short periods of time 
(Kalengayi et al.. 1975, Cameron et al.. 1978, Manson, 1983).
This could therefore be used as a marker to identify and 
quantitate preneoplastic cells. The GGT content of the two cell 
lines was quantitated, as was GGT in liver from normal and AFI^ 
fed animals. The hepatoma derived cell line, JB1 showed between 
50 and 500 times the GGT content of the cell line derived from 
normal liver - BL9L. The livers from AFB^ fed animals also showed 
several fold increases in GGT following AFB^ treatment for 
relatively short periods of time. Fluorescent tagging of GGT 
positive cells was attempted using fluorogenic substrates to the 
enzyme and also by employing antibodies raised to the enzyme.
It has been suggested that the expression of alkaline 
phosphatase on the surface of liver cells alters during the 
development of neoplasia (Kitagawa, 1971). The alkaline 
phosphatase activity of JB1 and BL9L cells was quantitated, and 
JB1 cells were found to have between 10 and 20 times the enzyme 
activity of BL9L cells. Histochemical staining of liver sections 
from rats fed AFB1 showed a few areas of positive staining cells. 
A fluorogenic substrate for the enzyme was therefore used to 
determine flow cytometrically if differences in alkaline
phosphatase activity in livers from control and AFB^ treated 
animals were detectable.
A trypsin-like enzyme has been reported to be associated 
with a number of cells with migratory ability including a range 
of tumours of differing cellular origin (Steven and Al-Ahmad, 
1983). A number of fluorescent probes to this enzyme, called 
guanidinobenzoatase, have been prepared (Steven et al.. 1985) and 
two of these were employed to determine if this enzyme showed 
acivity in transformed but not in normal liver cells. One of 
these probes, 9-aminoacridine appeared to stain both normal and 
preneoplastic cells in tissue sections, whilst the other probe 
used N«-dansyl-homoarginine, was shown, by flow cytometric 
analysis, to have more specificity for transformed cells.
The resistance of preneoplastic cells to the effects of a 
range of cytotoxic agents has been described by several groups 
(Judah et al.. 1977 Farber, 1979 , Farber 1979, Carr and Laishes, 
1981a, 1981b). One of the drugs which Carr and Laishes (1981a,
1981b) studied in this respect was adriamycin. Adriamycin is a. 
fluorescent compound, and as the degree of resistance to the drug 
appears to be linked to the intracellular content following 
incubation with adriamycin (Inaba and Johnson, 1978, Yanovich and 
Taub, 1983), flow cytometry could be used to distinguish those 
cells resistant to its cytotoxicity. The JB1 cell line has 
previously been shown to be resistant to adriamycin (G.E. Neal, 
personal communication), whereas the BL9L cells are sensitive to 
its effects. Therefore the relative intracellular content of the 
drug following its incubation with the 2 cell lines was 
determined. It was found that at an incubating concentration of
20 pM adriamycin, the BL9L cell contained 5 to 10 times as much 
drug as JB1 cells, and this difference in intracellular content 
could be observed by flow cytometric analysis of these cells. 
Therefore it should be possible to distinguish, flow 
cytometrically, normal from preneoplastic cells following 
incubation with adriamycin.
It has been postulated that the resistance of cells to a 
number of xenobiotics in livers from carcinogen treated animals 
is related to the observed elevation of GGT, glutathione and 
glutathione S-transferases (Smith et al.. 1977, Neal et al..
1981, Ketterer et al.. 1983) in the liver. Cells with elevated 
levels of GGT have also been shown to have elevated glutathione 
(Demi and Oesterle, 1980, Neal et al.. 1981,). The glutathione 
S-transferase content of the two cell lines was quantitated using 
a fluorescent substrate for glutathione - monobromobimane 
(Hulbert and Yakabu, 1983). It was found that JB1 cells had 
approximately twice the reduced glutathione content, and 5 times 
the monobromobimane-utilising GSH-transferase activity of BL9L 
cells. These cells, when stained with monobromobimane, showed 
differing mean fluorescence intensities. Therefore the 
possibility of staining, differentially, certain cells, from the 
livers of AFB^ fed animals using monobromobimane was examined.
Other parameters which could be exploited to allow 
separation of normal and preneoplastic cells were investigated. 
The possibility of raising an antibody to the surface protein of 
JB1 cells which would not cross react with BL9L cell surface 
protein was explored. Also the potential usefulness of a 
monoclonal antibody raised against a JB1 cell protein which seems
to be associated with cellular changes during AFI^ carcinogenesis 
was examined. The proliferative ability of preneoplastic cells 
was also considered as a method of identifing these cells by flow 
cytometric means.
In addition some preliminary studies were conducted as to 
the relationship between transformation with a known oncogenic 
factor and the phenotypic changes which can then be observed.
7.3 An examination of some carcinogen induced phenotypic changes 
using a flow cytometer
(a) Ploidy changes
The first feature of AFB^ carcinogenesis to be examined 
using the flow cytometric technique was the disruption of the 
normal change in ploidy which is a feature of increasing 
maturation in rats. The change in rat liver cell ploidy with age 
is a well documented phenomenon (Carriere, 1969) and the effect 
of feeding AFB1 has been previously reported (Neal et al.. 1976) 
however a different method of quantitating the relative 
proportions of diploid, tetraploid and octaploid cells was used 
in this early study. One of the advantages of using intercalating 
dyes for subsequent flow cytometric analysis of ploidy changes is 
the ability to sample very large numbers of cells or nuclei. The 
results previously published were confirmed. AFB^ treatment of 
young animals disrupts the normal development of polyploid cells 
and causes a reversion of the adult polyploid liver cell pattern 
to a predominantly diploid distribution.
Flow cytometry has been used by several groups to 
investigate the effect of carcinogens on the ploidy of rat or 
mouse liver cells (Steele et al.. 1981, Schwarze et al.■ 1984, 
Styles et al.. 1985). In general the nuclei are isolated from the 
liver cells before staining and analysis. However, a high 
proportion of hepatocytes of normal animals are binucleated - in 
this study around 40% of the liver cells from rats weighing 
approximately 180 g were binucleated. The number of binucleated 
cells has previously been reported to be reduced following a 
hepatocarcinogenic regime (Williams and Watanabe, 1978). No flow 
cytometric investigation has been conducted to establish by how 
much the binucleated population is reduced. Schwarze et al.. 
(1984) describe the use of a complex algorithm to compute the 
numbers of cells in each ploidy group from flow cytometric 
analysis of isolated nuclei, and cellular binucleation. However, 
this is assuming only 20% of the cells to be binucleated (Seglen, 
1973), although the number of binucleate cells is known to vary 
with the age of the animal (Carriere, 1969).
From the results presented in Chapter 3.2, it is possible to 
calculate the percentage of binucleate cells by comparing the 
values obtained when hepatocytes and nuclei are stained for DNA 
and analysed flow cytometrically. There is no necessity in this 
case to include a factor to take into account nuclear or cellular 
aggregation as the protocol DNADISC (appendix 1) allows gating 
and therefore exclusion of doublets of cells. Evidence is 
presented to suggest that AFB^ induces division of binucleates, 
and this contributes to the increase in the diploid population 
observed during feeding with the carcinogen. There is also a
reduction in the tetraploid population, and so the alteration in 
the relative proportions of 2n:4n nuclei is not due solely to an 
increase in the 2n population (Styles et al.. 1985). However, a 
further study would be required to confirm this and to monitor 
the change in binucleation with the progression of the 
carcinogenic regime.
The cause of the change in the proportion of cells in each 
ploidy group as a result of the administration of a carcinogen is 
not known. One group suggested that the reduction in the 
tetraploid population was the result of AFI^ having a selective 
action on the tetraploid cells (Neal et al.. 1976, Godoy et al.. 
1976). It was suggested that this specificity of the cytotoxic 
effect could be due to these mature hepatocytes having a greater 
capacity to metabolise the carcinogen. Other groups have 
suggested the converse, the diploid cells being the target for 
the cytotoxic action of the carcinogen, and division of the 
tetraploid cells resulting in loss of the tetraploid population 
(Steele et al.. 1981, Dirgernes and Elgjo, 1984). Steele et al.
(1981) reported that very few histologically observable mitotic 
figures were observed, and postulated that the tetraploid cells 
are in a state of telophase arrest, and are therefore able to 
undergo rapid cell division in the absence of DNA synthesis. In 
this study, DNA synthesis has been shown to be increased in 
animals fed AFB1 as compared to control animals, however, the 
carcinogenic regime had been administered for considerably longer 
periods of time than that of Steele et al. (1981) who were 
looking at effects on hepatocyte ploidy between 6 and 72 hours 
after administration of CC14> others have suggested that this
zou
return to a predominantly diploid population is another 
manifestation of the liver having undergone a change to the 
foetal state (Styles et al.. 1985), or that selection of cells 
resistant to the cytotoxic effects of the carcinogen results in 
co-selection for diploidy as the drug resistant phenotype is more 
likely to be expressed within the diploid genome (Schwarze
et al.. 1984). This would suggest that both tetraploid and
e
diploid cells would be affected by the cytotoxic effects of the 
carcinogen and only those cells which, by genetic alteration, had 
become resistant to cytotoxicity would continue to proliferate. 
Further studies would be required to establish which of these 
hypotheses is correct. One method would be to stain hepatocytes 
from control and carcinogen fed animals with a vital stain for 
DNA, and then sort the cells by flow cytometry into their 
respective ploidy groupings. Administration of the carcinogen to 
sorted cells in vitro would then allow it to be established 
whether the diploid or tetraploid cells are more sensitive to the 
cytotoxicity of the carcinogen. If the carcinogen resistant 
population, as a result of in vivo administration, is 
predominantly diploid or tetraploid, studies of BudR 
incorporation would allow the determination of the proliferative 
populations following carcinogenic insult.
(b) Enzymic changes
A number of enzymic changes were examined by flow cytometric 
means. The induction of GGT in foci of hepatocytes following
feeding with AFB1 ±s w e U  established (Hanson, 1983). This
induction of GGT positive foci has been observed during treatment 
with a number of dissimilar carcinogens and has therefore been 
suggested as a general marker for rat liver preneoplasia. It was 
not possible to distinguish GGT positive from GGT negative cells 
derived from AFB^ fed animals as fluorogenic substrates for the 
enzyme were being used, and the fluorescent products being 
soluble, were dispersed throughout the suspension medium and 
became associated with the enzyme negative cells. However, the 
mean fluorescence intensity was much greater for cells derived 
from an AFB^ treated animal than those from a control animal.
Two antibodies reported to be specific for GGT were tested 
against liver sections from rats on AFB^ contaminated diet. Both 
antibodies showed faint staining of a few groups of cells, 
however, these were not nearly so numerous or extensive as the 
foci of GGT positive cells demonstrated by histochemical staining 
for the enzyme. This suggests that these antibodies may react 
with certain of the isoenzymes of GGT (Tate and Meister, 1976), 
in which case a subpopulation of GGT positive cells would be 
selected if cells having antibody bound were sorted using the 
flow cytometer. An antibody having less specificity, or a panel 
of antibodies to the various isoenzymes would be required if all 
the GGT positive cells were to be selected. The isoenzymes of GGT 
vary in their sialic acid content (Tate and Meister, 1976, 
Tsuchida et al.. 1979). Studies of the degree of sialation of GGT 
in tissues from normal adult and foetal rats and from carcinogen 
treated animals has shown that malignant tissue, regenerating 
tissue and normal foetal tissue have sialic acid-rich enzyme. 
Normal adult liver and mammary tissue has GGT with a lower sialic
acid content (Jaken and Mason, 1978, Kottgen et al.. 1978). 
However, the sequence of the protein is the same. It is therefore 
surprising that there should be small groups of hepatocytes 
apparently expressing a particular form of the enzyme within the 
liver of a carcinogen fed animal. Differences in the forms of GGT 
found in kidney, foetal liver, adult liver, and preneoplastic 
foci could be explained by their differences in origin and 
induction, but variation in forms of the enzyme within a 
preneoplastic focus is more difficult to account for. As the 
amino acid sequence of the protein does not differ, but the 
variation is in the degree of sialation, there may be some 
alteration in the post-translational processing of the protein, 
varying, perhaps, with the stage of the cell cycle, although only 
a very few liver cells undergo mitosis at any one time, or the 
maturity of the cell. However, if this were the case, the enzyme 
positive cells identified by these antibodies would be expected 
to be scattered throughout the liver section, rather than appear 
in small areas of positive staining cells. Further studies 
involving dual staining of these cells with these antibodies and 
for the other phenotypic markers described above may give greater 
insight into the role of GGT in the carcinogenic process. Some 
groups have suggested that the induction of GGT expression during 
hepatocarcinogenesis is the result of activation of foetal genes 
(Taniguchi et al.. 1975). However, others have disputed this
explanation of induction of the enzyme (Vanderlaan and Phares, 
1981) and suggest that the increase in the proportion of GGT 
positive cells is the result of these being selected as a result 
of administration of the carcinogen. Cells having greater GGT
activity would have greater ability to detoxify carcinogens. This 
is supported by the increased levels of glutathione and 
glutathione S-transferases in cells from carcinogen treated 
animals as demonstrated histochemically (Demi and Oesterle, 1980, 
Neal et al.. 1981, Neal and Green, 1983) and flow cytometrically 
in this report.
Histochemical staining for alkaline phosphatase of sections 
of liver from control and AFB^ fed animals showed positive 
staining of small areas of hepatocytes in the sections from AFB^ 
fed animals. As serial sections were not used it was not possible 
to determine if these positive cells were in areas which also 
stained positively for GGT. However if these cells could be 
stained for both enzymes and then analysed flow cytometrically, 
staining of serial sections would not be necessary. Staining with 
a fluorogenic substrate and subsequent flow cytometric analysis 
did not however, support the histochemical staining. Cells 
derived from control animals had a higher fluorescence intensity 
than those from the AFB^ treated animals. The reasons for these 
contradictory results are not clear. The areas of positively 
stained hepatocytes in liver from AFB1 fed animals were so few 
that it would not have been unexpected if little difference in 
flow cytometric staining was observed between control and 
carcinogen fed animal cells. It would therefore appear that under 
these conditions, the fluorogenic substrate 3-0-methyl 
fluorescein phosphate is reacting with some other enzyme to give 
the fluorescent product. This is not unlikely as the compound has 
been reported to be unstable and its specificity for alkaline 
phosphatase is not confirmed (Watson et al.. 1979).
The presence of a trypsin-like enzyme - guanidinobenzoatase
(Steven and Al-Ahmad, 1983), on the cell membrane of hepatocytes
from animals fed AFB1 or control diet, was examined using 
/
fluorescent probes for the enzyme (Steven et al.. 1985). One of 
these probes Noc-dansyl-homoarginine seemed to stain a population 
of liver cells from AFB1 fed animals to a greater extent than the 
rest of the cells, or cells from a control animal. However, to 
establish if these cells showed other phenotypic changes, it 
would be necessary to stain the cells for another of the markers 
and then analyse flow cytometrically, or sort these cells and 
then establish if they showed other phenotypic changes. As this 
enzyme is apparently associated with migratory cells it may be 
staining tumour cells with metastatic potential. If there is a 
sequential appearance of phenotypic changes this might then be a 
later change than the others discussed above. A further study 
would be required to examine the phenotype of cells derived from 
animals fed AFB^ contaminated diet for increasing periods of 
time.
(c) Changes in systems of detoxification
The increases in GSH and GSH-transferases observed in liver 
cells from animals fed a carcinogenic regime have already been 
mentioned above. Animals on a carcinogenic regime have increased 
glutathione content in the liver (Fiala et al.. 1976) which has 
been demonstrated to be associated with the GGT positive foci in 
the liver (Demi and Oeserle, 1980, Neal et al.. 1981). Neal and 
Green (1983) also showed the levels of GSH-transferase to be
elevated following treatment with AFBj .
Monobromobimane reacts with glutathione to form a 
fluorescent product. This reaction is catalysed by all the 
GSH-transferase isozymes in liver (P.B. Hulbert, personal
communication). Therefore cells which have a greater amount of 
GSH or GSH-transferase activity could be distiguished from cells 
with less glutathione, or enzyme by incubating with
monobromobimane and then measuring their relative fluorescence 
intensities. On staining with monobromobimane, JB1 and BL9L cells 
have different mean fluorescence intensities when analysed flow 
cytometrically, with JB1 cells showing a greater mean 
fluorescence intensity. This was the expected result, as JB1 
cells have a higher glutathione content and also exhibit greater 
GSH-transferase activity. Staining hepatocytes from control and. 
AFB1 fed rats gave in both cases a population of cells staining 
with a higher mean fluorescence intensity. The cells derived from 
the carcinogen fed animal did however, have a greater percentage 
of cells with high mean fluorescence than had control animal
cells. Some variation in the degree of fluorescence of
hepatocytes stained with monobromobimane was to be expected as 
there is some variation in the glutathione content of hepatocytes 
across the liver lobule. To confirm that the increase in the 
number of highly fluorescent cells was a result of feeding with 
the carcinogen and that these cells also have elevated GGT (Neal 
et al.. 1981), it would be necessary to label the cells both for 
GGT and GSH. This would probably be most easily achieved if the 
monobromobimane stained cells were sorted into populations of 
differing mean fluorescence and the GGT content of these cells
then quantitated. The variation in the fluorescence of JB1 cells 
stained with monobromobimane is probably the result of some of 
these cells undergoing phenotypic changes during many rounds of 
subculturing.
Related to increases in the detoxifying enzymes is the 
development of resistance to a number of xenobiotics. The studies 
of Carr and Laishes (1981a, 1981b) showed that treatment of rats 
with the carcinogen 2-AAF induced resistance of some hepatocytes 
to a range of drugs. One of these was the fluorescent drug 
adriamycin, and as resistance to adriamycin has been reported to 
be related to the intracellular content, it seems that this might 
be another method for flow cytometrically identifying the liver 
cells which had undergone transformation as a result of 
carcinogenic insult. When hepatocytes derived from normal and 
AFB^ fed animals, were incubated in adriamycin, and then analysed 
in the flow cytometer, the control animal cells had higher 
fluorescence intensity than did the AFB1 fed animal cells at all 
concentrations of the drug. However, it was expected that two 
separate populations, one with high mean fluorescence and one 
with lower mean fluorescence would be observed amongst the cells 
from the treated animals. These populations would then correspond 
to the normal and AFB^  ^transformed cells. It is unclear why two 
such populations were not obtained. One explanation could be that 
the carcinogen has caused more cells to be resistant to 
adriamycin than to have elevated levels of GGT, Evidence for the 
possibility of the carcinogen exerting its effect on the entire 
hepatocyte population is the difference in of control
animals and animals fed 4ppm AFB^ in the diet for 6 weeks prior
to receiving an acute dose of AFB^. The of these latter
animals was at least 2 to 3 fold higher than that of control 
animals (Judah et al., 1977). If resistance to the cytotoxicity 
is confined to the foci of GGT-positive cells, no overall change 
in the LD5Q would be expected. The increase in suggests that 
there is an increased resistance to the effects of the carcinogen 
in all the cells of the liver. This seems to be reflected in the 
results of the studies of adriamycin uptake where all of the 
cells from the AFB^ fed animal show decreased uptake of the drug. 
There may however, be a quantitative difference between the GGT 
positive and negative cells in the degree of resistance, and 
therefore the uptake of adriamycin. This could be tested by 
double staining techniques or by sorting cells on one parameter 
and then quantitating the other.
(d) Changes in cellular proliferative ability
One of the often used systems for the study of the early 
stages of carcinogenesis is the Solt-Farber system (Solt and 
Farber, 1976). Neoplastic development is normally prolonged 
following exposure to a chemical carcinogen however, this system 
allows the rapid production of nodules of enzyme-altered cells.
The regime consists of three components, an initiator a 
selective growth inhibitor and a growth stimulus. For example 
rats first receive one acute dose of diethylnitrosamine (DEN) and 
2 weeks later are fed 0.02% 2-AAF for one week before being 
subjected to partial hepatectomy. Within 7 to 10 days following 
the operation, nodules 1 to 2 mm in diameter can be observed. The
number of these foci vary with the initial dose of DEN. These 
nodules will then regress, persist or progress to form tumours, 
as is normally seen following long term carcinogen 
administration. The proliferative ability of certain liver cells 
following carcinogen treatment has been studied previously by 
monitoring the simulation of initiated hepatocytes to grow into 
preneoplastic foci (Colurabano et al.. 1981), and by incorporation 
of [*H]thymidine as determined by autoradiography (Bannasch, 
1984). Presented here is additional evidence for the 
proliferation of hepatocytes following exposure to the carcinogen 
AFB^ which involves the use of flow cytometric analysis. Control 
animals and animals on AFB1 contaminated diet were injected with 
bromodeoxyuridine and sections of liver derived from these 
animals were stained for incorporation of the nucleoside with 
anti-BudR antibody. The AFB^ treated rats showed a considerably 
greater degree of BudR incorporation than did the control 
animals. In a future study it would be of interest to determine 
at which stage of the carcinogenic process this proliferation was 
first apparent, by feeding animals with contaminated diet for 
varying lengths of time before BudR injection. Sections stained 
for BudR incorporation could then be compared with serial 
sections stained for GGT to examine if the areas of proliferation 
were localised to the areas of preneoplastic foci. It would not 
be possible to use cells, isolated on the basis of BudR 
incorporation, from the total hepatocyte population for further
sVsll
use in functional studies. The cells cannot be stained and^remain 
viable as they must undergo acid treatment to sufficiently 
denature the DNA to allow penetration and binding of the antibody
to the BudR which has become incorporated into the DNA. However, 
studies of the induction of proliferation with respect to other 
phenotypic changes resulting from treatment with a carcinogen 
could be conducted using this technique.
7.4 Approaches to the use of flow cytometry in future studies of 
carcinogensis
The ease with which antibodies can be used to stain cells 
having a particular antigen, initiated attempts to raise a 
polyclonal antibody to the JB1 cell surface. These attempts were 
not successful although it is not clear if this was due to the 
method of preparation of the antigen, its lack of immunogenicity 
or simply a reduced response of the animal injected. Some studies 
were conducted using polyclonal antibodies reported to be raised 
to GGT (Tsao and Curthoys, 1980, Murphy et al.. 1984). However, 
the results were not as expected as both of these antibodies 
reacted with only a few hepatocytes from livers from AFB1 fed 
animals which showed large areas of GGT positive cells stained 
histochemically, although the bile ducts did give positive 
staining. A monoclonal antibody, MRC TU/J1 (Manson et al.. 1984) 
raised to JB1 cell protein showed some interesting staining 
patterns on tissue sections, and seems to be against an antigen 
whose expression is related in some way to the carcinogenic 
process. It would be of interest to examine some of the other 
phenotypic changes observed following a carcinogenic regime in 
those cells showing high levels of this antigen.
From these various methods for fluorescently tagging cells
which show changed phenotype as a result of treatment with AFB^ 
it is clear that some are more easily applicable to flow 
cytometry than others* Soluble fluorogenic substrates, such as 
those described above for staining GGT and alkaline phosphatase, 
have to be very specific for the particular enzyme to be examined 
and are not useful if the fluorescent product will diffuse into 
or become associated with the membranes of other cells in the 
population. If viable cells are to be required following
staining, it must be possible to achieve adequate separation of 
the two cell populations at levels of the drug or dye which are 
not toxic to the cells. Also if dyes or fluorescent substrates 
are to be used, for instance those used for staining
guanidinobenzoatase and cellular thiols, the difference in 
staining of the normal and changed cells must be great enough to 
determine those cells which are positive for the parameter in
question. If antibodies are to be used, it is necessary to have
an antibody which will bind to a part of the antigen which will 
allow identification of every molecule of that protein, and not 
cross react with others. When using tissue sections, or whole 
cells isolated from a tissue, the antibodies must be able to bind 
to a part of the antigen which is exposed when it is in the 
conformational state found in the membrane. That is, antibodies 
which bind to parts of the molecule normally shielded by the 
sugars of the glycoprotein or to the lipid domain, would not be 
useful. In addition adequate blocking is required when antibodies 
are employed to prevent non-specific binding to other cellular 
components.
The effect of fluorogenic substrates and fluorescent dyes
conjugated to . antibodies must be taken into account if 
functional studies are to be conducted on these cells following 
staining and sorting. The clearance of compounds from cells, or 
the internalisation and breakdown of molecules bound to the cell 
surface may affect the normal pattern of metabolism or protein 
turnover.
To further develop the work presented in this study, it 
would be necessary to stain the cells for several parameters at 
the same time, and therefore determine whether all the phenotypic 
changes occur simultaneously or if there is some sequence of 
early and later alterations to the cell phenotype. In many cases 
this would be technically difficult as the various fluorescent 
probes used require different excitation wavelengths, or their 
emission characteristics overlap. In addition some of the probes 
described are not specific for the parameter to be examined. 
Alternatively cells could be sorted on one parameter alone into 
two groups and the other features could then be examined by 
quantitative assays or histochemical staining of these two 
subpopulations. The separation of hepatocytes into subpopulations 
exhibiting various features of transformation, could then allow 
studies of changes in metabolism of AFB^  ^by these cells (Neal 
et al.. 1981), and changes in metabolism of other cytotoxic 
agents. Other features of transformation could also be examined, 
for instance anchorage-independance, and loss of contact 
inhibition.
One of the most interesting aspects of cell transformation 
is the role of oncogenes and a preliminary study of the 
phenotypic changes induced in an hepatocyte derived cell line by
the ras oncogene are presented here. It would be useful to 
determine if the phenotypically changed cells have an activated 
oncogene, or show elevated levels of a protoncogene. There are an 
increasing number of antibodies to oncogene products being 
produced (Drebin et al.. 1984), and these could be used to
identify those cells having the activated oncogene. For example, 
flow cytometric analysis has been conducted to detect elevated 
c-mvc gene product in tumour tissues from a variety of origins 
(J.V. Watson, personal communication). Phenotypic changes arising 
from the presence of the oncogene in the genome could then be 
examined. The sequence of events following transformation by an 
activated oncogene are not clear. It has been suggested that a 
single point mutation in the base sequence of a cellular
oncogene, leading to an amino acid substitution in the gene 
product, is solely responsible for the transforming potential of 
the oncogene (Reddv et al.. 1983, Yuasa et al.. 1983). However, 
if the phenotypic changes observed were caused by the mutation of 
a single gene, then all of the altered foci should become frank
tumours, and this is not the case. It seems probable that more
than one mutation is required per genome to give a cell
carcinogenic properties. A genetic alteration could cause 
increased GGT and glutathione levels and therefore the cell would 
be resistant to the cytotoxic effects of the carcinogen, a second 
mutational event elsewhere in the genome could confer differences 
in growth control as compared to an unchanged cell. It does not 
seem possible , however, to relate directly the changes in tissue 
in vivo following treatment with a carcinogen, to those observed 
in cells tranformed in vitro with an activated oncogene. There is
invariably a considerable degree of heterogeneity in the cells 
derived from carcinogen fed animals stained for a particular 
phenotypic change, whereas the ras transformed cells tended to 
show only a small degree of heterogeneity when staining with the 
markers used in this study. This difference does not seem to be 
entirely accounted for by contamination with normal cells, and 
therefore some other factor is involved resulting in variation in 
phenotype across the population of preneoplastic cells. It is 
possible that the greater heterogeneity observed in a population 
of normal cells as compared to the epithelial cell line used in 
the transformation studies, may have some influence on the 
phenotype following transformation. To determine if this was the 
case, the transformation of primary hepatocytes in vitro and 
subsequent determination of phenotype should show a similar 
degree of heterogeneity as do those cells derived from carcinogen 
fed animals. If, on the other hand, the heterogeneity becames 
established subsequent to transformation, in vitro transformation 
of primary hepatocytes should show less heterogeneity soon after 
the transformation event, with the population becoming more 
heterogenous.
In this study, flow cytometry has been used to examine 6 
phenotypic changes recognised to be involved in liver 
carcinogenesis. These were studied in isolation, however in 
future work it should be possible to use the conditions described 
above to determine which changes appear at certain times during 
carcinogenesis, and why foci of differing cellular phenotype can 
be observed in rat liver following carcinogen administration 
(Peraino et al). In addition, there are a large number of
phenotypic changes which could be examined, for example changes 
in a-fetoprotein (Onoe et al.. 1975) and aldehyde dehydrogenase 
activity (Jones et al.. 1984), if suitable substrates or 
antibodies were available. The use of lectins as markers for rat 
liver neoplasia (W.B. Butler, personal communication) may also be 
useful for flow cytometric studies. Such studies should give 
greater understanding of the cellular processes following the 
transformation event or events, and since the factors which 
control normal cell growth are also those involved during the 
carcinogenic process (Bishop, 1982), methods of identifying 
preneoplastic cells by phenotypic changes may be particularly 
important for therapy of the disease.
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Appendix 1 PROTOCOL DNADISC
10 REM HIST/LIST PROTOCOL DNADISC: DNA ANALYSIS (USING PROPIDIUM
20 REM IODIDE) W/DOUBLET DISCRIMINATION
30 REM X1=PMT2, AREA (RED FLUORESCENCE)=H1
40 REM Y1=PMT2, PEAK (RED FLUORESCENCE)=H2
50 REM Y2=PMT3, PEAK (FORWARD SCATTER)=H3
60 GET HI FROM P0RT1
70 GET H2 FROM P0RT2
80 GET H3 FROM P0RT3
90 LIST H1,H2,H3
100 LET P1=PAIR(H2,HI)
110 LET P2=PAIR(H3,H1)
120 HIST H1,H3,H4,P1,P2 
130 LET Z1=H1
140 IF REG 1 OF PI THEN HIST Z1 
150 LABEL HI WITH 'RED-FL,AREA'
160 LABEL H2 WITH 'RED-FL,PEAK#
170 LABEL H3 WITH 'FORWARD SCATTER'
180 LABEL PI WITH 'RED-FL,PEAK/Y VS AREA/X'
190 LABEL P2 WITH 'FWDSC/Y VS RDFL(AREA)/X'
200 LABEL Z1 WITH 'DNA-FL, VI/O DOUBLETS'
999 END
Appendix 2 PROTOCOL DNRSTUDY
10 REM DNRSTUDY
t
20 REM FWD SC VS FLUORESCENCE 
30 GET A1 FROM P0RT1/FLUORESCENCE 
40 GET A2 FROM P0RT3 /FWD. SCAT 
50 P1=PAIR A2,A1 
60 HIST Al,A2>PI 
70 LIST A1,A2
80 LABEL Al WITH 'FLUORESCENCE'
90 LABEL A2 WITH 'FWD.SCAT'
100 LABEL PI WITH 'FLU V FWD.SCAT'
110 IF NOT REG 1 OF Al THEN GO TO 999 
120 LET B2=A2 
130 HIST B2
140 LABEL B2 WITH 'FL REG 1 FWD.SCAT'
Appendix 3 PROTOCOL THREEPTDIF
10 REM HIST/LIST PROTOCOL THREEPTDIF: 3 PT DIFF W/ GATE FOR
20 REM IMMUNOFLUORESCENCE
30 REM X1=PMT2 (90' SCATTER)=HI
40 REM Y1=PMT3 (FORWARD SCATTER)=H2
50 REM X2=PMT1 (GREEN FLUORESCENCE)=H3
60 GET HI FROM P0RT1 /GET 90' SCATTER RAW PARAMETER
70 GET H2 FROM P0RT3 /GET FWD-SC RAW PARAMETER
80 GET H3 FROM P0RT2 /GET GRN-FL RAW PARAMETER
90 LIST H1,H2,H3
100 LET G1=H3
110 LET P1=PAIR(H2,H1)
120 HIST H1,H2,H3,P1
130 IF REG 1 OF PI THEN HIST G1
140 LABEL HI WITH '90' SCATTER'
150 LABEL H2 WITH 'FORWARD SCATTER'
160 LABEL H3 WITH 'GREEN FLUORESCENCE'
170 LABEL G1 WITH 'GRN-FL, REG1 OF PI'
180 LABEL PI WITH 'FWD-SC/Y VS 90'-SC/X'
999 END
Appendix 4 PROTOCOL MARKERS
10 REM MARKERS
20 GET Al FROM P0RT1 /FLUORESCENCE
30 GET A2 FROM P0RT3 /FWD.SCAT
40 P1=PAIR A2.A1
50 HIST Al,A2,P1
60 LOST A1,A2
62 LET B1=A1
64 LET B2=A1
66 IF REG 1 OF PI THEN HIST B1
68 IF REG 2 OF PI THEN HIST B2
69 HIST B1
70 LABEL Al WITH 'FLUORESCENCE'
80 LABEL A2 WITH 'FWD.SCAT'
90 LABEL PI WITH 'FLU V FWD.SCT'
92 LABEL B1 WITH 'FLU OF REG 1'
93 LABEL B2 WITH 'FLU OF REG 2'
94 LET G1=A2 
96 LET G2=A2
100 IF REG 1 OF PI THEN HIST G1 
105 IF REG 2 OF PI THEN HIST G2 
120 HIST G1,G2
130 LABEL G1 WITH 'FWD SCT OF REG 1' 
140 LABEL G2 WITH 'FWD SCT OF REG 2' 
999 END
Appendix 5 PROTOCOL ABDNA2
10 REM ABDNA2
20 REM BRDU INCORP IN S
30 GET HI FROM P0RT1 DNA FL. PEAK
40 GET H2 FROM P0RT2 DNA FL. AREA
50 GET H3 FROM P0RT4 ANTIBODY FL.
60 GET H4 FROM P0RT3 FWD. SCAT.
70 LIST H1,H2,H3,H4 
80 HIST H3,H4
90 IF NOT REG 1 OF H4 THEN GOTO 999 
100 P1=PAIR(H1,H2)
110 HIST PI 
120 G1=H2 
130 A2=H3 
140 A3=H3
150 IF NOT REG 1 OF PI THEN GOTO 999 
160 P2=PAIR(H3,H2)
170 HIST P2,G1 
180 LET Q1=G1 
190 LET Q2=G1 
200 LET Q3=G1
210 IF REG 1 OF P2 THEN HIST Q1
220 IF REG 2 OF P2 THEN HIST Q2
230 IF REG 3 OF P2 THEN HIST Q3
240 IF REG 2 OF PI THEN HIST A2
250 IF REG 3 OF PI THEN HIST A3
260 LABEL PI WITH 'DNA PEAK X VS AREA Y'
270 LABEL H4 WITH 'FORWARD SCATTER'
280 LABEL H3 WITH 'ANTIBODY FLOURESCENCE'
/
290 LABEL P2 WITH 'AB FL. Y:DNA FL.X'
300 LABEL A2 WITH 'AB FL.REG 2 OF PI'
310 LABEL A3 WITH 'AB FL.REG 3 OF PI'
320 LABEL G1 WITH 'DNA(AREA) W/0 DOUBLETS'
330 LABEL Q1 WITH 'DNA(AREA) OF REG 1 OF P2
340 LABEL Q2 WITH 'DNA(AREA) OF REG 2 OF P2
350 LABEL Q3 WITH 'DNA(AREA) OF REG 3 OF P2
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Som e toxicological and hepatocarcinogenic studies using a 
cytofluorograph and its associated  com puter facility
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Toxicology U nit, M edical Research Council Laboratories,
W oodm ansterne Road, C arshalton, Surrey  SM 5 4E F, U K
1. Introduction
Biochemical changes in tissues w hich occur as a result of a toxic insult often 
are restricted , at least initially, to a lim ited num ber of cells w ithin the target 
organ. In  the case of acute toxicides, this situation m ay be followed rapidly by the 
involvem ent of an increasing num ber of cells. How ever, in the case of m any 
chronic toxicides, including chem ical carcinogenesis, the num ber of cells affected 
m ay rem ain small for a very considerable period of tim e. Therefore, if one is 
studying  the m echanism  of a particular chronic toxicity, the initial response, 
w hich is probably of the greatest in terest, presents considerable practical p ro b ­
lem s. M any conventional biochem ical analyses require samples of a size w hich 
m akes the detection of changes in a small p roportion  of the cells difficult. A large 
change in a small num ber of cells may be lost in the variation of the assays. Even 
if a change is m easurable, then in the absence of o ther data, it is im possible to 
decide if it is the result of a small change in a large num ber of cells or a large 
change in small num ber of cells. I t is in this area tha t flow cytom etry can play an 
im portan t role. T h is form  of analysis has two m ajor requirem ents:
(a) single-cell suspensions; and
(b) a fluorochrom e whose cellular location is related to the biochem ical p a r­
am eter of interest.
If the tissue under consideration already consists of separate cells or can 
readily be dispersed into cell suspensions, then flow cytom etric techniques can be 
directly  applied. How ever, m any of the toxicological changes of interest, e.g. 
those induced in the liver, are dispersed th roughou t a solid tissue and therefore 
do not allow any flow cytom etric techniques to be applied directly. Recently, the 
advent of tissue dispersal techniques, such as the perfusion of the liver w ith col- 
lagenase solutions yielding suspensions of single cells, has facilitated the analysis 
and  subsequent separation of sub-populations of cells p resen t in such tissues by 
flow cytom etry.
Paralleling the developm ent of these cell-isolation techniques there  has also 
been an increasing developm ent of m ore sensitive enzym atic assays, some of the 
m ost sensitive of w hich are fluorim etric. In  the usual system , the activity of the 
enzym e under consideration form s a fluorescent p roduct from  a non-fluorescent 
substrate. F luorescent probes have been developed for a range of m acrom olecules 
w hich take advantage of interactions betw een m onoclonal or polyclonal antibody 
and cellular antigen. T h e  serum  location of the m acrom olecular antigen is
A b b r e v i a t i o n s :  G G T , y-glutamyltransferase; A FB 1( Aflatoxin B t ; GAM C, L-y-glutam yl-7-am ino- 
4-m ethylcoumarin.
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detected by the attachm ent of fluorescent groupings to the antibody. F luorescent 
reagents are also available w hich attach  to m acrom olecules w ith in  the cells by 
o ther m echanism s, e.g. the intercalative b ind ing  of prop id ium  iodide or e th id ium  
brom ide into D N A .
T hese developm ents, together w ith the increasing sophistication of the flow 
cytom eters them selves, have greatly assisted the usage of these techniques in toxi­
cological studies. In  our studies we have used the O rtho  Cytofluorograph.
2. F low  cytom etry
In  the cytofluorograph the individual cells, p resen t in dispersed cell suspen­
sion (or o ther particles, e.g. isolated nuclei) are caused to pass in single file 
th rough  an optical flow cell. W hile traversing this cell they are illum inated by a 
laser beam . T h e  laser light is scattered as a result. I f  a fluorochrom e capable of 
being excited at the wavelength of the laser light is p resen t on or in the cell, a 
fluorescent signal is also generated. T h e  scattered or fluorescent light is collected 
in photom ultip lier tubes via fibre optic receptors placed at certain  specific angles 
to the flow cell. Pulses generated in the pho tom ultip lier tubes are proportional to 
the collected light, and these are fed into the associated com puter, w hich collects 
and analyses the data. T h e  cytofluorograph therefore collects discrete data from  
individual cells and there is no ‘averaging’ of the param eter being estim ated 
w hich, as already referred to, is a factor of conventional biochem ical assays. I t  can 
therefore detect and quantitate changes occurring in a com paratively small p ro ­
portion  of cells w hich occur scattered th roughou t a tissue. T h e  very rapid accu­
m ulation of data and its subsequent analysis requires the associated com puter 
facility.
Besides analysis, the cytofluorograph has the capacity to sort the cells into 
th ree samples on the basis of, for exam ple, different levels of fluorescence. T h e  
extrem ely short passage tim e betw een the m onitoring of the individual cells and 
the carrying out of the sort decision also requires the presence of an efficient 
com puter control. T h e  enriched fractions of separated cells are then  available for 
fu rth e r biochem ical or physiological studies. I t  is obviously im portan t to ensure, 
if a tissue dispersal technique is used to obtain isolated cells, tha t the cells present 
in the isolate represent the proportions of those presen t in the original tissue.
3. E xperim ental use o f cytofluorograph
T h e  studies w hich we have com m enced using the O rtho  C ytofluorograph are 
concerned w ith the early changes in chem ical hepatocarcinogenesis. T h e  carcino­
gen used is the naturally  occurring  m y cotoxin aflatoxin B x. T h is  m aterial results 
from  the contam ination of stored foodstuffs, particularly  groundnuts, w ith the 
m ould  Aspergillus flavus  [1]. I t has been im plicated as a causal factor in the high 
level of prim ary liver cancer w hich occurs in certain parts of the th ird  world 
[2, 3], and also in toxicities in dom estic anim als fed contam inated protein  supple­
m ents in developed countries [4, 5].
T h e  m odel system  used in these studies is the rat, and the data given in table 1 
shows tha t a six week feeding w ith 4 p .p .m . aflatoxin Bj in the diet causes a 
subsequent high incidence of liver cancer. Clearly the irreversible change associ­
ated w ith carcinogenesis occurs after 3-4  weeks feeding w ith the carcinogen. 
Som e studies in the literature have indicated tha t the hepatocarcinogenic proces
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T able 1. Incidence of hepatic carcinoma in male Fischer rats 80 weeks after feeding diet containing 
4 p.p.m . aflatoxin B t for various periods of time as weanlings.
Duration of toxic feeding 
(weeks) Liver tum our incidence
1 ■ 0/15
2 0/15
3 1/15
4 8/15
5 17/20
6 19/20
in the rat is accom panied by an effect on nuclear ploidy of hepatocytes. T h e  
reasons for this are not fully understood  [6, 7].
W e have exam ined the hepatic nuclear ploidy changes occurring du ring  an 
hepatocarcinogenic feeding w ith low levels of aflatoxin using the cy to­
fluorograph, T here  was a m ajor effect of feeding w ith the toxin on the balance 
betw een diploid and tetraploid  cell populations of hepatocytes. T h e  developm ent 
of the predom inantly  tetraploid  cell population  occurs norm ally at the tim e of 
m aturation . I f  the experim ents were carried ou t com m encing w ith w eanling rats, 
p rio r to the developm ent of a tetraploid  hepatocyte population, then the develop­
m en t of the polyploid population was largely prevented (figure 1). If  the feeding 
w ith  the toxin was carried out using adult anim als, w hen a tetraploid  population  
of hepatocytes had already developed, then the size of th a t population was 
reduced (figure 2). T h is  therefore appears to be a selective toxic action of the 
aflatoxin B 1on a sub-population  of cells, nam ely the tetraploid  hepatocytes.
In terestingly , this response is also seen following the adm inistration  of m any 
hepatocarcinogens to the rat [6, 7, 8]. T h e  basis of this very in teresting ploidy 
change appears to be w orth  fu rther study. I t  has been proposed that the loss of 
the te trap lo id  population is a result of selective necrosis of these cells, since the 
induced loss of these cells often coincides w ith the period w hen feeding w ith  the 
toxin produces w idespread necrosis [9]. H ow ever, this does not appear to  be the 
en tire  explanation, since continued very low level feeding w ith a toxin can even­
tually  induce the ploidy change in the absence of overt necrosis. A lso, the 
decrease in the tetraploid  population is seen using carcinogenic toxins th a t are 
cen trilobular necrosing agents sim ilar to the effect observed w ith  aflatoxin B 1? 
w hich is a periportal necrosing agent. I t  does not therefore appear tha t the  selec­
tive loss of the tetraploid  population is associated w ith a specific necrosis of those 
cells.
If  one views the original developm ent of the tetraploid  population  as being 
due to a block in G2, then the effect of the toxin could be to release th a t block 
allowing the tetraploid  cells to recycle into the diploid status. Some evidence has 
been produced supporting  this theory [10]. T h e  im plication of such a reductive 
division in the presence of the carcinogen in term s of producing a perm anen t 
change in the genom e appears w orthy of fu rther exam ination.
T h e  cytofluorograph could be utilized in such studies to separate the d ip loid  
and tetraploid  hepatocytes in order to exam ine the basis for the ir differing sensiti­
vities to carcinogens, bu t this would require a fluorescent probe o ther than  the 
in tercalating fluorochrom es propid ium  iodide and eth id ium  brom ide, w hich can
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Figure 1. Changes in rat liver ploidy determined by cytofluorography with increasing age in control 
and A FBj-fed weanling rats, (a) Control fed male Fischer F344 rats. Days refer to age of rats; 
(b) Rats fed 4 p.p.m . A FB t in diet from age 21 days. ® — D iploid; H —Tetraploid; 
□ — Octaploid. Samples analysed after isolation of cells by collagenase perfusion followed by 
release of nuclei in 0-1% triton/0-1 % sodium citrate followed by brief ultrasonication and 
staining with 0-005% ethidium  bromide. Excitation 488 nm. Emission 630 nm  long pass filter.
not be used w ith intact viable cells. W ork is in progress on this subject using the 
H oechst vital D N A  stains.
A t the tim e when the continued feeding w ith low levels of aflatoxin B x induce 
the irreversible com m itm ent of some hepatic cells to form  carcinom as (table 1), 
there is the appearance of focal lesions consisting of cells w ith changed levels of 
certain  enzymes w hich can be dem onstrated  histochem ically. O ne of these 
enzym es is y-glutam yltransferase (G G T ) whose activity, although present in 
foetal and neonate liver is virtually absent from  the adult liver apart from  the bile 
duct cells. T h e  G G T  levels are elevated in m any of the pre-neoplastic foci and 
also in the eventual carcinom as. T h e  cytofluorograph could be used to quantitate
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Figure 2. Changes in rat liver ploidy determined by cytofluorography with increasing time of 
feeding with AFBj in young adult rats. Experimental feeding commenced age 10 weeks and 
continued for 10 weeks. Control feedings are indicated. Symbols as in figure 1.
the appearance .o f cells possessing elevated levels of this enzym e activity as a 
result of feeding with the carcinogen, providing appropriate fluorescent probes 
are available. As pointed out earlier, two approaches to this problem  are possib le :
(a) fluorescently tagged an tibod ies; and
(b) fluorogenic enzym atic substrates.
W e are engaged in developing the necessary antibodies to G G T  to exploit the 
first approach, b u t in the m eantim e have investigated the possibility of using a 
fluorogenic substrate [11]. W e have developed a cell line from  an aflatoxin- 
induced liver tum our w hich is positive for G G T  and an epithelial cell line from  a 
norm al liver w hich is negative for G G T . U sing these two cell lines it is possible 
to dem onstrate the feasibility of the second approach, since it is possible, using 
the fluorogenic substrate for G G T , G A M C , to d istinguish betw een the G G T - 
positive and G G T -negative cell lines in the cytofluorograph (figure 3). T h e  
advantage of this probe over the use of antibodies to quantita te  and subsequently  
sort these sub-populations would be its reversible nature, providing largely 
unchanged cells. Both of these approaches are under active investigation.
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Figure 3. D istribution of G G T  amongst G G T-positive (JB1) and G G T-negative (BL8L) cell lines 
assayed by flow cytometry. Cells detached from monolayer culture by trypsinization and incu­
bated in GAM C +  glycylglycine. Cells analysed using 20 m M  337 + 356 nm  excitation and 
emission analysed at 475-510 nm. (a) BL8L cells; (b) JB1 cells.
O ne fu rther feature of the changed sub-population of G G T -positive  cells, 
w hich em erges at the tim e of the irreversible com m itm ent to developm ent of 
neoplasia, is their resistance to the cytotoxic action of the chem otherapeutic agent 
adriam ycin [12]. T h is  is of practical im portance since this d rug  is used to treat a 
wide range of carcinom as in m an. T h e  drug is highly fluorescent, and the resist­
ance to its action is paralleled by a decreased content of the d rug  in the cells. T he  
cell lines already referred to in figure 3, w hich are positive and negative for 
G G T , are also resistant and sensitive respectively to adriam ycin, thus again 
parallelling the in vivo  differences between pre-neoplastic and ‘norm al’ liver 
tissues. U sing the adriam ycin resistant and sensitive cell lines in the presence of 
adriam ycin, it is possible to d istinguish these populations in the cytofluorograph 
(figure 4). A pplication of this probe to the cytofluorograph should therefore 
facilitate study  of the developm ent of this resistance and possibly its m echanism . 
T h e  drug, although it presum ably affects tum our grow th by reacting w ith D N A , 
inh ib iting  replication, nevertheless does have a cytotoxic action as d istinct from  
this [13]. I t  has been suggested that this action takes place at the cell surface, and 
we are carrying out studies in w hich the cell surface proteins are m odified to 
determ ine the effect of these changes on the uptake of adriam ycin into the cell.
In  sum m ary, the availability of techniques for the preparation  of isolated cell 
suspensions and the increasing num ber of biochem ical fluorescent probes are 
likely to lead to an increasing use of the cytofluorograph’ as a pow erful tool in 
toxicological and carcinogenic studies.
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F ig u r e  4. D if fe ren t i a l  in te rc e l lu la r  c o n te n t  o f  a d r ia m y c in  in a d r ia m y c in  sens i t ive  a n d  re s i s t a n t  cell 
lines. Cel l s am p les  i n c u b a te d  w ith  10 / iM  a d r ia m y c in  for  3 h p r io r  to analysis  in c y t o ­
f lu o ro g ra p h .  (a) A d r i a m y c in - r e s i s t a n t  (JB1) cell l ine ;  (b ) a d r ia m y c in - s e n s i t iv e  ( B L 8 L )  cell line. 
E x c i ta t io n  488 n m .  E m iss io n  500 n m  lo ng  pass  filter.
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